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ABSTRACT 
It is estimated that currently more than 382 million people are living with 
diabetes worldwide. Up to half of the people with diabetes are also affected 
by diabetic neuropathy as the most common complication of diabetes. 
Diabetic peripheral neuropathy (DPN) which begins with symptoms such as 
burning pain, tingling and numbness of the lower extremities, is the main 
factor predisposing diabetic patients to ulceration and subsequently to 
amputation. Other than glycaemic control and pain management, there is no 
effective therapy to prevent the DPN or halt its progression. Proper detection 
and management of DPN can improve quality of life and prevent morbidity 
and mortality of these patients. Limitations of conventional measures of 
neuropathy prompted the search for simple, rapid and non-invasive markers 
for screening, diagnosis and follow-up of DPN. 
While quantification of the corneal subbasal nerve plexus (SNP) using 
corneal confocal microscopy (CCM) has been shown to be a promising 
marker for detection and stratification of DPN in several studies over the past 
decade, no data is available concerning the natural course of changes to this 
nerve plexus in health or diabetes. Furthermore, there is uncertainty as to 
whether age influences the SNP. 
Prior to utilizing the SNP morphometric parameters in the longitudinal context 
to investigate these research gaps, two important studies were conducted 
relating to methodological development. The first experiment provided 
information in respect to employment of an automated algorithm for 
quantification of corneal nerve morphology and the suitability of using this 
technique in diabetic individuals without and with neuropathy compared with 
manual and semi-automated methods. In the second experiment, the 
repeatability of CCM in combination with automated analysis has been 
examined in a cohort of diabetic and healthy individuals, in which corneal 
nerve fibre length was found to be the most repeatable and reliable SNP 
morphometric parameter. Having addressed these two main methodological 
issues, application of corneal confocal microscopy combined with automated 
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image analysis in a cohort of healthy participants without diabetes or 
neuropathy revealed the effect of age on central corneal nerve morphology 
as well as the stability of this nerve plexus over three years using longitudinal 
data. Finally, the natural history of three main SNP structural parameters in a 
cohort of diabetic individuals with and without DPN was assessed and the 
longitudinal relationship between these parameters and established 
measures of neuropathy was determined. Corneal nerve fibre density 
decreased over time in DPN group compared to controls. Moreover, the SNP 
parameters found to be associated with some neuropathy measures. Overall, 
this study demonstrated stability of corneal nerve morphology in the healthy 
state and dynamic small fibre damage at the SNP associated with DPN, thus 
providing justification for ongoing efforts to establish corneal nerve 
morphology as an appropriate adjunct to conventional measures of DPN. 
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CHAPTER 1. INTRODUCTION 
1.1 Foreword 
In this chapter, diabetic peripheral neuropathy (DPN) as one of the most 
common complications of diabetes is briefly introduced. The significance of 
this body of work is then reviewed, followed by the aims and the research 
questions. An outline of the design is presented and the structure of the 
thesis is outlined. This chapter concludes with the candidate’s contribution 
towards this research project and to the LANDMark study. 
1.2 Background 
Diabetes is one of the most common diseases, with an estimate of 382 
million people living with this complex condition worldwide (International 
Diabetes Federation, 2013). This disease can lead to serious complications 
including nephropathy, retinopathy and neuropathy. Diabetes can cause a 
wide variety of nervous system problems among which DPN is one of the 
most important complications (Chin & Rubin, 2010). DPN is the most 
commonly encountered form of neuropathies and imposes significant public 
health burdens. Up to half of patients with diabetes have neuropathy (Boulton 
et al., 2004b) which leads to numbness, tingling, pain or weakness and 
typically begin in lower extremities and may progress proximally. Lack of 
awareness of foot injury may lead to foot ulcers which in advanced stages 
can result in lower limb amputation (Tesfaye, 2007). 
While poor glycaemic control is considered as the main risk factor for 
developing DPN, several studies have shown that other risk factors such as 
duration of diabetes, hypertension, hyperlipidaemia, obesity and smoking are 
involved as well (Tesfaye & Selvarajah, 2012). Studies investigating the 
natural history of neuropathy in diabetes mostly show a gradual worsening of 
DPN over time, despite differences between studies in the tests for 
neuropathy assessment (see section 2.2.1 Natural history of DPN). Although 
various aetiologies have been suggested, the precise pathogenesis 
responsible for loss and damage of nerve fibre underlying clinical DPN 
2 
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remains controversial and may involve direct metabolic compromise and 
microvascular ischemia (Tesfaye & Selvarajah, 2012). 
Other than glycaemic control, there is no effective therapy to prevent DPN 
(Callaghan et al., 2012b); however there are modifiable risk factors that have 
an important role in developing and worsening of DPN (Tesfaye et al., 2005). 
Accurate detection and management of complications can improve quality of 
life and prevent morbidity and mortality of these patients. Furthermore, lack 
of an early biomarker for nerve changes in diabetic neuropathy is one of the 
most important impediments of pharmacologic intervention in clinical 
research (Malik, 2014a; Ziegler & Luff, 2002). 
The development of a simple, non-invasive method for screening, diagnosis 
and follow-up of DPN has been explored because conventional techniques 
for assessment of diabetic neuropathy including nerve and skin biopsy, 
quantitative sensory tests (QST) and nerve conduction studies (NCS) are 
invasive, uncomfortable, expensive, unable to detect small fibre damage and 
repair or require highly specialised medical expertise and equipment 
(Skljarevski & Malik, 2007). Therefore, the establishment of an appropriate 
surrogate marker for DPN which can identify patients at risk and prompt more 
intense intervention including improved glycaemic, blood pressure and lipid 
control is crucial. Furthermore, a sensitive surrogate marker would 
significantly pave the way for development of effective disease-modifying 
therapeutics. As the most innervated tissue in the body (Müller et al., 1997) 
and being directly assessable to inspection using light, the cornea became a 
natural target for this purpose. 
1.3 Significance of the study 
Structural analysis of the corneal subbasal nerve plexus (SNP) using 
confocal microscopy (CCM) has been introduced as useful measure for 
assessing DPN. Several studies have suggested that this potential corneal 
measure can be used to monitor, non-invasively and cost-effectively, the 
progression of DPN and the effects of any clinical/therapeutic interventions 
(Ahmed et al., 2012; Hertz et al., 2011; Malik et al., 2003; Mehra et al., 2007; 
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Midena et al., 2006; Pritchard et al., 2011; Rosenberg et al., 2000; Tavakoli 
et al., 2010b). Hence, by identifying abnormalities in corneal nerve 
morphology, CCM might help clinicians to detect neuropathy more easily, 
and by repeat examination assess the benefits of interventions, such as 
improved glycaemic control and treating conventional vascular risk factors. 
Given the promising role of corneal nerve structure in screening and 
assessment of DPN, in the current literature there is no general agreement in 
regards to the effect of age on the SNP. Additionally, to date, no data exists 
on longitudinal changes in corneal morphology, either in the healthy eye or in 
neurological dysfunction. Moreover, a longitudinal study was required to 
support the cross-sectional studies that demonstrated the capability of CCM 
for detection and evaluation of DPN. 
This study focuses on the temporal changes of the corneal nerve 
microstructure and neuropathy measures in healthy individuals and 
participants with type 1 diabetes. The reason for including this type of 
diabetic participants (and not participants with type 2 diabetes) is that the 
underlying mechanisms in these two main types of diabetes are different and 
the pathogenesis of nerve damages may be differently influenced by 
metabolic factors in type 1 and type 2 diabetic patients (Kasalova et al., 
2006). Furthermore, evidence exists that these patients are prone to develop 
neuropathic changes sooner than type 2 diabetic patients (Kamiya et al., 
2005; Kasalova, et al., 2006). 
1.4 Aims of the study 
To date various methods have been developed and introduced to quantify 
corneal nerve parameters from CCM images. The first purpose of this 
research project was to assess the extent to which a newly developed fully 
automated method of SNP morphometric analysis agrees with two manual 
and semiautomated methods, which was essential particularly for this 
longitudinal study with repeated measurements over time where multiple 
images per participants needed to be analysed. The second aim was to 
explore the age-dependent alterations and the natural history of SNP 
morphology in healthy state. This would provide more information about the 
4 
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dynamic changes of this nerve plexus which has applications not only in 
respect to its utility in assessing DPN, but also in various ocular and systemic 
conditions. The third aim of this study was to investigate longitudinal changes 
in corneal nerve morphology in type 1 diabetic participants with and without 
neuropathy. Additionally, the relationship of this non-invasive corneal 
measure with conventional measures of neuropathy was examined and 
important risk factors associated with small nerve fibre damage has been 
addressed. 
1.5 Research questions 
From the main aims of this study, the following main research questions were 
derived: 
1. How does the fully automated method of SNP analysis agree with 
manual and semiautomated techniques in terms of SNP parameter 
quantification and detection capability in a cohort of healthy controls 
and diabetic individuals with and without neuropathy? 
2. Is SNP influenced by age and what is the behaviour of this nerve 
plexus over time in healthy state? 
3. What is the natural history of SNP in diabetic individuals? Is this 
different in diabetic people with and without neuropathy vs. healthy 
individuals? 
4. Is there any relationship between longitudinal changes in corneal 
nerve structure and conventional measures of neuropathy? 
1.6 Hypotheses 
The following specific hypotheses were tested in this study: 
1. Automated quantification of corneal nerve parameters provides 
comparable neuropathy detection ability to manual and 
semiautomated methods. 
2. CCM is able to detect the age-dependent alterations of SNP 
morphology in healthy individuals. 
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3. Temporal changes of the SNP are different in diabetic participants with 
and without DPN. 
4. Changes in corneal nerve structure relates to traditional measure of 
DPN. 
1.7 Structure of the thesis  
This thesis is presented for the PhD by publication and comprised of a series 
of cross-sectional and longitudinal studies to address the research questions. 
The overall structure of this thesis takes the form of eight chapters, including 
this introductory chapter. In Chapter 2, the literature relevant to the study is 
reviewed. This chapter begins with an introduction to diabetes and DPN, 
followed by a detailed review of corneal nerve morphology as potential 
measure of DPN. The third chapter presents the findings of the comparison 
study of the three quantification methods for SNP morphometric analysis, 
and has been published in the journal Cornea. Chapter 4 examines 
intraobserver repeatability and interobserver reproducibility of the SNP 
parameters quantification and serves as a linkage between chapters 3 and 5. 
The longitudinal nature of the study necessitated conducting interobserver 
and intraobserver repeatability study concerning corneal nerve morphology, 
which is important when measurements are repeated over time to detect real 
changes with some confidence levels, if there is any change. 
Chapter 5 presents the baseline characteristics of the participants in this 
longitudinal study. Data presented here is a part of data used to form a paper 
entitled “Longitudinal assessment of neuropathy in type 1 diabetes using 
novel ophthalmic markers (LANDMark): Study design and baseline 
characteristics” which has been published in the Diabetes Research and 
Clinical Practice journal. Chapter 6 explores the longitudinal assessment of 
corneal nerve structure over time and also highlights the effect of age on 
SNP morphology in healthy individuals. This is essentially basis of a paper 
which was published in the journal Investigative Ophthalmology and Visual 
Science. Chapter 7 examines the natural history of corneal nerve parameters 
in diabetic individuals with and without neuropathy and also explores the 
longitudinal relationship between potential corneal measures and the 
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traditional measures of DPN. This chapter encompasses a paper that has 
been published in the journal Investigative Ophthalmology and Visual 
Science. Finally, the last chapter (Chapter 8) gives a brief summary with a 
reflection on how effectively the research aims have been addressed. 
A list of references cited in this work is presented following Chapter 8 in APA 
style. Appendices included in this thesis are Acknowledgement of Joint 
Authors and Verification of Permissions, Human Ethics Approval Certificate 
and Participant Information and Consent Form. 
1.8 Candidate’s contribution to this research project and to the 
LANDMark study 
The studies included in this PhD thesis are associated with the existing 
database of the LANDMark study (Longitudinal Assessment of Neuropathy in 
Diabetes using novel ophthalmic MARKers) (Pritchard et al., 2014) which is a 
two-site four-year longitudinal observational study. The LANDMark study is a 
broad area of research that employed corneal confocal microscopy (CCM), 
non-contact corneal aesthesiometry, optical coherence tomography and 
visual field perimetry to investigate peripheral nerve morphology and function 
in individuals with type 1 and type 2 diabetes as well as control participants. 
The Brisbane site has completed the four-year longitudinal study in July 
2014; however, the Manchester site still is in progress and is scheduled to 
finish this year. 
This PhD project focused specifically on the utility of CCM for investigating 
longitudinal changes of corneal nerve morphology and comparison with 
conventional tests of neuropathy in healthy controls and type 1 diabetic 
individuals with and without DPN. Participant enrolment of the two study 
groups (controls and type 1 diabetes) began in late 2009 in LANDMark study 
and recruitment continued until November 2011. The candidate joined the 
LANDMark team and commenced his PhD in February 2012. By adhering to 
his defined role and understanding the end goals of the LANDMark project, 
the candidate pursued his specific research aims and actively helped the 
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team to accomplish its goals. As a member of the LANDMark research team, 
the candidate’s contribution involved:  
• Conducting ophthalmic examination for about 250 2-hour participant-visits 
during duration of the PhD candidature from May 2012 to July 2015 
(Table  1-1) 
• Data collection and recording observation on Case Report Forms 
• Data management including exporting and uploading participants’ data to 
the integrated data base 
• Preparation of documentation for health care practitioners (when required) 
and 24-hour follow up phone calls after their visits  
• Providing ophthalmic exit reports for LANDMark participants  
The specific contribution of the candidate in relation to his PhD project: 
• Conducting intra- and interobserver repeatability study of subbasal nerve 
parameters using CCM for 16 and 11 healthy participants and individuals 
with diabetes, respectively 
• Analysing 400 CCM images using each of the three techniques of manual, 
semi-automated and fully-automated (i.e. 1200 images analysed in total) 
• Automated analysis of CCM images for all control and type 1 participants 
from baseline to final visits (approximately 960 case visits) 
• Analysing, plotting and presenting the results related to this PhD project 
 










Diabetes 51 74 30 155 
Controls 25 43 26 94 




 Literature Review 9 
CHAPTER 2.  LITERATURE REVIEW 
2.1 Foreword 
This chapter provides a detailed overview of diabetic peripheral neuropathy 
(DPN), as one of the most important and prevalent complications of diabetes. 
Then, an overview of corneal anatomy and physiology and in particular 
corneal innervation is presented, followed by the effects of diabetes on the 
cornea. A review of current application of corneal confocal microscopy for in 
vivo assessment of subbasal nerve plexus with particular focus on the utility 
of this technique in relation to the assessment of DPN will be presented, 
subsequently. Finally, a summary of the literature review and the implications 
for this study are presented. 
2.2 Diabetic peripheral neuropathy 
Diabetes is a complex and chronic metabolic disorder characterized by 
hyperglycemia resulting from impaired glucose metabolism of the body. This 
condition occurs due to either deficiency in insulin secretion, insulin 
resistance or both. The most common types of diabetes are type 1 and type 
2 diabetes. Type 1 diabetes is an autoimmune response where destruction of 
the insulin-producing β-cells of the pancreatic islets occurs, while type 2 
diabetes results from both impaired insulin secretion and resistance to insulin 
action (Holt & Hanley, 2011). Type 1 diabetes can present at any age but this 
condition mainly occurs in children and young adults, while type 2 diabetes 
which is the most common form of diabetes, has been regarded a disease of 
middle-aged or elderly people (Meeking, 2011). 
Polyneuropathy or peripheral neuropathy is characterised by nerve 
abnormalities that are predominantly distal and symmetric with beginning in 
the lower extremities, which may gradually ascend (Chin & Rubin, 2010) 
(Figure  2-1). Diabetic distal symmetric polyneuropathy or diabetic peripheral 
neuropathy (DPN) is a chronic, symmetrical length-dependent neuropathic 
syndrome and the most common subtype of neuropathies (Chin & Rubin, 
2010; Dyck et al., 1993; Tesfaye, 2007). 
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Development of nerve loss in DPN usually follows a “stocking and glove” 
distribution. This is because the most distal part of nerves which are furthest 
from the nucleus in the dorsal root ganglion or anterior horn cell are affected 
first, although the pathophysiology underlying this phenomenon is not 
understood (Chin & Rubin, 2010; Ziegler et al., 2014a). 
DPN develops following long term hyperglycaemia, associated metabolic 
disturbances and cardiovascular risk factors (Tesfaye et al., 2010). The 
prevalence of DPN has been reported to be between 7.1% and 54% 
depending on study design, definition of DPN and type of diabetes, with the 
prevalence slightly higher amongst patients with type 2 diabetes (Dyck et al., 
1991; Harris et al., 1993; Tapp et al., 2003; Walters et al., 1992).  
 
 
Figure  2-1 Pattern of nerve damage in diabetic peripheral neuropathy 
In its early stages, symptoms of DPN which appear due to predominantly 
involvement of small nerve fibres of Aδ  and C types, start with burning feet, 
tingling and numb toes while the finding of neurologic examination and nerve 
conduction studies may be normal (Tavee & Zhou, 2009). Clinically, the 
process of DPN deterioration begins with decreased vibration sensation in 
the toes accompanied by a reduction or loss of ankle reflexes and may 
progress to more severe symptoms such as pain and loss of temperature 
and vibration sensation (Chin & Rubin, 2010). In some patients, foot 
ulcerations and even amputation are the late sequelae of DPN. Up to 15% of 
diabetic patients develop foot ulcers (Boulton et al., 2004a). Developing an 
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ulcer is accompanied with an increased risk of wound progression that may 
finally lead to amputation (Clayton Jr & Elasy, 2009). 
Therefore detecting diabetic patients with neuropathy from those without 
neuropathy is crucial. Evidence of reduced incidence of lower limb 
amputation, following a 1-hour education session for “high-risk” patients, plus 
a significantly lower incidence of new foot problems for patients as a result of 
an intensive education program (Barth et al., 1991; Malone et al., 1989) 
support this notion. These studies demonstrated that a simple education 
program significantly reduced the incidence of ulcer or foot and limb 
amputation in diabetic patients with neuropathy. 
2.2.1 Natural history of DPN 
It has been argued that the natural history of DPN has not been well 
understood, mainly due to scarcity of well-conducted prospective studies and 
inadequate knowledge of DPN pathogenesis (Tesfaye, 2007). In a 4-year 
follow-up study of 39 patients with DPN, Boulton et al. (1983) found a 
significant fall in median nerve motor conduction velocities that reflects 
continuing deterioration in nerve function. The Diabetes Control and 
Complications Trial (Leiter et al., 1995) provides valuable information 
regarding the development and progression of neuropathy in type 1 diabetes. 
This study was primarily designed as a therapeutic survey in which two group 
of patients were followed, one treated conventionally (control treatment) and 
another treated intensively. After 6.5 years of follow-up, the prevalence of 
clinical neuropathy increased from 8% at baseline to 22%. They also 
reported a very high (50%) prevalence of abnormal nerve conduction at study 
closeout in this group. Partanen et al. (1995) reported that the prevalence of 
neuropathy increased from 8.3% at baseline to 16.7% after 5 years and 
41.9% after 10 years in their cohort. In a 7-year longitudinal study of almost 
200 patients from the Rochester Diabetic Neuropathy Study cohort using a 
composite score of examinations and tests, Dyck et al. (1997) demonstrated 
that the average diabetic patient in their study worsened by 0.34 points per 
year (slope), whereas patients with diabetic polyneuropathy worsened by 
0.85 points per year. They also suggested that longitudinal assessment of 
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diabetic neuropathy would need to be conducted for a period of at least 3 
years to achieve a clinically meaningful effect. 
A 12-year prospective study of DPN by Coppini et al. (2001), using vibration 
perception thresholds (VPT), showed that approximately 20% of diabetic 
patients with a normal age-corrected VPT at baseline developed an abnormal 
VPT over this period. A prospective study from The Epidemiology of Diabetes 
Complications reported that 15% of their type 1 diabetes subjects who were 
free of DPN at the baseline developed DPN during the first 6 years of follow-
up (Forrest et al., 1997). Adler et al. (1997) reported that 20% of their 
participants without neuropathy at baseline developed neuropathy after an 
average period of 2.6 years. Similarly, van de Poll-Franse et al. (2002) in a 4-
year longitudinal assessment of DPN in type 2 diabetes found that 21.3% of 
diabetic patients without DPN at baseline, developed significant neuropathy. 
A prospective follow-up (mean follow-up, 4.7 years) of 231 people with type 2 
diabetes and without DPN at baseline revealed an incidence rate of 6.1 per 
100 person-year (Sands et al., 1997). In the placebo arm of a study, Brown et 
al. (2004) found a significant worsening of DPN using nerve conduction 
studies (NCS) and quantitative sensory tests (QST) over 12 months in a mild 
to moderate affected population. The European Diabetes (EURODIAB) 
Prospective Complication Study (Tesfaye, et al., 2005) assessed risk factors 
for the development of distal symmetric neuropathy in 1172 patients with type 
1 diabetes and reported that over a mean of 7.3 years of follow up, 
approximately one quarter of type 1 diabetic patients developed DPN. 
Although the differences in study design do not allow for precise comparison 
between studies, the above review clearly shows a significant gradual 
worsening of DPN in diabetic patients over time. However, more recent 
studies have documented lower deterioration and more stability of 
neuropathy measures compared to the older reports. The NATHAN 1 trial 
reported that NCS and QST results did not deteriorate in the placebo-treated 
group over 4 years (Ziegler et al., 2011). No significant changes to symptom 
scores, QST and NCS has also been found in a 3-year study of diabetic 
patients (Gibbons et al., 2013). Overall, there seems to be some evidence of 
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lower rates of DPN development and worsening and hence changing the 
natural history of DPN which to some extent may be explained by 
improvements in the patient care and management of diabetes compared to 
previous decades. 
2.2.2 Pathogenesis and risk factors of DPN 
The mechanisms leading to nerve degeneration in diabetic individuals are not 
completely understood and although several theories have been proposed, 
the overall mechanism is probably multifactorial and complex (Chin & Rubin, 
2010). The two main hypotheses are explained in the following sections. 
Metabolic Hypothesis: Development, progression and severity of DPN is 
related to hyperglycaemia. The significant association between glycaemic 
control and DPN has been found in several studies (Dyck et al., 1999; 
Tesfaye et al., 1996). The damaging effect of hyperglycaemia is further 
confirmed by the occurrence of neuropathy associated with impaired glucose 
tolerance (IGT). It has been shown that the neuropathy associated with IGT 
is milder than the neuropathy associated with newly diagnosed diabetes 
(Sumner et al., 2003).  
Despite the strong association between hyperglycaemia and DPN, the exact 
mechanism is not completely clear. One of the proposed mechanisms is 
accumulation of polyols (particularly sorbitol) in nerves. The aldose reductase 
pathway is activated by intracellular hyperglycaemia, resulting in increased 
sorbitol formation. Accumulation of sorbitol and fructose leads to reduced 
nerve myo-inositol, decreased sodium-potassium ATPase activity, alteration 
in protein kinase C subunits and slowed nerve conduction velocities (Chin & 
Rubin, 2010; Clark & Lee, 1995). Whilst the animal model experiments 
revealed consistent association between increased polyol pathway flux and 
decreased nerve conduction velocity, human studies are not consistent and 
most of clinical trials with aldose reductase inhibitors have failed (Li et al., 
2013; Malik & Veves, 2007). 
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Hyperglycaemia also leads to advanced glycation end-products (AGE) 
formation (Clark & Lee, 1995). Formation and accumulation of AGE is 
another important factor for peripheral nerve damage by directly affecting 
structural and functional proteins or indirectly activating receptors for AGEs 
(RAGE) (Wada & Yagihashi, 2005). The formation of AGE can be restricted 
by inhibitors and the interaction of AGE-RAGE may be hindered by 
recombinant RAGE (Malik & Veves, 2007). Animal studies demonstrated that 
development and progression of microvascular complications might be 
preventable by inhibition of AGE production (Tahrani et al., 2010).  
Oxidative stress is known as one of the most important mechanisms in the 
pathogenesis of DPN in animal studies, but to a lesser extent in human 
neuropathy (Malik & Veves, 2007). Both chronic and acute hyperglycaemia 
cause oxidative stress in the peripheral nerve system that can promote the 
development of DPN (Vincent et al., 2004). 
Vascular Hypothesis: It has been hypothesised that microvascular disease 
can result in nerve ischemia. Sural nerve biopsies revealed defects in 
endoneurial vessels and reduced oxygen tension in diabetic patients with 
DPN, compared with diabetic patients without DPN. Tesfaye et al. (1993) 
used sural nerve photography (3 cm of sural nerve is exposed at the ankle 
using an operating microscope) and fluorescein angiography and found 
microvascular abnormalities in epineurial arteries and veins as well as 
arteriosclerosis on the nerve surface and impaired blood flow in subjects with 
chronic DPN. Blood vessel thickening, reduplication of basal lamina and 
occlusion with platelet aggregates are further evidences of vascular 
hypothesis in DPN (Chin & Rubin, 2010). 
A considerable amount of literature has been published on risk factors for 
DPN. DPN increases with both age (from 5% in the 20-29 year age group to 
44.2 % in the 70-79 year age group) and duration of diabetes (Young et al., 
1993). Using multiple regression modelling, Adler et al. (1997) reported that 
age at enrolment (P < 0.0001, OR = 1.05), duration of diabetes (P = 0.003, 
OR = 1.03) and HbA1c (P = 0.03, OR = 1.06) were significant risk factors for 
DPN. A longitudinal study of risk factors for DPN severity showed that age, 
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diabetes duration, HbA1c, height and body mass index (P < 0.05) were the 
most important risk factors during follow up (van de Poll-Franse, et al., 2002). 
Significant correlations have been found between the presence of DPN with 
age (P < 0.05), duration of diabetes (P < 0.001), quality of metabolic control 
(P < 0.001), height (P < 0.01), the presence of background or proliferative 
diabetic retinopathy (P < 0.01), cigarette smoking (P < 0.001), high-density 
lipoprotein cholesterol (P < 0.001) and the presence of cardiovascular 
disease (P < 0.05) (Tesfaye, et al., 1996). Several subsequent studies 
confirmed the aforementioned risk factors as significant risk factors for DPN 
(Booya et al., 2005; Dyck, et al., 1999; Forrest, et al., 1997; Gomez-Viera et 
al., 2001; Manes et al., 2002; Morkrid et al., 2010; Tesfaye, et al., 2005; 
Wiggin et al., 2009; Ziegler et al., 2008). 
In summary, neural structural alterations as a result of diabetes occur 
through several biochemical pathways, comprising interactions between 
glycaemic control, duration of diabetes and other cardiovascular risk factors. 
Although metabolic and vascular factors are the main aetiology for 
developing DPN, recent studies have shown that these mechanisms are 
likely to interact and are involved at all stages of DPN (Cameron et al., 2001; 
Tesfaye & Selvarajah, 2012). 
2.2.3 Social and economic burden of DPN 
DPN significantly reduces the quality of life of patients and also is a 
substantial burden both for society and health insurance (Happich et al., 
2008). Damage to Aδ and unmyelinated C-class nerve fibres is responsible 
for most of the symptoms and signs experienced by diabetic patients with 
peripheral neuropathy, which include: burning or stabbing pain, 
hyperaesthesia, paraesthesia, and loss of pain and temperature sensation 
(Boulton, et al., 2004b; Tavee & Zhou, 2009). Symptoms are usually worse at 
night and often affect patient’s sleep (Tavee & Zhou, 2009). When DPN is 
associated with neuropathic pain, it potentially affects both mental and 
physical components of quality of life (Van Acker et al., 2009). The 
associated sensory (e.g. loss of sensation and numbness) and motor 
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symptoms (e.g. weakness) initially affect the foot and toe and can ascend 
proximally.  
Up to 15% of diabetic patients develop foot ulcers and 80% of amputations 
are preceded by foot ulceration (Boulton, et al., 2004a; Boulton et al., 2005; 
Frykberg et al., 2006). Although development of foot ulcers are multifactorial, 
the main cause is unperceived trauma due to reduced pain sensation 
(Frykberg, et al., 2006). 
A longitudinal study by Abbott et al. in a large population of diabetic patients 
demonstrated that the foot ulceration is more common in diabetic 
neuropathy, with the annual incidence rising from less than 1% in those 
without neuropathy to 7.2% in patients with established DPN (Abbott et al., 
1998). Ramsey et al. (1999) investigated 8905 patients with type 1 and type 
2 diabetes and found a cumulative incidence of 5.8% of developing foot ulcer 
over three years observation and reported that the attributable cost for a 40 
to 65 year-old male with a new ulcer was nearly $28,000 during the two years 
after diagnosis. The risk of foot amputation has been reported to be 23 fold in 
patients with diabetes compared to people without diabetes (Holman et al., 
2012). Strategies that reduce amputation risk by earlier detection may 
potentially save $2 to $3 million of medical costs over three years in the 
United States (Ollendorf et al., 1998). The total annual cost of managing DPN 
in the United States and United Kingdom has been reported to be $16.8 
billion and $1.2 billion, respectively (Gordois et al., 2003). 
It is clear that from a public health perspective, DPN leads to extensive 
reduction of the quality of life and imposes considerable economic burdens; 
therefore, appropriate diagnosis and early detection of DPN can provide 
several benefits for both diabetic patients as well as society. 
2.2.4 Diagnostic tests for DPN 
A broad range of tests are commonly used to screen for, diagnose and to 
monitor the progression of DPN. The majority of these tests assess functional 
loss due to disease; however, direct structural observation of nerve tissue 
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itself is also possible. An outline of the most common methods is presented 
here. 
Signs and symptoms: Neuropathy disability score (NDS) is a quantitative 
measure of neuropathy which includes pain sensation, vibration sensation, 
temperature sensation and Achilles tendon reflex of both feet and is recorded 
from 0 to 10 (Abbott, et al., 1998; Young, et al., 1993). Diabetic neuropathy 
symptom score (DNSS) is a validated and fast measure of neuropathic 
symptoms for clinical practice (Meijer et al., 2002) which includes four 
questions and it is completed by the patient. The total score is recorded from 
0 to 4. Although assessment of signs and symptoms are among the most 
commonly used test for DPN, a recent study (Dyck et al., 2010) has found 
that they are associated with poor diagnostic reproducibility. 
Quantitative sensory tests (QST): QST provide valuable quantitative 
information on sensory function in polyneuropathies, particularly in DPN 
(Perkins & Bril, 2003). They offer a relatively robust mean of defining 
neuropathy severity (Boulton, et al., 2004b) and have shown adequate 
proficiency (Dyck et al., 2014). However, these tests require the cooperation 
and concentration of the examinee and they may also be affected by 
anthropometric variables (Boulton, et al., 2004b; Skljarevski & Malik, 2007) 
which are the main disadvantages of this method. Furthermore, given that 
the QST of thermal and pain sensation has been proposed to assess small 
fibre damage and dysfunction (Arezzo, 1999), a subsequent study has shown 
the lack of relationship between QST and small myelinated or unmyelinated 
fibre  pathology identified using nerve biopsy technique (Malik et al., 2001). 
Nerve conduction studies (NCS): NCS stimulate a nerve at one point along 
its course and measure the signal at another point. Whilst NCS have been 
reported to be reliable and objective tests for assessment of large nerve 
function (Dyck, et al., 1997; Husstedt et al., 1997; Kohara et al., 2000), their 
reproducibility have been shown to be limited (Litchy et al., 2014). Moreover, 
they need trained individuals and studies in subjects with impaired glucose 
tolerance (IGT) and diabetes demonstrated that earliest nerve fibre damage 
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occurs in small fibres and NCS may not be sensitive enough to detect early 
functional changes (Malik et al., 2011; Skljarevski & Malik, 2007). 
Nerve and skin biopsy: Nerve biopsy is an invasive and highly specialized 
procedure that allows the direct examination of myelinated and unmyelinated 
nerve fibre damage and repair using light or electron microscopy (Malik, et 
al., 2011). Compared to nerve biopsy, skin biopsy is a less invasive 
technique. Skin biopsy is an accepted means to assess small fibre nerves 
and to allow morphometric analysis of epidermal and dermal nerves (Lauria 
et al., 2009) (Figure  2-2). Intraepidermal nerve fibre density (IENFD) is used 
as a morphometric parameter and is expressed as the number of nerves per 
length of nerve section (nerve/mm). Both techniques are demanding 
procedures requiring expertise and laboratory for processing and quantifying. 
They are also not appropriate tests for longitudinal assessment as biopsies 
need to be taken at different sites for the purpose of re-assessment. 
 
Figure  2-2 Skin biopsy of normal intraepidermal nerve fibre (IENF) (arrow) in 
a healthy control participant (A) and absence of IENFs with only dermal 
nerve fibres (arrow) in a diabetic patient with severe neuropathy (B). Figure 
reprinted with permission from Copyright Clearance Center. Malik, R.A., et al. 
Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor 
polyneuropathy. Diabetes/Metabolism Research and Reviews. 2011. 27(7): 
678-684. 
Filament test: The 10-g monofilament examination is a simple, practical and 
accurate means for DPN screening; however this is not a quantitative test 
and there are some limitations in its specificity for DPN onset (Perkins et al., 
2010). 
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Neuropad®: Neuropad is a relatively new adhesive visual indicator test which 
measures sweat production in the feet. This test has been shown to have 
high sensitivity and negative predictive value but low-moderate specificity 
and positive predictive value for the diagnosis of DPN (Papanas et al., 2013).  
2.2.5 Treatment of DPN 
Several studies have been performed using pharmacologic agents on the 
basis of pathogenetic mechanisms including aldose reductase inhibitors, 
AGE inhibitors, vasodilators and nerve growth factors; however, to date no 
effective therapy has been approved for treatment of peripheral neuropathy 
in diabetes (Li, et al., 2013). In the first instance, glycaemic control and 
considering cardiovascular risk factors are the main focus of management 
(Tesfaye & Selvarajah, 2012). In diabetic patients with painful DPN, 
pharmacological management with antidepressants, anticonvulsants, and 
opioids is recommended, but these drugs are often limited by unfavourable 
side-effects (McGreevy & Williams, 2012). 
While accurate diagnosis and estimation of changes are essential to test 
potential therapies for DPN, lack of a reliable and sensitive clinical marker 
has been one of the most important impediments in clinical trials (Malik, 
2014a; Ziegler & Luff, 2002). As outlined above, the inherent and associated 
shortcomings of the conventional measures of neuropathy indicate that a 
simpler, more practical and sensitive measure of neuropathy, that can be 
used to monitor changes over time, has to be explored. 
In the past decade, corneal nerve morphology at subbasal nerve plexus 
(SNP) has been the centre of attention as a potential marker of DPN. In fact, 
the anatomical location and transparency of the cornea make this tissue 
ideally suited for direct observation of nerve structure pathology using in vivo 
corneal confocal microscopy (CCM). The next section deals with the SNP 
structure as a promising sensitive and reiterative measure of neuropathy in 
more detail. 
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2.3 Morphology of corneal subbasal neve plexus as a potential measure 
of DPN  
2.3.1 Anatomy and physiology of the cornea 
The cornea is a transparent and avascular connective tissue of the front of 
the eye and, in combination with the precorneal tear film, plays an important 
role via providing a proper anterior refractive surface and protects the eye 
against infection and structural damage to the deeper components of the eye 
(DelMonte & Kim, 2011; Farjo et al., 2008). Histologically, the human cornea 
consists of five basic layers, three cellular layers (epithelium, stroma, and 
endothelium) and two acellular interfaces (Bowman and Descemet 
membranes) (Figure  2-3). Corneal thickness is approximately 0.5 mm at the 
centre and this thickness increases gradually to the periphery. 
 
Figure  2-3 Histological cross section of the cornea. Figure reprinted with 
permission from Elsevier. Farjo, A. A., et al. (2008). Corneal Anatomy, 
Physiology and Wound Healing. In M. Yanoff & J. S. Duker (Eds.), 
Ophthalmology. 203-207. 
Epithelium: In addition to its contribution as the main barrier to penetration of 
microorganisms and certain noxious substances, the epithelium-tear film 
provides approximately two third of the total refractive power of the eye. The 
epithelium is 4–6 cell layers thick (40–50 μm), the most superficial corneal 
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cells consist of 2 to 3 layers of polygonal cells, then 2-3 layers of supra-basal 
or wing cells and the basal layer forms a single cell layer (Farjo, et al., 2008). 
Bowman layer: This is not a real membrane but rather a condensed layer of 
collagen. This layer is approximately 15 μm thick, protects the stroma and 
maintains corneal shape (Riordan-Eva, 2002). 
Stroma: The stroma is the thickest layer of the cornea (80% to 85% of total 
corneal thickness). It is composed of densely packed, highly ordered 
collagen fibres (Lamella) (Farjo, et al., 2008). This highly arranged network 
results in corneal transparency and reduced light scattering. Collagen 
molecules are generated by keratocytes which are the main cell type in the 
corneal stroma. 
Descemet’s membrane: A thin acellular layer with approximate 10 μm 
thickness has an amorphous ultra-structural texture and represents the 
basement membrane of the endothelium. 
Endothelium: It is a single layer of flat hexagonal (honeycomb-like) cells with 
a thickness of 4 μm in adulthood. This layer is responsible for maintaining the 
corneal stroma in a relatively deturgescent state (DelMonte & Kim, 2011).  
Dua et al. (2013) reported the discovery of new acellular layer at the most 
posterior lamellae of the stroma with 10 μm thickness; however, there has 
been some debate in the literature concerning the existence of this layer 
(McKee et al., 2014). 
2.3.2 Corneal innervation 
The ex vivo anatomy of the corneal nerves has been studied in detail by light 
and electron microscopy and in combination with immunohistochemical 
techniques (Al-Aqaba et al., 2010; He et al., 2010; Marfurt et al., 2010; Müller 
et al., 2003; Müller, et al., 1997). The human cornea is the most densely 
innervated surface tissue of the body (606 terminals/mm2 in the suprabasal 
layers of the central corneal epithelium) (Marfurt, et al., 2010). Corneal nerve 
fibres are mainly sensory and derived from the nasociliary branch of the 
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ophthalmic division of the trigeminal nerve (Müller, et al., 2003). Corneal 
autonomic nerve fibres consists of sympathetic fibres which are derived from 
the superior cervical ganglion and parasympathetic fibres that originate from 
the ciliary ganglion (Al-Aqaba, et al., 2010). 
In the periphery, bundles of nerves enter the cornea in the middle third of the 
stroma and run forward anteriorly in a radial fashion to the centre. These 
nerves lose their perineurium and myelin within approximately 1 mm of the 
corneal limbus to maintain cornea transparent (Marfurt, et al., 2010; Müller, et 
al., 2003). In the interface between Bowman’s layer and anterior stroma, the 
subepithelial nerve plexus is formed by the stromal nerves. After penetrating 
Bowman’s layer, nerves continue parallel to the corneal surface between 
Bowman’s layer and the basal epithelial cell layer (Müller, et al., 2003) and 
form the subbasal nerve plexus (SNP) which provides innervations to the 
subbasal layer of the epithelium and eventually ends within superficial 
epithelial layers of the cornea (Figure  2-4). The subbasal nerve plexus 
includes a spiral-like assemblage of long, curvilinear subbasal nerve fibres 
which forms a whorl-like arrangement located about 2.5 mm infronasal to the 
corneal apex (Marfurt, et al., 2010). 
 
Figure  2-4 (A) Diagram of human cornea nerves in stroma and subbasal 
plexus. (B) 3-D representation of the corneal subbasal nerve plexus. Figures 
reprinted with permission from Copyright Clearance Center. (A) Müller, L.J., 
et al., Corneal nerves: structure, contents and function. Experimental Eye 
Research, 2003. 76(5): 521-542, and (B) Erie, J.C., et al., The effect of age 
on the corneal subbasal nerve plexus. Cornea, 2005. 24(6): 705-709. 
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Two main types of human corneal nerves are unmyelinated C fibres which 
are small diameter (2-4 µm) beaded nerves and respond to thermal and 
chemical stimuli and Aδ fibres that are large diameter (6 µm ) straight nerves 
and respond primarily to mechanical stimuli (Müller, et al., 1997). Sensation 
of pain in human cornea results from mechanical, thermal and chemical 
stimulation of the cornea (Al-Aqaba, et al., 2010). Although the corneal 
innervation provides sensation, it has a significant role in the integrity of the 
ocular surface. The corneal nerve fibres also have an important influence on 
the corneal trophism (nourishment of the tissue) and contribute to the 
maintenance of a healthy corneal surface (Marfurt, et al., 2010). 
2.3.3 Cornea and diabetes 
Retina and cornea are two main ocular tissues that are profoundly impacted 
from hyperglycemia. Diabetic keratopathy, or the corneal complications of 
diabetes, occurs in up to 70% of diabetic patients (Lutty, 2013). Various 
corneal changes associated with diabetes have been reported, ranging from 
cellular dysfunction to failure to repair the damaged structures and functions. 
Gekka et al. (2004) found impairment in corneal epithelial barrier function in 
diabetic patients and reported that diabetic patients with higher HbA1c levels 
were more disposed to impaired barrier function in the corneal epithelium. 
Lee et al. (2006) studied 200 patients with diabetes and showed that diabetic 
subjects had thicker corneas, lower cell density and hexagonality, and more 
irregular cell size. Similarly Inoue et al. (2002) reported impaired endothelial 
cell structure. 
Increase in central corneal thickness has been reported in several studies 
which has been thought to be due to insufficient endothelial cell function, 
resulting in corneal oedema (Goldich et al., 2009; Lee, et al., 2006; 
McNamara et al., 1998; Rosenberg, et al., 2000); in contrast, some 
investigations demonstrated no difference in central corneal thickness 
between diabetes and control subjects (Hager et al., 2009; Inoue, et al., 
2002; Wiemer et al., 2007). Diabetes has a significant effect on corneal 
hydration control (McNamara, et al., 1998) and can also affect corneal 
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biomedical parameters including increased corneal hysteresis and corneal 
resistance factor (Goldich, et al., 2009; Hager, et al., 2009). 
Corneal nerve structure is altered by diabetes (He & Bazan, 2012; Mocan et 
al., 2006) and may also lead to diabetic keratopathy which is difficult to 
manage clinically (Bikbova et al., 2012). These patients have epithelial 
basement membrane and integrin alterations and impairment of epithelial 
wound healing (Chen et al., 2009; Ljubimov et al., 1998). Due to the 
structural and functional abnormalities in the diabetic cornea, these patients 
are theoretically at a higher risk for development of more complications such 
as recurrent corneal erosions, superficial punctuate keratitis, delayed wound 
healing and re-epithelialization, decreased sensitivity and susceptibility to 
injury and ulceration (Bikbova, et al., 2012; Lutty, 2013; Wiemer, et al., 2007). 
2.3.4 Corneal confocal microscopy  
In vivo corneal confocal microscopy (CCM) is a quick and non-invasive 
technique which enables reiterative microstructural imaging and evaluation of 
the human cornea at high resolution in health and disease. Until recently it 
was largely used as a tool for research laboratories, but now is considered as 
a powerful diagnostic tool for a variety of ocular and neurological conditions.   
The principle of CCM (Figure  2-5) is that a beam of light (e.g. Laser) passes 
through a light source and focused by an objective lens into a small volume 
of a tissue (e.g. cornea) (Guthoff et al., 2009). The objective lens collects a 
mixture of emitted as well as reflected light from the illuminated point and 
projects this mixture to a conjugate spot in an “image” plane where the 
pinhole aperture is positioned. Light mixture is separated by a beam splitter 
and then reflected into the detection apparatus. The pinhole aperture blocks 
light from out-of-focus areas of the specimen and only the light from the focal 
plane passes through the pinhole to the detector where the light signal is 
transformed to electrical signal. Obstruction of the light that is not coming 
from the focal point  results in sharper images (Guthoff, et al., 2009). The 
resultant image is an image with very high resolution but very narrow field of 
view. The small field of view in confocal microscopy imaging is overcome by 
 25 
Literature Review 25 
scanning multiple points or slits to create the image (Inoué, 2006; Jalbert et 
al., 2003). 
 
Figure  2-5 Schematic principle of the corneal confocal microscopy. Figure 
reprinted with permission from Copyright Clearance Center. Guthoff, R.F. et 
al., In vivo confocal microscopy, an inner vision of the cornea - a major 
review. Clinical and Experimental Ophthalmology, 2009. 37(1):100-117. 
There are currently two CCM instruments on the market; the Nidek 
ConfoScan 4 which is a white-light slit scanning (SSCM) instrument, and the 
Heidelberg Retina Tomograph with Rostock Corneal Module which is a laser 
scanning (LSCM) instrument. The LSCM became available in 2004 and is 
able to produce images with higher contrast from different layers of the 
cornea, in particular the SNP. 
2.3.4.1 CCM and assessment of cornea in ocular conditions and diseases 
As a transparent and anteriorly located tissue of the eye, the cornea has 
been studied extensively at cellular level in normal status as well as in 
several ocular diseases using in vivo CCM. Rapid and non-invasive image 
acquisition from different corneal layers and structures helps both clinicians 
and researchers to extract important information in respect to changes 
caused by various ocular conditions and diseases. This technique has been 
used both qualitatively and quantitatively to characterize conditions such as 
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dry eye, ocular allergies and glaucoma (Benítez-del-Castillo et al., 2007; 
Labbé et al., 2012; Villani et al., 2013b; Zhang et al., 2011), corneal ectasia 
and dystrophies  (Efron & Hollingsworth, 2008; Patel et al., 2009a), infectious 
keratitis and corneal ulcers (Hamrah et al., 2012; Labbé et al., 2009), the 
effect of contact lens wear (Zhivov et al., 2007), orthokeratology lens wear 
(Lum et al., 2012) and corneal cross-linking (Kaya et al., 2011), and the 
assessment of nerve regeneration after penetrating keratoplasty and different 
forms of corneal refractive surgery (Darwish et al., 2007a; Darwish et al., 
2007b; Erie et al., 2005b).  
2.3.4.2 Assessment of subbasal nerve plexus in healthy people using CCM 
and the effect of age 
Using electron microscopy, Muller et al. performed a unique qualitative 
morphological analysis of corneal nerve architecture and concluded that 
human corneal nerves degenerate within 13.5 h after death, which results in 
a number of difficulties for accurate structural analysis of human corneal 
nerves (Müller, et al., 1997). In vivo CCM has addressed the problem of 
disappearing subbasal nerve plexus post-mortem. This rich nerve plexus has 
been studied extensively over the past decade. CCM observations are in 
agreement with histological studies (Oliveira-Soto & Efron, 2001); nerve 
fibres perforate Bowman’s layer and eventually form a dense neural plexus 
just beneath the basal epithelial cell layer and appear as bright, well defined 
linear structures connected with anastomoses (Figure  2-6A) and organized in 
a vortex pattern (Figure  2-6B) in the inferior nasal quadrant of the cornea 
(Guthoff, et al., 2009; Patel & McGhee, 2005). 
Several corneal nerve parameters have been used by researchers such as 
nerve fibre length, density, branching and tortousity (Grupcheva et al., 2002; 
Malik, et al., 2003; Oliveira-Soto & Efron, 2001; Patel & McGhee, 2005; 
Rosenberg, et al., 2000). Although there is no universally accepted 
consensus regarding the definition of corneal nerve parameters, the three 
main SNP parameters studied by CCM include corneal nerve fibre density 
(CNFD; the total number of major nerves per mm2), branch density (CNBD; 
the number of branches emanating from major nerves per mm2) and fibre 
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length (CNFL; total length of all nerves and branches in units of mm/mm2) 
(Malik, et al., 2003; Papanas & Ziegler, 2013). However, CNFL appears to be 
the most standardized, generally accepted and frequently reported 
morphometric parameter of the SNP. Findings of several studies for reported 
SNP parameters from the centre of cornea in healthy corneas are presented 
in Table  2-1. 
 
Figure  2-6 Laser-scanning confocal microscopy images of subbasal nerve 
plexus from centre (A) and whorl pattern (B). Each image is 400 x 400 µm. 
As shown in Table  2-1, the reported SNP parameters differ significantly 
among studies. For example, CNFL in healthy corneas have been reported to 
range from 0.6 to 13.5 mm/mm2 for SSCM and from 10.1 to 27.9 mm/mm2 
with LSCM. The disparity is likely to be related to differences in methodology 
such as number and quality of selected images, study participants or 
quantification technique. Another important difference is in the definition of 
the SNP parameters. For instance, some investigators have only quantified 
nerve branches longer than 50 mm when measuring the total length of 
nerves.The differences between SNP parameters reported in studies using 
SSCM and LSCM modalities might be because of contrast, brightness, depth 
of field and instrument sensitivity for detecting subbasal nerve plexus. Whilst 
the images acquired using LSCM have a relatively uniform contrast and 
brightness, images captured using SSCM are brightest along vertical strip 
and become darker laterally, which may potentially affect the visibility of 
nerve fibres at the edge of the image (Patel & McGhee, 2005).  
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Table  2-1 Quantification of subbasal nerve parameters in healthy individuals. Values are presented as mean ± SD, unless 
otherwise stated. 












Grupcheva et al. (2002) 25 
25 
25 ± 5 
70 ± 5 
SSCM 1-3 Automated N/A N/A 632.3 ± 287.6* 
582.4 ± 327.1* 
Malik et al. (2003) 18 58 ± 12 SSCM 3-5 Manual 44.5 ± 14.1 78.9 ± 30.4 13.5 ± 0.3 




30 ± 6 
65 ± 3 
SSCM Various Manual N/A 61.9 ± 10.9 
43.0 ± 12.1 
10.6 ± 1.4 
8.3 ± 1.2 
Niederer et al. (2007) 85 38 ± 16 LSCM 3 Manual N/A N/A 20.3 ± 6.5 
Quattrini et al. (2007) 15 55 ± 5 SSCM 3-5 Manual 43.2 ± 5.1 27.4 ± 3.3 6.1 ± 1.2 
Erie et al. (2008) 18 38 ± 10 SSCM 2-4 Semi-automated N/A N/A 10.7 ± 5.6 
Niederer et al. (2008) 52 26 ± 7 LSCM 3 Manual N/A N/A 22.4 ± 6.0 
Patel et al. (2009) 31 35 ± 12 LSCM 2 Manual N/A N/A 25.9 ± 7.0 
Patel et al. (2009b) 20 
20 
20 
26 ± 3 
44 ± 5 
61 ± 7 
LSCM 2 Manual N/A N/A 10.6 ± 6.8 
10.1 ± 6.8 
10.6 ± 6.6 
Tavakoli et al. (2010b) 17 55 ± 5 SSCM 3-5 Manual 45.6 ± 4.5 25.4 ± 3.0 11.2 ± 0.9 
Tavakoli et al. (2011b) 18 57 ± 3 SSCM 3-5 Manual 46.0 ± 3.8 35.6 ± 6.7 13.5 ± 0.8 
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Hertz et al. (2011) 20 41 ± 17 LSCM 1 Manual 31.9 ± 9.4 37.2 ± 17.7 16.1 ± 4.1 
Wu et al. (2012) 64 39 ± 18 LSCM 1 Manual 45.0 ± 12.0 37.0 ± 15.0 18.0 ± 4.0 
Hume et al. (2012) 23 40 ± 15 LSCM 6 Manual 30.9 ± 5.8 75.3 ± 19.4 19.9 ± 3.5 
Zhivov et al. (2013) 20 66 ± 13 LSCM 1 Manual N/A 141.9 ± 85.7 20.0 ± 6.7 
Tavakoli et al. (2013) 10 47 ± 3 LSCM 5 Manual 35.8 ± 1.5 100.9 ± 13.1 27.9 ± 1.3 
Petropoulos. (2013b) 19 23± 1 LSCM 5 Manual 38.3 ± 3.9 58.1 ± 23.0 27.6 ± 4.0 
Sivaskandarajah et al. 
(2013) 
64 38 ± 16 LSCM 2 Manual 45.3 ± 12.0 39.7 ± 16.9 18.8 ± 4.5 
Parissi et al. (2013) 106 50 (15-88)† LSCM 4 Automated N/A N/A 18.6 ± 4.8 
Pritchard et al. (2014) 154 46 ± 15 LSCM 3-8 Manual N/A 83.5 ± 45.8 23.2 ± 6.3 
Petropoulos et al. (2014) 55 52 ± 11 LSCM 6 Automated 30.0 ± 6.9 50.4 ± 24.7 21.2 ± 3.5 
CCM, corneal confocal microscopy; SSCM, Slit-scanning confocal microscope; LSCM, Laser-scanning confocal microscope; CNFD, corneal nerve fibre 
density; CNBD, corneal nerve branch density; CNFL, corneal nerve fibre length; N/A, not available. 
 *µm/mm2, † mean (range) 
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The effect of age on the SNP structure: In the current literature, there is no 
good agreement among previous studies concerning the age-dependent 
alteration of subbasal nerve plexus using ex vivo and in vivo techniques. 
While He et al. (2010) in an ex vivo study of 22 donor corneas aged from 19 
to 80 years reported that subbasal nerve fibre density reduced with age, 
Marfurt et al. (2010) using an immunohistochemical staining technique found 
no significant correlation between CNFL and age in corneas of six donors 
aged 19 to 78 years.  
Such a disagreement exists among studies using in vivo CCM as well. 
Grupcheva et al. (Table  2-1) found a significant difference in CNFL between 
the two age groups of healthy corneas (Grupcheva, et al., 2002), whereas a 
study by Erie et al. found no correlation between age and nerve fibre length 
in 65 individuals (aged 15-79 yeas) with healthy cornea (r = 0.21, P = 0.09) 
(Erie et al., 2005a). In a subsequent study, Niederer et al. (2007) reported a 
0.9% per year reduction in subbasal nerve fibre density in their participants 
aged 18-87. In another CCM study of 60 healthy human participants, the 
authors reported no significant difference in mean total nerve density 
between their three age groups (group 1: aged < 35 years, group 2: aged 
35–50 years, and group 3: aged > 50 years) (Patel, et al., 2009b). However, 
in a more recent study of 106 healthy participants, Parissi et al. (2013) 
observed a mean decline in CNFL of 0.25% to 0.30% per year.  
Studies outlined above clearly illustrate the inconsistency in the literature in 
regard to the relationship between age and the SNP morphometric change. 
The design employed in previous studies reporting the effect of age on the 
SNP morphology has been cross-sectional, which does not necessarily mean 
the real age effect, because measurements are taken on subjects with 
different ages and the differences are attributed to the effect of age. The 
discrepancies between studies reporting the possible relationship between 
age and SNP structural parameters warrants conducting a longitudinal study 
in a healthy population by examining the same participants over a period of 
time in order to examine the real effect of age. 
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2.3.5 Utility of corneal nerve morphology for DPN assessment 
In the process of DPN development small nerve fibres, which constitute 70-
90% of peripheral nerves, are the first to be damaged (Malik, et al., 2011). 
Cornea which is the most innervated tissue in the body and mainly consists 
of sensory small nerve fibres (unmyelinated C fibres and Aδ fibres) (Al-
Aqaba, et al., 2010; Müller, et al., 2003) is not an exception. Studies have 
also shown that the mechanisms leading to nerve degeneration at cornea 
such as polyol pathway and formation of advanced glycation end-products 
(Jacot et al., 1998; Kaji et al., 2000; Stitt, 2001) are similar to those involved 
in DPN. 
CCM as a technique for quantitative assessment of the SNP morphology has 
developed during the past decade and has led to an improved understanding 
of nerve damage in diabetes. Using CCM, there is a large number of 
published studies demonstrating deficits of the SNP structural parameters in 
presence of diabetes (De Cilla et al., 2009; Messmer et al., 2010; Midena, et 
al., 2006; Mocan, et al., 2006; Nitoda et al., 2012; Zhivov, et al., 2013; Ziegler 
et al., 2014b). 
The first study of CCM in DPN was reported by Rosenberg et al. (2000). 
These authors described a significant nerve fibre bundle decrease in patients 
with DPN compared to those without DPN (P < 0.05). Since then, CCM has 
increasingly been employed to examine the morphology of SNP in relation to 
DPN. The findings of various cross-sectional studies for pathology of the 
three most important and frequently reported SNP parameters in respect to 
DPN are summarized in Table  2-2. As can be seen from Table  2-2, the SNP 
damage is not only more pronounced in individuals with DPN, it is also 
associated with DPN severity. The SNP parameters also have shown 
moderate to high sensitivity and specificity for diagnosis of DPN. 
The usefulness of CCM in DPN assessment is not limited to its diagnostic 
and stratification ability. It has been shown that this instrument is able to 
detect early corneal nerve repair after simultaneous pancreas and kidney 
transplantation in type 1 diabetes. While there was no significant 
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improvement in neurologic deficit, QST, electrophysiology, IENFD and 
corneal sensitivity, significant improvements occurred in CNFD (P < 0.05), 
CNBD (P < 0.01), and CNFL (P < 0.05) 12 months after successful 
transplantation (Tavakoli, et al., 2013). Another study by Tavakoli et al. 
(2011b) revealed that improvement in risk factors for DPN can result in 
morphological repair of the corneal nerves. In this observational study, after 
24 months follow up, CNFD and CNBD increased significantly with 
improvement in glycaemic control and cardiovascular risk factors associated 
with diabetic neuropathy. They also reported that the improvement in CNFD 
correlated significantly with the improvement in HbA1c (r = -0.51, P = 0.008). 
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Table  2-2 Cross-sectional studies that investigated the diagnostic ability of the corneal subbasal nerve parameters in respect to 
diabetic peripheral neuropathy (DPN) 
Author (year) Type of 
CCM 
N (DM/C) Main Outcomes 
Rosenberg et al. 
(2000) 
TSCM 44 (23/9) A significant decrease in the nerve fibre bundles in patients with severe DPN vs. without DPN 
A significant decrease in the nerve fibre bundles in patients with mild to moderate neuropathy 
vs. without DPN 
Malik et al. (2003) SSCM 36 (18/18) CNFD and CNFL were significantly reduced in moderate and severe neuropathy groups vs. 
controls 
CNBD was significantly reduced in mild, moderate and severe neuropathy groups vs. controls 
CNFD, CNBD and CNFL showed a tendency for greater reduction with increasing DPN severity 
Midena et al. 
(2006) 
SSCM 69 (42/27) A significant decrease in the number of nerve fibres and branching pattern in diabetic patients 
vs. controls with a statistical trend suggesting progression of the corneal neuropathy with DPN 
Quattrini et al. 
(2007)  
SSCM 69 (54/15) Significantly lower CNFD in mild, moderate and severe DPN vs. controls 
Significantly lower CNBD in mild, moderate and severe DPN as well as in diabetic participants 
without neuropathy vs. controls 
Both CNFD and CNBD showed significant reduction with increasing DPN severity 
Significant correlations between CNFD and IENFD (r = 0.39), between CNBD and IENBD (r = 
0.41) and between CNFD and CST (r = - 0.40) 
Tavakoli et al. 
(2010b) 
SSCM 118 (101/17) CNFD, CNBD and CNFL decreased significantly with increasing neuropathy severity 
CNFD, CNBD and CNFL found to be correlated with NDS (r; - 0.48, -0.51 and -0.58, 
respectively) 
CNFD of < 27.8/mm2 showed sensitivity of 82% and specificity of 52% for diagnosis of DPN 
Tavakoli et al. 
(2011a) 
SSCM 154 (128/26) CNFD, CNBD and CNFL significantly decreased with increasing severity of DPN 
CNFD, CNBD and CNFL showed significant correlations with NDS (r; -0.34, -0.31 and -0.43, 
respectively) 
Nitoda et al. (2012) LSCM 43 (25/18) Moderate correlations between CNFD and CNFL with clinical and neurological tests of DPN (r, 
from -0.36 to -0.58) 
Hertz et al. (2011) LSCM 46 (26/20) CNFD, CNBD and CNFL showed significant incremental decrease with increasing DPN severity 
34 
34 Literature Review 
Author (year) Type of 
CCM 
N (DM/C) Main Outcomes 
Edwards et al. 
(2012b)  
LSCM 292 (231/61) CNBD and CNFL were significantly reduced in diabetic participants with DPN vs. controls 
CNFL was significantly reduced in diabetic participants without DPN vs. controls 
Modest correlations of CNBD and CNFL with NDS, cold and warm sensation thresholds, 
vibration perception threshold and peroneal conduction velocity (r = 0.15 to 0.25) 
CNFL was correlated to HbA1c (r = -0.24) and duration of diabetes (r = -0.20) 
Ahmed et al. 
(2012)  
LSCM 153 (89/64) CNFD, CNBD and CNFL were significantly lower across controls, diabetic participants without 
and with neuropathy 
CNFL (with AUC of 0.88) best discriminated participants with DPN from controls compared with 
CNFD and CNBD 
Zhivov et al. 
(2013) 
LSCM 38 (18*/20) Significantly lower CNFD, CNBD and CNFL in DPN group vs. controls 
Sivaskandarajah et 
al. (2013) 
LSCM 160 (96/64) Significantly lower CNFD, CNBD and CNFL in DPN group vs. controls and diabetic participants 
without DPN 
Modest correlation between CNFD, CNBD and CNFL and cold detection threshold (r; 0.32, 0.37 
and 0.37, respectively) 




Significantly lower CNFL in diabetic participants with neuropathy vs. without neuropathy group 
and controls 
Significantly lower CNFL in without neuropathy group vs. controls 
Petropoulos et al. 
(2014) 
LSCM 241 (186/55) A significant reduction in manual and automated CNFD, CNBD and CNFL with increasing 
neuropathic severity 
Manually quantified CNFD and automated quantification of CNFL yielded highest AUC and 
sensitivity/specificity to rule out DPN 
CCM, corneal confocal microscopy; DM/C, diabetes/controls; TSCM, tandem-scanning confocal microscope; SSCM, Slit-scanning confocal 
microscope; LSCM, Laser-scanning confocal microscope; CNFD, corneal nerve fibre density; CNBD, corneal nerve branch density; CNFL, 
corneal nerve fibre length; IENFD, intra-epidermal nerve fibre density; CST, cold sensation threshold; NDS, neuropathy disability score; 
AUC; area under curve; DPN, diabetic peripheral neuropathy. 
*diabetic participants with DPN  
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IENF assessment using skin biopsy is an invasive and objective technique 
for evaluation of small nerve fibre loss and likely presents the gold-standard 
method (England et al., 2009). As an alternative, small nerves in the 
subbasal nerve plexus of the cornea have been proposed to be examined 
directly and more importantly non-invasively by CCM. Quattrini et al. 
quantified small nerve fibre pathological changes using the technique of IENF 
(skin punch biopsy) and CCM in 54 diabetic patients stratified for neuropathy 
and found that whereas both techniques accurately reflect the severity of 
neuropathy, CCM has a superior ability to detect earlier stages of nerve 
pathology compared with IENF (Quattrini, et al., 2007). 
While alteration to several SNP parameters have been reported, compared 
with other parameters, CNFL has been proposed to be the optimal and most 
reliable parameter to detect nerve injury in diabetes, as demonstrated by 
advantages in repeatability, reproducibility and concurrent validity (Ahmed, et 
al., 2012; Efron et al., 2010; Hertz, et al., 2011). Furthermore, CNFL appears 
to be a sufficiently sensitive measure of nerve pathology and reassuringly, 
age and the use of contact lenses do not confound assessment of CNFL for 
the screening of neuropathies such as DPN (Oliveira-Soto & Efron, 2003; 
Wu, et al., 2012). In a more recent study by Petropoulos et al. (2013b), 
CNFD and CNFL were found to be the most repeatable parameters, where 
CNFD was superior to CNFL for intra- and inter-observer repeatability 
measurements. This finding is in contrast to the higher reliability of CNFL as 
reported by Hertz et al. (2011). 
In vivo wide-field assessment of the SNP has revealed that the density and 
distribution of SNP nerves is different in the central and peripheral regions of 
human cornea either in healthy state (Patel & McGhee, 2005) or in diabetic 
patients with and without neuropathy (Edwards et al., 2012a). This is more 
evident when central cornea is compared to the whorl area (Figure  2-6). 
Patel and McGhee (2005) reported significantly higher CNFL in the whorl 
region (25.3 ± 0.6 mm/mm2) compared with the central cornea (21.7 ± 1.4 
mm/mm2). Qualitative assessment of two generated maps has also provided 
some evidence of more pronounced nerve damage in the whorl region of a 
36 
36 Literature Review 
diabetic patient with neuropathy compared to a diabetic patient without 
neuropathy (Edwards, et al., 2012a).  
Although employing this novel technique of SNP assessment would offer 
valuable insights into identifying alterations of the SNP microstructures 
overtime, the image capturing and montaging are time consuming, labour 
and resource intensive. Because of the convenience and ease of imaging 
from the central cornea, which significantly reduces the chair time – an 
advantage for the current study with large number of participants – this 
region has been selected to be assessed in in the majority of previous 
studies.  
The association between established measures of DPN and corneal nerve 
parameters has also been explored. Tavakoli et al. (2010b) found moderate 
correlations between NDS and the three main SNP parameters (CNFD r = -
0.48, CNBD r = -0.51, and CNFL r = -0.58). Very modest correlations of 
CNBD and CNFL with NDS, cold and warm sensation thresholds, vibration 
perception threshold and peroneal conduction velocity (r = 0.15 to 0.25) were 
also reported in a subsequent study of 231 diabetic individuals with 
predominantly mild or no neuropathy (Edwards, et al., 2012b). Modest 
associations between CNFD, CNBD and CNFL and cold detection threshold 
(r; 0.32, 0.37 and 0.37, respectively) were also reported in a most recent 
study of corneal nerves and conventional small nerve fibre tests in type 1 
diabetic participants (Sivaskandarajah, et al., 2013).  
The review presented in previous sections clearly demonstrates the clinical 
relevance of corneal innervation to development of peripheral neuropathy in 
diabetes. The corneal sensory nerves, which consist of small nerve fibres of 
Aδ and C types, originate from ophthalmic division of the trigeminal nerve. 
These two types of nerve fibres are the earliest that undergo damage in 
DPN. Additionally, animal studies have shown the impairment of corneal 
nerve structure and function in diabetic rats (Davidson et al., 2014; Jacot, et 
al., 1998). Subclinical abnormalities of trigeminal and facial nerve 
involvement in diabetes (Urban et al., 1998) and corneal neuropathic ulcer 
 37 
Literature Review 37 
associated with diabetes (Schultz et al., 1983) are further evidences of 
involvement of the corneal nerve tissue in diabetes.   
As outlined above, given the potential role of corneal nerve structure in 
assessment of DPN, to our knowledge, no study has been conducted 
concerning the natural course of the SNP structure over time in diabetic 
patients. Additionally, despite the fact that several cross-sectional studies 
have shown the existence of relationship between the SNP parameters and 
conventional examination methods of neuropathy, it is not clear how the 
longitudinal changes in the SNP parameters relate to the established 
measures of DPN in diabetic individuals over time. This is important because 
if the SNP morphology is to be considered as an adjunct to those of 
traditional measures, there should be comparable changes to some 
established measures. Otherwise the possibility remains that these measures 
might not be related and therefore can affect the usefulness of the SNP 
morphology as potential measure of DPN.  
2.4 Summary of knowledge gaps and objectives of this research 
program 
The feasibility of assessing SNP morphology via CCM and the promising role 
of this modality as an indicator of corneal nerve damage or repair and the 
potential for assessment of peripheral neuropathies, in particular DPN, has 
led to an increase in the scope of this approach.  
The large and growing body of literature showing a relationship between 
quantitative analysis of SNP parameters and various ocular and systemic 
pathologic conditions highlights the importance of understanding the natural 
morphometric characteristics of the SNP over time. Besides, the uncertainty 
and true extent of age effect on the SNP morphology required a longitudinal 
study examining the same participants over a period of time which enables 
us to explore the true age effect in a healthy population. Therefore, the first 
main question in this study sought to determine the age-dependent 
alterations and longitudinal course of SNP structure in healthy individuals. 
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As reviewed above, several studies have attributed the pronounced corneal 
nerve pathology in diabetes to diabetic peripheral neuropathy. With reference 
to the lack of previous investigation concerning the natural history of corneal 
nerves in diabetes, the second main question explored the natural history of 
the SNP parameters in diabetes individuals without and with neuropathy and 
attempted to fill this research gap. Furthermore, the longitudinal relationship 
between changes in corneal nerve structure and established measures of 
neuropathy in individuals with diabetes was addressed. 
Application of CCM in studies with large numbers of participants where 
multiple images from each participant need to be analysed as well as in 
longitudinal studies such as the present study with repeated measurements 
over time, necessitated employment of a fully automated analytical system to 
overcome shortcomings which are associated with manual and semi-
automated techniques. Thus, the third research question dealt with the 
association, agreement and detection capability of manual, semi-automated 
and fully automated techniques of SNP morphometric quantification. 
Since the main theme of this project was the natural history of SNP structure 
in participants with diabetes and healthy controls with annual repeated 
measurement of the SNP parameter, the fourth research question sought to 
examine the intra- and interobserver repeatability of these parameters in 
control and diabetes participants. Hence, prior to undertaking the 
investigation of the above mentioned first and second research questions, 
two studies were conducted addressing the third and fourth research 
questions which were related to the methodological development. 
Consequently, the orientation of the rest of this thesis will be as following: 
• Chapter 3, where the association, agreement and detection capability 
of the three segmentation techniques of manual, semi-automated and 
fully-automated has been examined. 
• Chapter 4, where the results of an intra- and interobserver study of the 
SNP parameters were presented. 
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• Chapter 5, the general methodology and the baseline characteristics 
of the participants included in this longitudinal study have been 
delineated. 
• Chapter 6, the age-dependent alterations and longitudinal course of 
SNP structure in healthy individuals over three years have been 
addressed. 
• Chapter 7, natural history of SNP morphology in a cohort of diabetic 
individuals without and with neuropathy has been investigated. 
• Chapter 8, a summary of the finding and directions for possible future 




 Comparison of Manual, Semi-automated and Fully-automated Quantification of the Subbasal Nerve Plexus 41 
CHAPTER 3. COMPARISON OF MANUAL, SEMI-AUTOMATED AND 
FULLY-AUTOMATED QUANTIFICATION OF THE SUBBASAL NERVE 
PLEXUS 
3.1 Foreword 
In line with the main aim of this PhD project to find out the natural course of 
corneal nerve morphology in a cohort of type 1 diabetic individuals without 
and with neuropathy and control participants, the paper presented in this 
chapter describes an important element of research methodology – 
comparison of a newly developed segmentation algorithm with semi-
automated and manual methods. A fully-automated image analysis system 
which allows objective subbasal nerve quantification is essential for 
eliminating disadvantages that are associated with semi-automated and 
manual approaches. If this technique is to be employed, it must be able to 
detect the differences between groups and also show high association with 
those of manual and semi-automated methods. Once the diagnostic ability 
and the association of fully-automated segmentation are established, further 
evaluations such as intra- and interobserver repeatability study of the nerve 
parameters (next chapter) could be tracked. These are also of high 
importance for this longitudinal project and will be explained in the next 
chapter. The paper that is presented in this chapter has been published in 
the journal Cornea: 
Dehghani C, Pritchard N, Edwards K, Russell AW, Malik RA, Efron N. Fully 
automated, semiautomated, and manual morphometric analysis of corneal 
subbasal nerve plexus in individuals with and without diabetes. Cornea 2014; 
33:696-702. 
3.2 Abstract 
Purpose: To determine the association, agreement and detection capability 
of a fully-automated, semi-automated and manual method of corneal nerve 
fibre length (CNFL) quantification of the human corneal sub-basal nerve 
plexus (SNP).  
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Methods: Thirty-three participants with diabetes and 17 healthy controls 
underwent laser scanning corneal confocal microscopy. Eight central images 
of the SNP were selected for each participant and analysed using a manual 
(CCMetrics), semi-automated (NeuronJ) and fully-automated (ACCMetrics) 
software to quantify CNFL. The repeated-measures ANOVA analysis was 
used to examine the differences between the three methods. To explore the 
association and agreement between methods, the correlation coefficients, 
intraclass correlation coefficient (ICC) and Bland-Altman tests were applied.   
Results: For the entire cohort, mean CNFL values quantified by CCMetrics, 
NeuronJ and ACCMetrics were 17.4 ± 4.3, 16.0 ± 3.9 and 16.5 ± 3.6 
mm/mm2, respectively (P < 0.01). CNFL quantified using CCMetrics was 
significantly higher than those obtained by NeuronJ and ACCMetrics (P < 
0.05). The three methods were highly correlated (correlation coefficients from 
0.87 to 0.98, P < 0.01). The ICC values were 0.87 for ACCMetrics vs. 
NeuronJ and 0.86 for ACCMetrics vs. CCMetrics. Bland-Altman plots of the 
CNFL values showed good agreement between the manual, semi-automated 
and fully-automated analysis. A small underestimation of CNFL was 
observed using ACCMetrics with increasing amount of nerve tissue. All three 
methods were able to detect CNFL depletion in diabetic participants (P < 
0.05) and in those with peripheral neuropathy as defined by Toronto criteria 
compared to healthy controls (P < 0.05).  
Conclusion: Automated quantification of CNFL provides comparable 
neuropathy detection ability to manual and semi-automated methods. 
Because of its speed, objectivity and consistency, fully-automated analysis of 
CNFL might be an advantage in studies of diabetic neuropathy.  
3.3 Introduction 
The human cornea is one of the most richly innervated surface tissues in the 
body (Müller, et al., 2003). The corneal sub-basal nerve plexus (SNP) is 
located between Bowman’s layer and the corneal basal epithelium. The SNP 
originates from sub-Bowman’s nerves penetrating Bowman’s layer 
perpendicularly, branching into one or more subbasal nerves which run 
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parallel to the ocular surface (Al-Aqaba, et al., 2010; Marfurt, et al., 2010). At 
this interface, corneal nerves anastomose extensively with each other to form 
a dense and homogenous nerve plexus and eventually terminate within the 
superficial epithelial layers of the cornea (Marfurt, et al., 2010). 
The SNP has been studied extensively in vivo using corneal confocal 
microscopy (CCM). Quantification of this nerve plexus appears to be a 
promising non-invasive and sensitive marker for detection and stratification of 
diabetic peripheral neuropathy (DPN) (Edwards, et al., 2012b; Malik, et al., 
2003; Quattrini, et al., 2007; Tavakoli, et al., 2010b), a prevalent and 
debilitating complication of diabetes (Callaghan et al., 2012a). As such, valid 
and reliable quantification of the structural status of the SNP is crucial to 
optimize detection, monitor progression and assess possible intervention and 
treatment strategies in clinical disorders affecting peripheral nerves, 
especially DPN. 
Numerous morphologic parameters of the SNP have been reported, such as 
nerve fibre beading, length, branching and tortuosity (Grupcheva, et al., 
2002; Malik, et al., 2003; Oliveira-Soto & Efron, 2001). Compared with other 
parameters, corneal nerve fibre length (CNFL) has been suggested to be the 
optimal and most reliable parameter to detect nerve injury in diabetes, as 
demonstrated by advantages in repeatability, reproducibility and concurrent 
validity (Ahmed, et al., 2012; Efron, et al., 2010; Hertz, et al., 2011). CNFL 
appears to be a sufficiently sensitive measure of nerve impairment and 
reassuringly, age and the use of contact lenses do not confound assessment 
of CNFL for the screening of neuropathies such as DPN (Wu, et al., 2012).  
Currently, quantification of SNP parameters from images obtained via in vivo 
CCM is mostly based on manual and semi-automated techniques (Ahmed, et 
al., 2012; Hertz, et al., 2011; Labbé, et al., 2012; Petropoulos, et al., 2013b; 
Wu, et al., 2012). These procedures include manual tracing of nerves and 
then calculation of the nerve fibre parameters with a segmentation algorithm 
method written in Matlab (Dabbah et al., 2009) or Java (Meijering, 2010), 
which are tedious, time-consuming and subjective, require experience and 
are prone to variability between and within observers (Dabbah et al., 2011; 
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Efron, et al., 2010; Petropoulos, et al., 2013b; Scarpa et al., 2008). Fully-
automated analytical techniques have been developed to obviate the 
limitations of manual analysis and to extend the diagnostic value of this 
technique to clinical practice (Dabbah, et al., 2011; Ferreira et al., 2012; 
Holmes et al., 2010; Parissi, et al., 2013; Scarpa, et al., 2008). Furthermore, 
application of CCM in large cohort studies where multiple images from each 
participant need to be analysed - perhaps by team of assessors and 
repeated over time in longitudinal investigations - necessitates development 
of a fully-automated system to overcome these limitations. 
The purpose of this study was to compare two methods of manual and semi-
automated analysis – CCMetrics (Dabbah, et al., 2009) and NeuronJ 
(Meijering, 2010) - with an automated analysis system (ACCMetrics) 
(Dabbah, et al., 2011), for analysing SNP images obtained by in vivo CCM in 
healthy controls and individuals with diabetes. The capability of these 
techniques to detect reduced CNFL in individuals with DPN was also 
investigated. 
3.4 Methods 
3.4.1 Study participants 
Data were accessed from a random subset of 50 participants from a total 
cohort of 314 participants at the Brisbane site of the ongoing LANDMark 
(Longitudinal Assessment of Neuropathy in Diabetes using novel ophthalmic 
Markers) study (Pritchard, et al., 2014). Specifically, in this retrospective, 
cross-sectional study data were acquired from the “year three” examinations 
of these participants, and included 17 healthy controls and 33 individuals with 
diabetes who were stratified into those with (N = 13) and without (N = 20) 
neuropathy. The first 20 and 40 participants’ IDs in the LANDMark database 
were initially selected for controls and diabetic groups, respectively. Then 
participants who did not have the “year three” examination were excluded. 
Exclusion criteria were: a history of ocular surgery, trauma or disease; or 
systemic disease (apart from diabetes), which might have affected the 
cornea. Four participants (2 controls and 2 with diabetes), who were current 
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soft contact lens wearers, were asked to refrain from lens wear on the day of 
their examination. Diabetes was the only known cause of the presence of 
peripheral neuropathy.  
Ethical approval was obtained from the Princess Alexandra and Mater 
Hospital and Queensland University of Technology research ethics 
committees. The study was conducted in accordance with the principles of 
the Declaration of Helsinki. 
3.4.2 Corneal confocal microscopy 
Laser-scanning CCM was conducted using the Heidelberg Retinal 
Tomograph (HRT3) with Rostock Corneal Module (Heidelberg Engineering 
GmbH, Heidelberg, Germany). This device generates 2-dimensional images, 
consisting of 384 X 384 pixels, covering an area of 400 X 400 µm when used 
with a X63 objective lens. The cornea of the dominant-hand side of the 
participant was anesthetized with 1 drop of 0.4% benoxinate hydrochloride 
(oxybuprocaine hydrochloride; Bausch & Lomb, NSW, Australia). Participants 
were instructed to fixate on a near target with the contralateral eye. The CCM 
was advanced forward, and gentle contact was established between the front 
of the applanation cap and the cornea; this procedure was facilitated by a 
side-mounted CCD camera that allowed the examiner to ensure that the 
central region of cornea was being examined. Using the manual focusing and 
section mode, multiple images of the SNP were captured from the central 
cornea of each participant. All captured images were saved digitally, and 
then the first 8 images of the SNP of each participant displaying in-focus 
nerves and not overlapping more than 20% among selected images 
(Vagenas et al., 2012) were chosen for analysis. 
3.4.3 Neuropathy assessment 
All participants underwent detailed assessment of neuropathy including nerve 
electrophysiology (peroneal motor nerve amplitude and conduction velocity), 
neuropathy disability score (NDS) (Young, et al., 1993) and diabetic 
neuropathy symptoms score (DNSS) (Meijer, et al., 2002). The Toronto 
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criteria (Tesfaye, et al., 2010) were used to determine the presence of 
neuropathy; specifically, individuals were considered to have neuropathy if 
they had abnormal nerve conduction (compared with age-matched controls in 
the LANDMark study) and a sign (NDS score ≥ 3 of 10) or symptom (DNSS ≥ 
1 of 4) of neuropathy.  
3.4.4 Morphometric analysis of SNP images 
Eight images were analysed from each of the 50 participants using each of 
the three techniques described below (i.e. 1,200 images analysed in total) by 
one investigator (C.D), who was masked with respect to diabetes/neuropathy 
status of the participants. The average CNFL of eight images was calculated 
to determine the CNFL measure of each participant. 
CCMetrics is a custom-designed manual nerve analysis software package 
developed at the University of Manchester (Manchester, United Kingdom) 
(Dabbah, et al., 2009). All clearly visible nerves were traced with a manual 
drawing module (Figure  3-1). The software converts manual tracings of the 
SNP to measures of corneal nerve fibre length (CNFL), corneal nerve density 
and corneal nerve fibre tortuosity. However, for purpose of this study, only 
the results of CNFL, which is defined as total length of all nerve fibres in the 
CCM image (in units of mm/mm2), were considered.  
NeuronJ is an semi-automated nerve tracing software package (Meijering, 
2010) which is a plug-in module for ImageJ, a free Java-based image 
analysis software. Nerve tracing is initiated by locating the beginning of the 
nerve of interest and the tracing algorithm subsequently computes and 
shows the ‘optimal’ path (Figure  3-1). In some areas with low contrast 
nerves, the program fails to find the correct path. In such a case there is an 
option to switch to manual tracing mode; however, this option was not used 
here. CNFL was calculated by tracing all the nerve fibres and nerve branches 
in the image. This length was then divided by the area of the field-of-view 
provided by the CCM to derive the value of CNFL in units of mm/mm2. 
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ACCMetrics is a fully-automated software package (Dabbah, et al., 2011) 
also developed at the University of Manchester (Manchester, United 
Kingdom), which allows automatic nerve detection (Figure  3-2). The software 
is optimised for 384 X 384 pixels CCM images with the field of view of 400 X 




Figure  3-1 Screen snapshots of manual (CCMetrics) (top) and semi-
automated (NeuronJ) (bottom) methods of corneal nerve quantification 
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Figure  3-2 Fully-automated (ACCMetrics) analysis of corneal subbasal nerve 
parameters  
Time analysis 
The average time taken per frame for manual identification and/or tracing of 
nerves and software analysis was determined with a digital timing device.  
This procedure was conducted for all participants using each technique, all 
performed by the same operator (C.D.). 
Interobserver variability of CNFL quantification 
To determine interobserver variability in quantification of CNFL, one image 
from each of 15 randomly selected participants was selected from our data 
set. Quantification of CNFL was performed on all of these images by a 
second observer using each of the three techniques described above.  
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3.4.5 Statistical analysis 
IBM SPSS (version 21.0) was used to analyse the results. All data are 
presented as the mean ± standard deviation (SD). Normality of the data was 
assessed by Shapiro-Wilk test and appropriate statistical techniques were 
employed. Differences between methods were examined by using repeated-
measures analysis of variance (ANOVA) and Bonferroni correction. The 
Pearson correlation and intraclass correlation coefficients (ICC) were applied 
to explore the relationship between the three methods of CNFL 
quantification. Correlation coefficient was used to test if the measurements 
by a pair of methods are related. ICC, which measures the average 
correlation, was used to assess reliability and consistency between two 
methods.  
Bland-Altman plots (Bland & Altman, 1986) were generated to facilitate an 
appreciation of the extent of between-method differences and the relation 
between these differences and the overall magnitude of CNFL. This 
statistical approach is a robust way for comparing two methods of clinical 
measurements and comprised of a graph of the difference between two 
methods against the average of the two methods as well as calculating 95% 
limits of agreements (Bland & Altman, 1995). We would expect 95% of 
differences between the pair of measurements to lie between upper and 
lower limits of agreement. The independent samples t-test, one-way ANOVA 
and Scheffe’s post-hoc test were also used to establish differences between 
groups. P-values of < 0.05 were considered significant for all statistical tests. 
Interobserver variability of CNFL was determined using the paired-samples t-
test and ICC.  
The sample size determination was undertaken based on previous studies in 
which similar methodology (e.g. stratification, CNFL definition and analysis) 
were used (Ahmed, et al., 2012; Edwards, et al., 2012b). The effect size was 
determined using available CNFL data in different groups. Analysis using 
G*Power 3 software (Faul et al., 2007) showed that a total of 36 participants 
(12 participants per three groups), under the assumption of a type 1 error (α 
level) of 0.05 and 90% power, were required to discriminate the difference 
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among groups. Enrolment continued, until the smallest group (diabetes with 
DPN) contained 13 subjects, resulting in a total of 50 participants. 
3.5 Results 
The clinical characteristics of the 50 participants are shown in Table  3-1. Age 
was not significantly different between diabetic individuals without DPN 
(DPN-ve), with DPN (DPN+ve) and control group (P = 0.56). The DPN-ve 
and DPN-ve groups had significantly higher HbA1c (P < 0.001) and lower total 
cholesterol (P < 0.01) compared to controls. The DPN+ve group found to 
have higher duration of diabetes compared with DPN-ve group.  
For the entire cohort, the mean CNFL quantified by CCMetrics, NeuronJ, and 
ACCMetrics were 17.4 ± 4.3 mm/mm2, 16.0 ± 3.9 mm/mm2, and 16.5 ± 3.6 
mm/mm2, respectively (repeated-measures ANOVA, P < 0.01). The CNFL 
determined using CCMetrics was found to be significantly higher than that 
determined using ACCMetrics and NeuronJ (mean differences 0.9 and 1.4 
mm/mm2, respectively, P < 0.05). Mean CNFL values did not differ between 
those obtained using ACCMetrics versus NeuronJ (mean difference 0.5 
mm/mm2, P = 0.07). 
The three methods were highly correlated (correlation coefficients 0.87–0.97, 
P < 0.01) with the strongest correlation between CCMetrics and NeuronJ (r = 
0.97, P < 0.001). The calculated ICC values were 0.87 (95% confidence 
intervals: 0.77–0.92) for ACCMetrics versus NeuronJ and 0.86 (0.77–0.92) 
for ACCMetrics versus CCMetrics. Table  3-2 summarizes the results of 
comparison between methods in the entire cohort, control, and diabetic 
groups.
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Table  3-1 Clinical demographic results in study participants. Data are mean ± SD unless otherwise indicated 
Characteristics C  
(n = 17) 
DPN-ve 
 (n = 20) 
DPN+ve 
(n = 13) 
P-value Significant Differences from  
pairwise comparisons 
Age (years) 58.8 ± 10.1 61.3 ± 11.2 62.8 ± 8.4 0.56† NS 
HbA1c (%) 5.5 ± 0.3 7.9 ± 0.9 8.0 ± 1.2 < 0.001‡ C vs. DPN-ve and DPN+ve, P < 0.001 
Duration of diabetes 
(years) 
- 18.8 ± 10.2 28.2 ± 16.9 0.004§ DPN-ve vs. DPN+ve, P = 0.004 
Total cholesterol 
(mmol/L) 
5.9 ± 1.2 4.3 ± 1.1 4.3 ± 1.2 < 0.001† C vs. DPN-ve and DPN+ve, P < 0.01 
BMI 26.7 ± 3.7 28.5 ± 5.3 31.4 ± 5.3 0.03† C vs. DPN+ve, P < 0.03 
Systolic blood pressure 
(mmHg) 
117.0 ± 16.5 123.2 ± 13.3 123.1 ± 9.7 0.33† NS 
Diastolic blood pressure 
(mmHg) 
73.7 ± 9.4 73.4 ± 7.4 70.5 ± 5.2 0.47† NS 
†One way ANOVA t-test; ‡Kruskal Wallis test; §Independent samples t-test.  
C, controls; DPN-ve, diabetic individuals without DPN; DPN+ve, diabetic individuals with DPN; NS, no significant difference 
 Comparison of Manual, Semi-automated and Fully-automated Quantification of the Subbasal Nerve Plexus 52 
Table  3-2 Comparison of corneal nerve fibre length (CNFL) as obtained using ACCMetrics (CNFL-ACCMetrics), CCMetrics 
(CNFL-CCMetrics) and NeuronJ (CNFL-NeuronJ) in total cohort (N = 50), controls (N= 17) and diabetic (N = 33) 
participants. 
   CNFL-ACCMetrics CNFL-NeuronJ 
   Total Control 
group 













Mean CNFL difference (mm/mm2) 0.88* - - 1.40** - - 















Mean CNFL difference (mm/mm2) - 1.84** - - 1.56** - 
















Mean CNFL difference (mm/mm2) - - 0.39 - - 1.31** 
Pearson correlation - - 0.88** - - 0.96** 
ICC 
(95% CI) 
- - 0.88** 
(0.77-0.94) 















Mean CNFL difference (mm/mm2) - - - 0.51 - - 
Pearson correlation - - - 0.87** - - 
ICC 
(95% CI) 










Mean CNFL difference (mm/mm2) - - - - -0.28 - 
Pearson correlation - - - - 0.81** - 
ICC 
(95% CI) 











Mean CNFL difference (mm/mm2) - - - - - 0.92* 
Pearson correlation - - - - - 0.87** 
ICC 
(95% CI) 
- - - - - 0.87** 
(0.75-0.93) 
* P-value < 0.05; ** P-value < 0.01; ICC, intra-class correlation coefficient; CI, confidence interval. 
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Bland–Altman plots comparing the automated technique with the 
semiautomated and manual procedures are shown in Figure  3-3. For the 
comparison of ACCMetrics versus NeuronJ (Figure  3-3A), the downward 
slope of the regression line indicates that, for higher mean CNFL values, a 
lower value was assigned to CNFL as obtained using ACCMetrics (R2 = 0.01, 
P = 0.42). A similar downward trend was observed for the comparison of 
ACCMetrics versus CCMetrics (Figure  3-3B). However, only for the latter 
comparison, there was a weakly significant relationship between the 
difference in the CNFL and mean CNFL (R2 = 0.09, P = 0.03). For the 
comparison of CCMetrics and NeuronJ (Figure  3-3C), the upward slope 
indicates that, for higher mean CNFL values, a higher value was assigned to 
CNFL as obtained by CCMetrics, and there was a modest relationship 
between the difference in the CNFL and mean CNFL (R2 = 0.15, P < 0.01). 
The average time to obtain a value of CNFL per image for each technique in 
this study was 96 ± 25 seconds for CCMetrics, 64 ± 20 seconds for NeuronJ, 
and 13 ± 2 seconds for ACCMetrics (repeated-measures ANOVA, P < 
0.001). All 3 pairwise comparisons were significantly different (Bonferroni, P 
< 0.001). 
Interobserver repeatability of CNFL quantification was assessed for each of 
the three techniques. The mean difference in CNFL between the two 
observers and ICC values were as follows: NeuronJ—0.62 mm/mm2 (paired t 
test, P = 0.16) and 0.95 (P < 0.01); CCMetrics—0.75 mm/mm2 (P = 0.11) and 
0.97 (P < 0.01). CNFL values quantified by ACCMetrics were identical for 
both observers. 
Three methods revealed reduced CNFL in diabetic individuals compared with 
controls (independent t test, P < 0.05). Using the NDS, 4 diabetic participants 
had mild (NDS: 3–5), 3 had moderate (NDS: 6–8), and 1 had severe (NDS: 
8–10) neuropathy. Of the 33 participants with diabetes, 13 (39%) met the 
Toronto criteria for the presence of neuropathy.  
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Figure  3-3 Relationship between differences in CNFL vs. mean CNFL for 
ACCMetrics vs. NeuronJ (A), ACCMetrics vs. CCMetrics (B) and CCMetrics 
vs. NeuronJ (C). On each graph, the solid line indicates the linear regression 
and the dashed lines indicate the 95% limits of agreement. C, controls; DPN-
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Table  3-3 Corneal nerve fibre length (CNFL) values in healthy controls (C) 




 (n = 17) 
DPN-ve 
(n = 20) 
DPN+ve 







18.1 ± 2.7 16.3 ± 3.8 14.8 ± 3.8 0.043 C vs. DPN-ve, P = 0.307 
C vs. DPN+ve, P = 0.045 




18.3 ± 2.9 15.4 ± 4.1 13.8 ± 3.0 0.002 C vs. DPN-ve, P = 0.046 
C vs. DPN+ve, P = 0.004 




19.9 ± 3.4 17.0 ± 4.5 14.8 ± 3.1 0.002 C vs. DPN-ve, P = 0.074 
C vs. DPN+ve, P = 0.003 
DPN-ve vs. DPN+ve, P = 
0.281 
Values are presented as mean ± SD 
Table  3-3 summarizes quantified CNFL values pertaining to the three 
methods of morphometric analysis, stratified according to the neuropathy 
status. There was a significant difference between groups for all measures (P 
< 0.05). CNFL values were significantly lower for individuals with neuropathy 
compared with controls for all 3 methods of morphometric analysis (P < 
0.05). CNFL reduction as estimated with NeuronJ was marginally significant 
(P = 0.046) in individuals with diabetes without neuropathy compared with 
controls. 
3.6 Discussion 
The increasing interest in assessing morphological parameters of the SNP in 
relation to peripheral neuropathies highlights the need for a reliable, quick, 
highly repeatable, and reproducible method of analysis, particularly when 
these parameters are to be assessed in longitudinal studies, perhaps by 
multiple operators, or to examine the benefits of possible interventions. To 
overcome shortcomings associated with manual tracing and quantification of 
the SNP parameters, several research groups have developed fully 
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automated nerve fiber analysis software (Dabbah, et al., 2011; Ferreira, et 
al., 2012; Scarpa, et al., 2008; Scarpa et al., 2011). This study assessed the 
reliability of a manual (CCMetrics), semiautomated (NeuronJ), and fully 
automated software (ACCMetrics) analysis system for CNFL quantification in 
a diverse cohort of healthy individuals and participants with diabetes. 
Age was well matched between individuals with diabetes and healthy 
controls (P = 0.31). Lower level of total cholesterol was observed in 
participants with diabetes compared to controls, as 25/33 (75%) participants 
with diabetes were receiving lipid lowering therapy with statins vs. none of 
the 17 controls. CCMetrics, the technique requiring the most observer input, 
yielded higher CNFL values compared with NeuronJ and ACCMetrics. The 
lower CNFL values obtained using ACCMetrics compared with CCMetrics 
was not unexpected, because a human observer is able to detect a higher 
number of nerves (particularly low-contrast nerves) than the automatic 
algorithm used in ACCMetrics. Furthermore, during the development of the 
algorithm for nerve detection, the threshold for detection was deliberately 
increased to minimize the recognition of background artefacts. Indeed, 
underestimation of this SNP parameter by fully automated segmentation 
seems to be consistent with previous studies (Dabbah, et al., 2011; Ferreira, 
et al., 2012; Scarpa, et al., 2008). The difference between CNFL values 
obtained using NeuronJ and ACCMetrics was neither clinically nor 
statistically significant. This may be ascribed to the fact that the “manual 
tracing” mode of NeuronJ was not used in this study and all tracings were 
performed using the “optimal” path detection mode. 
The Bland-Altman plots (Figure  3-3) and ICC values (Table  3-2) confirm 
excellent agreement between both semi-automated and manual methods vs. 
fully-automated segmentation. The three methods were also strongly 
correlated. The correlation between each of the semi-automated and manual 
methods vs. the fully-automated analysis were identical (r = 0.87, P < 0.01), 
but slightly lower than that obtained by Scarpa et al. (Scarpa, et al., 2008) 
and Dabbah et al. (Dabbah, et al., 2011). Scarpa et al. (2008) analysed 90 
images of the SNP from 76 normal and 14 abnormal subjects and reported a 
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correlation coefficient of 0.94. When they applied their automatic procedure 
to an independent source with 80 images from normal participants, the 
correlation coefficient between the automatic and manual method reduced to 
0.89. 
As noted above, an underestimation of CNFL determined using ACCMetrics 
compared to CCMetrics was observed with increasing amount of nerve 
tissue. The difference between the correlation coefficients in our study (r = 
0.87) and those of Dabbah et al. (r = 0.95) in which 68 participants (20 
controls and 48 diabetic participant) were investigated, can be attributed 
partly to the lower number of individuals with moderate and severe 
neuropathy (NDS ≥ 6) in the present study (8%) compared with their study 
(19%).  
In a recent study of 106 healthy individuals, Parissi et al. (2013) reported a 
mean CNFL difference of 0.07 mm/mm2 and a linear association of CNFL 
with slope of 0.91 between NeuronJ and automatic methods. In our study, 
however, the mean CNFL difference was 0.5 mm/mm2 and the linear 
association slope was 0.81. The difference in results may be due to the 
differences between two studies in respect to the population size and 
composition and the number of selected images for each participant (mean 
4.3 images in their study vs. 8 images in our study).  
Perfect interobserver agreement in CNFL quantification when using 
ACCMetrics, is not surprising given that this is a fully-automated technique 
that requires no manual input from the observer. The high interobserver 
repeatability for NeuronJ and CCMetrics reported here is consistent with 
previous studies (Efron, et al., 2010; Hertz, et al., 2011; Petropoulos, et al., 
2013b). Manual, semiautomated, and fully automated methods of CNFL 
quantification were able to differentiate individuals with neuropathy from 
controls. Fully automated nerve analysis was about 7× and 4× faster than 
manual and semiautomated morphometric analysis methods, respectively. 
These findings highlight the advantages of the fully automated versus manual 
and semiautomated methods of CNFL analysis, particularly for large cohort 
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trials and longitudinal studies that require analysis of large numbers of 
images. 
 
Figure  3-4 Examples of subbasal nerve length estimation. The original 400 X 
400 µm image of a participant with diabetes and peripheral neuropathy (A). 
Analysis of the original image is shown for CCMetrics (CNFL = 11.8 
mm/mm2) (B), ACCMetrics (11.64 mm/mm2) (C), and NeuronJ (10.0 
mm/mm2) (D). Cells and artefacts that were erroneously identified as nerve 
fibres are indicated with arrowheads. Low-contrast and faint nerves, which 
could not be identified, are indicated with arrows.  All images are 400 X 
400µm. 
Despite the ease of fully-automated CNFL analysis, both false negative and 
false positive errors were evident upon close visual inspection of the 
processed images. Common nerve tracing errors made by the automatic 
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nerve-tracking algorithm included: (a) failure to detect nerves which are thin, 
out of focus or faint, and (b) erroneous recognition of other structures as 
nerve segments, dendritic cells and other artefacts (Figure  3-4). Although 
these shortcomings can be improved by performing manual post-analysis 
editing of images that have undergone initial automated segmentation, the 
marginal overall advantage of such a process may be offset by the 
introduction of inadvertent operator bias and consequent reduction of 
repeatability (Holmes, et al., 2010; Scarpa, et al., 2008), and significant, 
resource intensive and time-consuming manual input. It should also be noted 
that the underestimation of CNFL when using ACCMetrics, compared with 
CCMetrics, may limit the capacity of this software program to detect changes 
in CNFL in early diabetic neuropathy.  
In conclusion, we have demonstrated that fully automated analysis can 
compute CNFL values, which are in close agreement with systems that use 
manual and semiautomated segmentation. These three techniques are also 
capable of differentiating those with and without DPN. Because of its speed, 
objectivity, and consistency, fully automated analysis of CNFL might be 
advantageous in studies of diabetic neuropathy.  
3.7 Subsequent validity study of fully-automated image analysis 
algorithm 
The findings we presented in this study in relation to the reliability of 
ACCMetrics for CNFL quantification are supported by a recent study by 
Petropoulos et al. (2014) who reported a high correlation between manual 
(CCMetrics) and fully-automated (ACCMetrics) quantification of CNFL (r = 
0.89) in 186 participants with diabetes and 55 controls. Similar to this study, 
they found significantly reduced CNFL in participants with DPN compared 
with controls using both manual and fully-automated techniques while there 
was a slight underestimation of CNFL as obtained using ACCMetrics 
compared to CCMetrics. Although our study did not compare the three 
techniques for other SNP parameters than CNFL, Petropoulos and co-
workers in their recent study also validated automated CNFD and CNBD 
against those obtained manually. 
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CHAPTER 4. INTRA- AND INTEROBSERVER REPEATABILITY OF 
CORNEAL NERVE PARAMETERS 
4.1 Foreword 
Addressing the issues of intra- and interobserver repeatability of the 
measurement procedures are critical in longitudinal studies where the 
differences in the values are to be monitored over time. Therefore, this was 
an essential part of the research methodology to allow application of corneal 
confocal microscopy (CCM) with automated image analysis for this 
longitudinal study. Although previous studies have evaluated repeatability 
and reproducibility of measurement of the SNP parameters in diabetic and 
healthy individuals, they either focused on the image analysis level and/or 
they used manual quantification method (Efron, et al., 2010; Hertz, et al., 
2011; Petropoulos, et al., 2013b). However, this study was designed to 
assess the intra- and interobserver repeatability of the subbasal nerve 
parameters obtained using corneal confocal microscopy (CCM) while images 
were analysed by employing fully-automated quantification method.  
4.2 Abstract 
Purpose: To assess intra- and interobserver repeatability of the SNP 
parameters measurement.  
Methods: For the purpose of interobserver repeatability, sixteen participants 
(six controls and 10 with diabetes) underwent CCM examination twice by the 
same observer. For another group of 11 participants (five controls and six 
with diabetes), a second observer then repeated the CCM examination. Eight 
selected central corneal images were then analysed using a fully-automated 
technique. 
Results: There were no significant differences between mean SNP 
parameters of two sessions for intra- and interobserver assessment. 
Moderate to high intraclass correlation coefficients were found for all three 
SNP parameters (0.81-0.94, P < 0.01). The coefficients of repeatability for 
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intra- and interobserver assessments were: CNFD, 8% and 9.8%; CNBD, 
20.1 % and 22.9% and CNFL 3% and 3.6%, respectively. 
Conclusion: Among the three SNP parameters, CNFL is the most 
repeatable and reliable parameter and gives good observer-independent 
results. Assessment of SNP morphology can be used in this longitudinal 
study to evaluate possible changes over time. 
4.3 Intraobserver test-retest repeatability of the SNP parameters 
4.3.1 Methods  
To assess the consistency of measurement of SNP parameters from one 
time to another, test-retest was conducted by performing the CCM procedure 
followed by automated image analysis for 16 participants on the same day of 
examination and each participant was tested twice, at least 30 minutes apart. 
Participants were enrolled from the ongoing LANDMark study (Pritchard, et 
al., 2014) and informed consents were obtained from all of them. Prior to the 
examination, participants underwent slit-lamp biomicroscopy examination to 
ensure the absence of any corneal compromise. The methodology of CCM 
examination was identical to the methods explained in the previous chapter 
(see section 3.4.2 Corneal confocal microscopy, page 45). 
Evaluation of intraobserver repeatability was assessed by intraclass 
correlation coefficient (ICC), coefficient of repeatability (CoR) and Bland-
Altman method (Bland & Altman, 1986). The CoR was calculated as 1.96 
times the standard deviation of between the two measurements. A two-way 
random effects ICC was used for consistency of individual measurements. A 
CoR ≤ 20% was considered good and 20% to 50%, acceptable. IBM SPSS 
Statistics version 21 was used for all statistical analyses. 
4.3.2 Results  
Characteristics of the participants and the outcomes of SNP parameters are 
presented in Table  4-1. Paired t-test revealed no significant differences 
between test-retest measurements for CNFD, CNBD and CNFL (P = 0.59, P 
= 0.88 and P = 0.94, respectively). The results of ICC, limits of agreement 
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(LoA) and coefficient of repeatability (CoR) are shown in Table  4-2. Among 
the three SNP parameters, CNFL showed the highest ICC and the lowest 
CoR.  
Table  4-1 Characteristics of participants in intraobserver repeatability study. 
Values are mean ± SD or count for categorical variables. 
Parameter  Range 
Age (years) 53 ± 18 17-77 
Sex (Male/Female) 7/9 - 
Group (Control/Diabetes) 6/10 - 




20.2 ± 7.0 
19.7 ± 5.8 
 
1.6 – 32.8 
8.6 – 30.5 
CNBD (no/mm2)    
test 29.6 ± 18.8 1.0 – 82.8 
retest 29.2 ± 16.6 4.7 – 74.2 
CNFL (mm/mm2)   
test 16.4 ± 3.0  8.5 – 21.0 
retest 16.4 ± 3.2 10.6 – 22.1 
CNFD, corneal nerve fibre density; CNBD, corneal 
nerve branch density; CNFL, corneal nerve fibre length 
Table  4-2 Summary of mean difference, ICC, LoA and CoR for intraobserver 
repeatability study 
 Mean difference 
( test - retest) 
ICC 95% CI LoA CoR 
Lower Upper Lower Upper 
CNFD 
(no/mm2) 
0.56 0.81 0.53 0.93 -7.30 8.40 8% 
CNBD 
(no/mm2) 
0.40 0.84 0.60 0.97 -19.50 20.20 20.1% 
CNFL  
(mm/mm2) 
-0.02 0.90 0.75 0.97 -2.68 2.63 3% 
CNFD, corneal nerve fibre density; CNBD, corneal nerve branch density; CNFL, 
corneal nerve fibre length; ICC, intraclass correlation coefficient; CI, confidence 
interval; LoA, limits of agreement; CoR, coefficient of repeatability 
64 




Figure  4-1 Bland-Altman plots of the relationship between differences in 
subbasal nerve parameters (A) CNFD, (B) CNBD and (C) CNFL vs. their 
mean for intraobserver test-retest study. On each graph, the solid line (red) 
indicates the linear regression and the dashed lines (blue) indicate the 95% 
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Bland-Altman plots for test-retest difference and the mean of the test-retest 
were generated for CNFD, CNBD and CNFL and are illustrated in Figure  4-1. 
There was no significant relationship between mean CNFD (R2 = 0.11, P = 
0.21), CNBD (R2 = 0.05, P = 0.40) and CNFL (R2 = 0.02, P = 0.59) vs. their 
respective test-retest difference.   
4.4 Interobserver repeatability of the SNP parameters 
4.4.1 Methods  
The same procedure was conducted to examine interobserver repeatability 
for 11 participants, five healthy and six with diabetes. Each participant 
underwent CCM examinations twice by two experienced observers on the 
same day of examination. Eight images per examination were collected by 
the observer and analysed using fully-automated algorithm.  
Assessment of intraobserver repeatability was carried out by estimating ICC 
and CoR. A two-way random effects ICC was used to examine the 
consistency of measurements between two observers. A CoR ≤ 20% was 
considered good and 20% to 50%, acceptable. Bland-Altman plots (Bland & 
Altman, 1986) were also generated to depict the limits of agreement between 
two observers for measurement of the SNP parameters.  
4.4.2 Results  
Characteristics and estimates of SNP parameters of the recruited participants 
for assessment of interobserver repeatability are presented in Table  4-3. The 
mean difference between observer 2 and observer 1 was: -1.70 nerve/mm2 
for CNFD, -4.65 nerve/mm2 for CNBD and -0.72 mm/mm2 for CNFL. 
However, the differences between mean CNFD, CNBD and CNFL measured 
by two observers were not statistically significant (paired t-test, P = 0.29, P = 
0.22 and P = 0.21, respectively).  
A summary of estimated ICC, LoA and CoR are shown in Table  4-4. Similar 
to intraobserver study, CNFL showed the highest ICC and lowest CoR. The 
Bland-Altman plots of agreement between two observers for the SNP 
parameters are shown in Figure  4-2. No significant association was found 
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between mean CNFD (R2 = 0.14, P = 0.25), CNBD (R2 = 0.16, P = 0.21) and 
CNFL (R2 = 0.01, P = 0.91) vs. their respective interobserver difference. 
Table  4-3 Characteristics of the participants in interobserver repeatability 
study. Values are mean ± SD or count for categorical variables. 
Parameter  Range 
Age (years) 51 ± 11 30-65 
Sex (Male/Female) 6/5 - 
Group (Control/Diabetes) 5/6 - 




20.3 ± 10.6 
18.6 ± 8.7 
 
7.0 – 39.8 
4.7 – 32.0 
CNBD (no/mm2)    
observer 1 35.5 ± 32.7 2.3 – 100.8 
observer 2 30.9 ± 28.0 2.8 – 85.9 
CNFL (mm/mm2)   
observer 1 16.9 ± 5.1  9.0 – 26.1 
observer 2 16.2 ± 5.1 9.2 – 24.4 
CNFD, corneal nerve fibre density; CNBD, corneal 
nerve branch density; CNFL, corneal nerve fibre length 
Table  4-4 Summary of mean difference, ICC, LoA and CoR for interobserver 
repeatability study 
 Mean difference 
( observer 2 – 
observer 1) 
ICC 95% CI LoA CoR 
Lower Upper Lower Upper 
CNFD 
(no/ mm2) 
-1.70 0.87 0.58 0.96 -11.54 8.14 9.8% 
CNBD 
(no/ mm2) 
-4.65 0.93 0.75 0.98 -27.60 18.29 22.9% 
CNFL  
(mm/ mm2) 
-0.72 0.94 0.78 0.98 -4.33 2.86 3.6% 
CNFD, corneal nerve fibre density; CNBD, corneal nerve branch density; CNFL, 
corneal nerve fibre length; ICC, intraclass correlation coefficient; CI, confidence 
interval; LoA, limits of agreement; CoR, coefficient of repeatability 
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Figure  4-2 Bland-Altman plots of the relationship between differences in 
subbasal nerve parameters (A) CNFD, (B) CNBD and (C) CNFL vs. their 
mean for interobserver study. On each graph, the solid line (red) indicates 
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4.5 Discussion 
In this study, the repeatability of SNP parameters within one observer 
(intraobserver) and between two observers (interobserver) was examined. 
Amongst the three evaluated SNP parameters, CNFL achieved the highest 
criteria for intraobserver repeatability with an ICC of 0.90, which 
demonstrates a very good reliability between test and retest, as well as an 
estimated CoR of 3% which also indicates a high repeatability of this 
parameter. CNFD also demonstrated a moderate ICC (0.81) and low CoR 
(8%). Although CNBD also showed a moderate ICC (0.84), the calculated 
CoR was only in the acceptable level. 
Petropoulos et al. (2013b) performed an intraobserver study for a cohort of 
19 healthy individuals on two separate occasions seven days apart. Similar 
to the current study, they found no significant difference between two 
sessions for CNFD, CNBD and CNFL and they reported the highest 
consistency for CNFL and CNFD. However, compared to our study they 
found lower ICC values (CNFD, 0.81 vs. 0.74; CNBD, 0.84 vs. 0.61 and 
CNFL, 0.90 vs. 0.70) and higher CoR (CNFD, 8% vs 17%; CNBD, 20.1% vs. 
64%; and CNFL, 3% vs. 19%). These differences can be attributed to the 
time interval between sessions (30 minutes in our study vs. one week in their 
study), the image selection criteria (e.g. 8 images from the hand dominant 
side vs. 10 images from both eyes) and the analysis method (automated vs. 
manual technique). 
Regarding the interobserver study, although the mean differences of the 
three SNP parameters were larger compared with the test-retest 
intraobserver study; the estimated mean values did not differ between two 
observers. Estimated ICCs were also moderate to high between two 
measurements, indicating good reliability between observers. CNFL and 
CNFD again showed the highest repeatability while CNBD achieved an 
acceptable CoR. Comparable to our findings, Ishibashi et al. (2012) reported 
good interobserver reproducibility for CNFD and CNFL in 14 healthy 
participants using coefficient of variation, while CNBD only received a poor 
reproducibility. 
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Although they performed the reproducibility study by re-examining the 
selected CCM images using manual quantification method, our results are in 
general agreement with the conclusion of Hertz et al. (2011); CNFL has the 
superior reliability compared to the other SNP parameters.  
The mean difference of the SNP parameters in interobserver assessment 
implies that the observer 1 captured images with higher nerve density; 
however these differences, in particular for CNFL and CNFD, are minor to 
consider in clinical practice because they are practically insignificant and 
negligible. Furthermore, they showed good agreement and high ICCs 
between the two observers.  
Variations in measurement of the SNP parameters may occur because CCM 
captures images from an area of 400 X 400µm, therefore difficulties in 
locating such a small are in the central cornea at second measurement may 
result in these small variations. Other sources of variability might be 
attributable to different focusing, participant cooperation and controlling eye 
movements during image acquisition. Our findings suggest that if the CCM 
examinations are conducted in the same centre, similar good results would 
be possible when done by another observer, assuming that the same 
methodology (e.g. image capturing and analysis) is employed. It should be 
noted that if CCM is to eventually be adopted widespread, it is worth 
repeating this study using inexperienced observers. 
In conclusion, these findings indicate that measurement of the SNP 
parameters, in particular CNFL, using CCM and automated image analysis is 
highly repeatable within and between observers, which allows their 
application for longitudinal studies, provided that CCM examinations are 
done using similar methodology.  
Considering the results of the study presented in the previous chapter 
(Chapter 3) and the outcomes of the present study, we chose to employ 
CCM in combination with automated algorithm to test the main hypotheses 
which are presented in next chapters.   
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CHAPTER 5. OVERALL METHODOLOGY AND BASELINE 
CHARACTERISTICS OF THE PARTICIPANTS 
5.1 Foreword 
This chapter describes the overall methodology related to this longitudinal 
research project. Specific methodology related to each experiment has been 
presented in respective chapters. 
5.2 Participants 
As stated in section 1.8 (page 6), this PhD project was associated with the 
ongoing LANDMark study. Participants were enrolled as a part of this study 
(Brisbane site) conducted at Anterior Eye Lab, Queensland University of 
Technology (QUT). Ethical clearances were granted by QUT, Princess 
Alexandra Hospital and Mater Hospital research ethics committees 
(Appendix 1).  
Participants were recruited from the Centre for Diabetes and Endocrinology 
at Princess Alexandra Hospital and Mater Hospitals and the general 
population in Brisbane. Prior to their enrolment, written informed consent was 
obtained from all participants (Appendix 2), consistent with the Declaration of 
Helsinki. In LANDMark study, the following inclusion and exclusion criteria 
were applied at enrolment: 
Inclusion criteria: 
• Aged 14 to 75 years old 
• Signed written informed consent 
• Type 1 or type 2 diabetes, or no diabetes for control group 
• Being willing to participate and comply with the experimental protocol 
Exclusion criteria: 
• History of corneal trauma and surgery 
• History of ocular or systemic disease which may affect the cornea 
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• Concurrent ocular disease, infection or inflammation 
• History of systemic disease (e.g. malignant disease, congestive heart 
failure, major psychosis, certain auto immune diseases) 
• History of neuropathy due to non-diabetic cause 
• Current or active diabetic foot ulcer or infection 
• Participating in any other interventional research trial 
The following exclusion criteria applied to control group 
• Diabetes 
• GADAb positive 
• Presence of neuropathy  
Exclusion criterion specific to this research project: Further to the overall 
LANDMark exclusion criteria, in this study participants with type 2 were 
excluded. Additionally, participants with type 1 diabetes with moderate and 
severe neuropathy (neuropathy disability score [NDS] ≥ 6) were also 
excluded in the longitudinal aspect of this research program. 
Figure  5-1shows the number and procedure of participant enrolment in this 
study. 
 
Figure  5-1 Flow chart diagram of study participants at baseline visit  
Screened 
n = 227 
Excluded 
n = 11 
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n = 216 
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study 
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n = 39 
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5.3 Definition of neuropathy 
The definition of neuropathy has been derived from the “Toronto criteria” 
(Tesfaye, et al., 2010) that rely on the presence of abnormal 
electrophysiological finding, based on age-matched controls at the site, in 
addition to clinical signs and/or symptoms, which was defined as one or more 
of the followings: (i) neuropathy disability score (NDS) ≥ 3 of 10 (Young, et 
al., 1993) or (ii) diabetic neuropathy symptom score (DNSS) ≥ 1 of 4 (Meijer, 
et al., 2002). This definition has been used throughout this thesis. The cut-off 
values that were applied for abnormal nerve conduction in this study are 
presented in Table  5-1. These cut-offs are based on age-matched control 
individuals at the Brisbane site. 
Table  5-1 Abnormal nerve conduction criteria in this study 
Parameter 
Cut-off 
Age < 54 years Age ≥ 54 years 
Peroneal CV ankle to fibula head*  < 45 m/s < 42 m/s 
Sural CV *  < 40 m/s < 38 m/s 
Tibial CV *# < 43 m/s 
CV, conduction velocity 
a. *Less than 10th percentile for healthy individuals without neuropathy 
b. Nerve conduction is considered abnormal if (either) peroneal or sural CV is 
below age-referenced cut-off values.  
c. #If sural not present, nerve conduction is considered abnormal for Toronto 
neuropathy if tibial CV is below 43 m/s for any age. 
 
5.4 Assessment of neuropathy 
A summary of the methods applied for neuropathy assessment are presented 
below. 
5.4.1 Neuropathy signs and symptoms 
NDS: NDS is a quantitative measure of neuropathy and was carried out using 
2 Neurotips (Owen Mumford Ltd., Oxford, UK) loaded in Neuropens, 128 Hz 
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tuning fork, Metal rods, 2 beakers, hot and cold water and tendon hammer. 
This test included pain sensation, vibration sensation, temperature sensation 
and Achilles tendon reflex of both feet (Figure  5-2) and each abnormal 
response resulted in 1-point increase in score. Sharp and blunt ends of the 
Neurotip were applied on the pulp of the great toes in random order and the 
participant was asked to tell whether they think the painful stimulus occurred 
during sharp or blunt stimulus.  
To examine the vibration sensation, the circular base of the vibrating and 
non-vibrating tuning fork was held against the end of the great toes in turn 
and the participant was instructed to tell whether the vibration occurred 
during time 1 or time 2. To test the temperature sensation, two beakers were 
filled with hot and cold water and one of the metal rods was placed in the hot 
water and the other in the cold water for 30 seconds. The rods were pressed 
in turn against the foot dorsum and the participant was asked to say whether 
the warm sensation occurred during time 1 or time 2.  
All the above procedures were repeated 3 times and the response was 
considered normal if correct responses were ≥ 2/3. Achilles tendon reflex 
was tested with a hammer strike while participant was sitting with legs 
horizontal, and bent so that the knee faced outward from the body. 
Alternatively, the participant was asked to kneel on a chair. Finally, the NDS 
score was recorded from 0 to 10 (Abbott, et al., 1998; Young, et al., 1993). In 
this study, the DPN severity was classified using NDS score and only 
participants with NDS ≤ 5 were included. 
 
Figure  5-2 Pain sensation (A), vibration sensation (B), temperature sensation 
(C) and Achilles tendon reflex (D) 
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DNSS Questionnaire:  This questionnaire (Table  5-2) is a validated and fast 
measure of neuropathic symptom for clinical practice (Meijer, et al., 2002) 
which includes 4 questions and it is completed by the participant. For each 
participant the total score was recorded from 0-4, based on the positive 
answers.  
5.4.2 Quantitative sensory tests (QST) 
Quantitative thermal and vibration assessment were carried out with the 
Medoc TSA-II NeuroSensory Analyzer and the VSA-3000 Vibratory Sensory 
Analyzer (Medoc Advanced Medical Systems, Ramat-Yishai, Israel) for 
threshold determination. Vibration perception was measured on the plantar 
surface of the big toe and thermal (warm and cold) sensation was assessed 
on the dorsal surface of the foot on the hand dominant side.  
Table  5-2 Diabetic neuropathy symptom score questionnaire 
1. Are you suffering of unsteadiness in walking? 
(i.e. need for visual control, increase in the dark, walk like a drunk man, lack of contact 
with floor) 
□ Yes (1) □ No (0) 
2. Do you have a burning, aching pain or tenderness at your legs or feet? 
(i.e. occurring at rest or at night, not related to exercise, exclude claudicatio intermittens) 
□ Yes (1) □ No (0) 
3. Do you have prickling sensations at your legs and feet? 
(i.e. occurring at rest or at night, distal>proximal, stocking glove distribution) 
□ Yes (1) □ No (0) 
4. Do you have places of numbness on your legs or feet? 
(i.e. distal>proximal, stocking glove distribution) 
□ Yes (1) □ No (0) 
Total Score _____/4 
5.4.3 Nerve conduction studies (NCS) 
The Nihon Kohden Neuropack S1 (Nihon Kohden Corporation, Tokyo, 
Japan) was used for nerve conduction studies. The limb temperature was 
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maintained above 31oC. Peroneal motor nerve conduction velocity (ankle to 
fibula head), amplitude (ankle to extensor digitorum brevis) and F wave 
latency were determined on the hand dominant side of the participants.  
5.5 Ophthalmic procedures 
All ophthalmic procedures were conducted following the medical procedures. 
Typically the eye on the hand-dominant side was examined unless otherwise 
indicated. 
5.5.1 Screening procedures 
This procedure began with measurement of visual acuity using Bailey-Lovie 
chart. Slit lamp examination of the cornea and anterior segment was 
performed for presence of any corneal compromise or finding that may affect 
the study results. Intraocular pressure measurement of the test eye was 
performed using iCare tonometer (Tiolat Oy, Helsinki, Finland). 
5.5.2 Corneal confocal microscopy 
The Heidelberg Retina Tomograph 3 (HRT3) in combination with Rostock 
Corneal Module (Heidelberg Engineering, Germany) was utilized to acquire 
multiple images of the corneal subbasal nerve plexus (SNP). This instrument 
is a laser-scanning confocal microscope (LSCM) and has a field of view of 
400 X 400 µm when used with a 63X objective lens.  
A large drop of high-viscous eye gel (GenTealEyes; Novartis, North Ryde, 
NSW, Australia) was placed between the microscope objective and the 
Perspex “TomoCap” that covered the objective. The gel optically couples the 
objective lens to the Perspex cap. The cornea of the dominant-hand side of 
the participant was anaesthetised with one drop of 0.4% benoxinate 
hydrochloride (oxybuprocaine hydrochloride; Bausch & Lomb, NSW, 
Australia). The head of the participant was placed in the head and chin rest, 
and the overall height of the instrument table was adjusted for comfort. The 
participant was instructed to fixate on a near target with the contralateral eye. 
The CCM was advanced forward until the laser beam fell in the centre of the 
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pupil (Figure  5-3). The instrument was slowly moved onto the cornea until 
gentle contact was established between the front of the applanation cap and 
the cornea; this procedure was facilitated by a side-mounted CCD camera 
that displays a magnified, real-time image of the cap.  
Using the manual focusing, the SNP usually appeared at approximately 50-
60 µm. For each participant multiple images from SNP of the central cornea 
were obtained using “section mode” which enables manual acquisition of a 
single image at a time with the aid of a foot pedal. The acquired images were 
saved digitally. 
5.5.3 Image sampling and analysis 
Investigators have used arbitrary numbers of images for analysis of the SNP 
morphology in the majority of previous studies. For the purpose of this 
research program, we followed the established protocol by Vagenas et al. 
(2012). This protocol offers optimized sampling paradigm for the central 
cornea and involves selection of a prescribed number of centrally-located 
images with minimum overlap that enhance the consistency of the procedure. 
Therefore, eight SNP images displaying in focus nerves and not overlapping 
by more than 20% were chosen for each participant at each visit. Selected 
images were then analysed using ACCMetrics (Figure  5-4), which has been 
explained in more detail and also compared with manual and semi-
automated methods in Chapter 3. ACCMetrics as objective and fast method 
of corneal nerve segmentation showed good agreement with manual and 
semi-automated techniques, and its capability to detect depletion of the 
subbasal corneal nerves in individuals with DPN was comparable to those 
techniques.  
The three quantified SNP morphometric parameters acquired using 
ACCMetrics include corneal nerve fibre density (CNFD; the total number of 
major nerves per mm2), branch density (CNBD; the number of branches 
emanating from major nerves per mm2) and fibre length (CNFL; total length 
of all nerves and branches in units of mm/mm2).  
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Figure  5-3 Corneal light reflex at the centre of pupil 
 
Figure  5-4 ACCMetrics analysis of corneal nerve parameters. Original 400 X 
400 µm image of subbasal nerve plexus of a type 1 participant with 
neuropathy (A). Annotation of the same image by automatic analysis with 
CNFD = 12.5 nerve/mm2, CNBD = 25.05 nerve/mm2, and CNFL = 12.5 
mm/mm2 (B). Note that CNFD and CNBD are the number of major nerves 
(red lines) per mm2 and the number of branches emanating from major 
nerves (green dots) per mm2, respectively. CNFL is the total length of all 
nerves and branches (all blue and red lines) and expressed as mm/mm2.  
5.6 General health and metabolic measures 
Information related to history of general health were collected including 
questions of medical history, age, duration of diabetes (self-reported or 
based on health care practitioner reports), and alcohol and tobacco 
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consumption. The following relevant health measures and blood biochemistry 
parameters were obtained at each annual visit: 
Blood pressure: Blood pressure (systolic and diastolic) was measured using 
the WelchAllyn automatic digital sphygmomanometer (WelchAllyn Inc, NY, 
USA).  
Body measurements: Weight and height were measured and body mass 
index (BMI) was calculated. 
HbA1c and lipid profiles: Visits also included an assessment of glycaemic 
control (HbA1c), total cholesterol, low density lipoprotein cholesterol (LDL), 
high density lipoprotein cholesterol (HDL) and triglycerides which were 
assayed by a local certified pathology laboratory (Sullivan Nicolaides 
Pathology, Queensland, Australia). 
5.7 Data management and analysis 
Generated data from each participant were recorded on case report forms 
and then along with data from other sources such as pathology laboratory 
transferred to a central database. The data reported here were obtained from 
the database and all analyses were performed using IBM SPSS version 21. 
5.8 Sequence of tests and main outcome variables  
Medical and neuropathy assessments were often conducted at the beginning 
of the annual visits, followed by ophthalmic procedures. NCS usually were 
performed at the end of study visit. A summary of tests conducted and 
outcome variables recorded for participants at annual visits are shown in 
Table  5-3 
5.9 Length of this longitudinal study 
Lack of a previously conducted longitudinal study in respect to human 
corneal nerve morphology made it difficult to design a study with an 
appropriate length in order to allow clinically and pathologically significant 
changes to be observed. It has been suggested that longitudinal 
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assessments of diabetic neuropathy need to be conducted for a period of at 
least three years to achieve a meaningful and clinically significant change in 
QST results (Dyck, et al., 1997). 
Substantial deterioration of clinical neurological examination has been shown 
in a previous longitudinal study with follow up duration of 2-4 years (van de 
Poll-Franse, et al., 2002). Significant worsening of DPN using NCS and QST 
over 12 months (Brown, et al., 2004) have also been reported. Considering 
these findings and previous studies of the relationship between traditional 
tests of neuropathy and corneal nerve morphology, a 4-year follow up with a 
baseline visit was chosen. 
Table  5-3 Procedures and outcome parameters in this study 
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5.10 Sample size calculation 
Since the main hypothesis in this current study was the greater progression 
rate of SNP pathology in the neuropathy group compared to the control 
participants, the required sample size was calculated considering this 
hypothesis. The principle outcome measures for this hypothesis relate to 
change in CNFL and CNFD as the most reliable and repeatable parameters 
over a four year period. In the absence of pre-existing longitudinal data, the 
available baseline data of the LANDMark participants (type 1 diabetes and 
controls) were analysed to determine the sample size, because the mean 
and SD of the these parameters pertaining to the three groups of interest 
(control, type1 without and with neuropathy) could be obtained. The G*Power 
3 software (Faul, et al., 2007) was used to calculate the effect size given the 
means and SD of three groups. Our desired power and significant level were 
set at 0.90 and 0.05, respectively and a priori analysis (sample size N is 
computed as a function of power level 1-β, significance level α, and the effect 
size) was applied, which resulted in an effect size of 0.3. Considering the 
required four subsequent visits, a total sample size of 100 was estimated. To 
compensate a 20% drop-out during study period, the total sample size was 
increased to 120 (40 participants in each group). Therefore, recruitment from 
LANDMark continued until the smallest group (diabetes with DPN) contained 
40 participants resulting in a total of 207 participants. 
5.11 Baseline characteristics of the participants included in this study 
This section describes the recruited three groups and reports the baseline 
characteristics of the participants including demography, health and 
metabolic measures, neuropathy assessment and SNP parameters. 
Allocation of individuals to one of the three groups and exclusion of ineligible 
individuals was undertaken by details of which were outlined in previous 
sections (5.2 Participants and 5.3 Definition of neuropathy). 
Normality of the data was examined using the Kolmogorov-Smirnov test and 
the appropriate tests were applied for analysis. Statistical measures including 
analysis of variance (ANOVA) with Scheffe post hoc test, t-test and other 
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nonparametric statistical tests were employed according to the 
characteristics of specific data elements. It should be noted that this section 
only gives an overview of participants at baseline who were stratified to three 
groups – namely  controls, diabetes without DPN (DPN-ve) and  diabetes 
with DPN (DPN+ve) - across a range of measures and more details are 
included in respective chapters (Chapters 6 – 7). 
Table  5-4 shows the clinical characteristics and demographic data of 
participants at baseline based on neuropathy status. The mean age of the 
cohort was 48.4 ± 15.2 and 47% of the cohort were males. Although there 
was no significant difference between the mean age of participants with 
diabetes and controls (47.3 ± 15.4 vs. 51.0 ± 14.7, respectively, P = 0.11), 
DPN+ve group was found significantly older than controls and DPN-ve group. 
No sex difference was found among the three groups. DPN+ve group had 
longer duration of diabetes (29.6 ± 14.8) compared with DPN-ve group (16.3 
± 12.7, P < 0.001). 
In regards to health and metabolic measures, there was no significant 
difference among groups for height, weight, BMI, diastolic blood pressure, 
HDL and triglycerides. As expected, mean HbA1c of DPN-ve (7.9 ± 1.3) and 
DPN+ve (8.2 ± 1.6) groups were higher than controls (5.4 ± 0.3), however, it 
did not differ between DPN-ve and DPN+ve groups. Systolic blood pressure 
was significantly higher in DPN+ve group than DPN-ve group and controls. 
Mean total cholesterol and LDL were lower in both DPN-ve and DPN+ve 
groups compared with controls. 
All the SNP parameters and established measures of neuropathy were 
significantly different between groups (ANOVA, P < 0.05). The results of 
pairwise comparisons between groups are presented in Table  5-4. 
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Table  5-4 Demographics and clinical characteristics of the participants at the baseline. Results are expressed as mean ± 
SD or counts for categorical variable. 
 DPN status at baseline   
Characteristics Controls DPN-ve DPN+ve P-value 
(ANOVA) 
Group difference 
(Scheffe post hoc) 
Demographics 
Age (years) 51.0 ± 14.7 43.9 ± 15.7 56.5 ± 9.6 < 0.001# DPN+ve vs. Controls , DPN-ve† 
DPN-ve vs. controls† 
Sex (male/female) 26/34 49/59 22/17 0.402** - 
Diabetes duration (years) 0 16.3 ± 12.7  29.6 ± 14.8 < 0.001§ DPN+ve vs. DPN-ve§ 
Health and metabolic measures 
Height (cm) 170.4 ± 8.7 170.1 ± 9.8 171.2 ± 8.2 0.832* - 
Weight (kg) 76.1 ± 16.4 76.6 ± 14.7 80.2 ± 14.4 0.361* - 
BMI (kg/m2) 26.1 ± 5.2 26.4 ± 4.3 27.4 ± 4.8 0.405* - 
Systolic BP (mmHg) 116.1 ± 13.6 117.8 ± 13.8 129.4 ± 20.0 < 0.001‡ DPN+ve vs. DPN-ve, Controls§ 
Diastolic BP (mmHg) 72.8 ± 7.0 72.1 ± 7.9 74.2 ± 10.3 0.392* - 
HbA1c (%) 5.4 ± 0.3 7.9 ± 1.3 8.2 ± 1.6 < 0.001‡ Controls vs. DPN-ve, DPN+ve§ 
Total cholesterol (mmol/L) 5.4 ± 1.2 4.7 ± 0.9 4.9 ± 1.1 < 0.001# Controls vs. DPN-ve, DPN+ve† 
HDL (mmol/L) 1.5 ± 0.4 1.5 ± 0.4 1.6 ± 0.4 0.324 - 
LDL (mmol/L) 3.5 ± 1.1 2.7 ± 0.7 2.7 ± 0.9 < 0.001‡ Controls vs. DPN-ve, DPN+ve§ 
Triglycerides (mmol/L) 1.1 ± 0.6 1.0 ± 0.6 1.1 ± 0.6 0.717 - 
Corneal nerve parameters 
CNFD (number/mm2) 22.3 ± 8.0 18.3 ± 7.1 16.3 ± 8.3 < 0.001* Controls vs. DPN-ve, DPN+ve† 
CNBD (number/mm2) 35.1 ± 23.8 24.2 ± 17.4 23.7 ± 20.9 0.003‡ Controls vs. DPN-ve, DPN+ve§ 
CNFL (mm/mm2) 18.1 ± 3.7 16.0 ± 3.8 15.0 ± 4.3 < 0.001* Controls vs. DPN-ve, DPN+ve†  
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 DPN status at baseline   
Characteristics Controls DPN-ve DPN+ve P-value 
(ANOVA) 
Group difference 
(Scheffe post hoc) 
Quantitative Sensory Tests 
Cold sensation threshold (°C) 28.4 ± 2.8 27.4 ± 5.1 23.4 ± 7.2 < 0.001‡ 
 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Warm sensation threshold (°C) 38.0 ± 4.1 37.4 ± 3.8 41.6 ± 3.7 < 0.001‡ 
 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Vibration threshold (Hz) 7.0 ± 8.1  8.7 ± 10.3 25.7 ± 22.2 < 0.001‡ 
 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Nerve Conduction Studies 
Peroneal F latency (ms)  49.6 ± 5.2 51.5 ± 4.9 55.7 ± 5.0 < 0.001* 
 
Controls vs. DPN+ve†  
DPN-ve. vs DPN+ve† 
Peroneal nerve amplitude (mV) 4.7 ± 2.3 5.2 ± 2.7 2.7 ± 1.8 < 0.001‡ 
 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Peroneal nerve conduction 
velocity (m/s) 
49.0 ± 5.5 46.7 ± 5.0 39.6 ± 5.9 < 0.001* 
 
Controls vs. DPN-ve, DPN+ve†  
DPN-ve vs. DPN+ve†  
Neuropathy disability score (0–10) 0.4 ± 0.9 0.6 ± 0.9 2.2 ± 1.5 < 0.001‡ 
 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Diabetic neuropathy symptom score 
(0–4) 
0.1 ± 0.3 0.2 ± 0.5 1.1 ± 1.0 < 0.001‡ 
 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
DPN-ve, diabetic participant without neuropathy; DPN+ve, diabetic participant with neuropathy 
* One way ANOVA, **Chi-Square, †Scheffe post hoc, ‡Kruskal Wallis, §Mann-Whitney, #Welch ANOVA 
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 5.12 Discussion 
The baseline findings of the enrolled participants were presented in this 
section. Overall, a relatively large cohort of 207 participants enrolled in this 
study, including 147 type 1 individuals without and with neuropathy and 60 
healthy controls, without peripheral neuropathy and/or diabetes. It should be 
noted that baseline characteristics are briefly discussed here and a more in-
depth and specific discussion is presented in respective chapters (Chapters 
6-7). 
The cohort was sex-balanced (47% males) and age was well-matched 
between diabetes and control groups. DPN+ve group was found to be older 
than DPN-ve and control groups. DPN+ve group also had higher HbA1c, 
longer duration of diabetes and higher systolic BP compared with those 
without DPN. These factors are among the most important risk factors for 
development and progression of neuropathy in patients with diabetes (see 
section 2.2.2 Pathogenesis and risk factors of DPN). While total cholesterol 
and LDL level were not different between DPN+ve and DPN-ve groups, lower 
level of these parameters were observed in comparison with controls. This 
can be attributed to the fact that 35% of diabetic participants were receiving 
lipid-lowering medications at baseline visit. 
Using Toronto criteria and NDS, of 147 diabetic participants, 39 had mild 
DPN at baseline visit. The proportion of DPN+ve group to the diabetic group 
(27%) was suitable for assessing the natural history of SNP morphology in 
this group and to compare with DPN-ve and control groups. QST, NCS, NDS 
and DNSS were able to differentiate DPN+ve group from controls and DPN-
ve group. These findings were not surprising, because symptoms, signs and 
NCS constitute the basis on which diabetic neuropathy was diagnosed in this 
study.  The baseline findings showed that corneal nerve parameters obtained 
from CCM were able to differentiate type 1 diabetic participants without and 
with mild neuropathy from controls. These outcomes are in agreement with 
previous studies that examined the SNP morphology in relation to DPN 
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(Table  2-1) and confirm depletion of the SNP structural parameters in 
presence of DPN. 
We employed an up-to-date definition for DPN which consists of NCS and 
signs and/or symptoms of neuropathy. Furthermore, a battery of established 
measures (symptoms, deficits, QST and NCS) were measured which would 
enable us to compare SNP structural parameters against them in terms of 
longitudinal changes over time. Given the lack of data in the literature 
regarding the natural history of corneal nerve morphology, this longitudinal 
study will provide insights to the usefulness of SNP morphology as a 
potential measure of neuropathy.     
In conclusion, the data acquired at baseline indicate that the study has 
recruited an appropriate cohort to address the main objectives. For example 
the baseline glycaemic control (HbA1c 8.1%) and total cholesterol (4.7 
mmol/l) in the diabetic cohort of this study are comparable with previous 
longitudinal diabetic studies (Epidemiology of Diabetes Interventions and 
Complications (EDIC) Research Group, 1999; Lorbeer et al., 2011). 
Additionally, employment of CCM in combination with automated analysis 
provides an accurate and reliable method to estimate small nerve fibre 
damage at SNP level in diabetic individuals without and with neuropathy. 
5.13 Directions for subsequent experiments 
Application of CCM in combination with a fully-automated algorithm was 
found to be advantageous in reducing dependence of labour-intensive 
methods, while providing comparable results to manual and semi-automated 
techniques. We also found that this technique was repeatable within and 
between observers. Having addressed these important methodological 
aspects, the experiments presented in next chapters (Chapter 6-7) were 
conducted to address the main objective of this project. 
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CHAPTER 6. AGE EFFECT AND LONGITUDINAL ASSESSMENT OF 
SUBBASAL NERVE STRUCTURE IN HEALTHY STATE 
6.1 Foreword 
Using a longitudinal approach, the effect of age on three main subbasal 
nerve structural parameters obtained using corneal confocal microscopy was 
investigated in this study. These morphometric parameters include corneal 
nerve fibre density (CNFD), branch density (CNBD) and fibre length (CNFL). 
Furthermore, the longitudinal behaviour of these parameters over three years 
were also examined by fitting linear mixed models which are robust statistical 
methods for repeated measures analysis. This chapter, which addressed the 
second research question as defined in section 1.5 of Chapter 1, essentially 
forms the basis of a paper published in Investigative Ophthalmology and 
Vision Science journal as follows: 
Dehghani C, Pritchard N, Edwards K, Vagenas D, Russel AW, Malik AR and 
Efron N. Morphometric stability of the corneal subbasal nerve plexus in 
healthy individuals: a 3-year longitudinal study using corneal confocal 
microscopy. Invest Ophthalmology and Vision Science 2014; 55:3195-3199. 
6.2 Abstract 
Purpose: To examine the age-dependent alterations and the longitudinal 
course of subbasal nerve plexus (SNP) morphology in healthy individuals. 
Methods: Laser-scanning corneal confocal microscopy, ocular screening, 
and health and metabolic assessment were performed on 60 healthy 
participants at baseline and at 12-month intervals for 3 years. At each annual 
visit, eight central corneal images of the SNP were selected and analysed 
using a fully-automated analysis system to quantify CNFD, CNBD and CNFL. 
Linear mixed model approaches were fitted to examine the relationship 
between age and these parameters, and their longitudinal changes over 
three years. 
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Results: At baseline, mean age was 51.0 ± 14.7 years. The cohort was sex-
balanced (P = 0.30). Age (P = 0.27), CNFD (P = 0.48), CNBD (P = 0.95) and 
CNFL (P = 0.98) did not differ between sexes. A total of 52 participants 
completed the 36-month visit and 49 participants completed all visits. No 
significant effect of age was found for CNFD (F [1, 87] = 0.72, P = 0.40) and 
CNBD (F [1, 42] = 0.53, P = 0.47). However, age had a significant effect on 
CNFL (F [1, 33] = 4.77, P = 0.04) with a linear decrease of 0.05 mm/mm2 per 
one year increase in age. None of the three parameters showed significant 
changes over the 36-month period (CNFD, F [1, 168] = 2.32, P = 0.13; CNBD, F 
[1, 30] = 2.05, P = 0.16 and CNFL, F [1, 3] = 0.38, P = 0.58). 
Conclusions: Corneal nerve parameters showed a stable course over a 36-
month period in healthy individuals, although there was a slight linear 
reduction in CNFL with age. The findings of this study have implications for 
understanding the time-course of the effect of pathology and surgical or 
therapeutic interventions on the morphology of the SNP and serves to 
confirm the suitability of corneal nerve structure as a screening/monitoring 
marker for peripheral neuropathies. 
6.3 Introduction 
In vivo corneal confocal microscopy (CCM) is a rapid, non-invasive and 
reiterative technique which enables microstructural evaluation of the human 
cornea at high resolution. The anatomical location and transparency of the 
cornea make this tissue structure ideally suited for confocal microscopic 
assessment (Lagali et al., 2013). Image acquisition using CCM from different 
corneal layers and structures helps both clinicians and researchers to extract 
important information in respect to alterations induced by various ocular and 
systemic conditions. 
The subbasal nerve plexus (SNP), which is a dense array of nerves located 
between the corneal basal epithelium and Bowman’s layer, is the main 
corneal nerve structure studied in vivo using CCM as a result of distinct 
morphologic attributes such as length of the nerve bundles and their parallel 
arrangement in relation to the ocular surface. Structural analysis of the SNP 
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has been used to evaluate ocular conditions such as dry eye, ocular allergy 
and glaucoma (Benítez-del-Castillo, et al., 2007; Labbé, et al., 2012; Villani, 
et al., 2013b; Zhang, et al., 2011), corneal ectasia and dystrophies (Efron & 
Hollingsworth, 2008; Patel, et al., 2009a), the effect of contact lens wear 
(Efron et al., 2002; Hollingsworth & Efron, 2004) and assessment of nerve 
regeneration after penetrating keratoplasty (Darwish, et al., 2007a), and 
different forms of refractive surgery (Darwish, et al., 2007b; Erie, et al., 
2005b). The CCM has also been deployed to assess small nerve fibre 
pathology induced by several systemic conditions including diabetes 
(Edwards, et al., 2012b; Tavakoli, et al., 2010b), Fabry disease (Tavakoli et 
al., 2009), idiopathic neuropathy (Tavakoli et al., 2010a) and chemotherapy 
(Ferrari et al., 2013). 
Given the utility of SNP evaluation in screening, detection and monitoring of a 
wide range of systemic and corneal neuropathies, it is important to 
understand how aging might affect this nerve plexus. However, there is 
inconsistency in the literature with respect to the relationship between age 
and neural morphometric change in the SNP using ex vivo and in vivo 
techniques. While a number of studies have reported no significant change in 
the subbasal nerve morphology with age (Erie, et al., 2005a; Marfurt, et al., 
2010; Patel, et al., 2009b), others have reported a decrease in nerve density 
with age (He, et al., 2010; Niederer, et al., 2007; Parissi, et al., 2013) and 
there is also uncertainty as to the age at which SNP structural loss become 
significant. Furthermore, to our knowledge no data are available concerning 
the dynamic morphologic changes of corneal nerves in health or disease 
over time. 
The two primary objectives of this study were to investigate: (1) the 
relationship between age and the three main morphometric parameters of the 
SNP obtained from CCM (CNFD, CNBD and CNFL); and (2) longitudinal 
changes of these measures over three years in healthy human corneas.  
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6.4 Methods 
6.4.1 Study participants 
Following approval from the research ethics committee of Queensland 
University of Technology (Queensland, Australia) and obtaining written 
informed consent, 60 healthy participants were enrolled. Participants were 
recruited from the community in Brisbane, Australia, as a part of 4-year 
LANDMark study (Pritchard, et al., 2014). Exclusion criteria were: history of 
corneal surgery, trauma or disease, glaucoma, evidence of corneal 
compromise, ocular and systemic diseases (e.g. diabetes) that might have 
adversely affected the cornea and history of neuropathy. These criteria were 
reassessed at each annual visit. 
All participants underwent assessment of visual acuity, slit lamp 
biomicroscopy and tonometry and all corneas were confirmed to be within 
clinical norms. Four participants were current soft contact lens wearers and 
were asked to refrain from contact lens wear on the day of examinations. 
Contact lens wearers were not excluded from the present study, because 
previous investigations of the impact of contact lens wear on morphologic 
changes in subbasal nerves using CCM have failed to demonstrate any 
impact (Oliveira-Soto & Efron, 2003; Patel et al., 2002; Wu, et al., 2012). All 
participants were observed at baseline and the examinations continued at 
12-month intervals over three years for a total of four visits. The study was 
conducted in accordance with the tenets of the Declaration of Helsinki. 
6.4.2 Corneal confocal microscopy and image analysis 
At each visit, all participants underwent corneal confocal microscopy 
examination approximately at corneal apex using the Heidelberg Retina 
Tomograph 3 with Rostock Corneal Module (Heidelberg Engineering GmbH, 
Dossenheim, Germany). One eye (on the side of hand dominance) was 
selected and anaesthetized with a drop of 0.4% benoxinate hydrochloride 
(oxybuprocaine hydrochloride; Bausch & Lomb, NSW, Australia).  
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Eight central corneal images per participants, displaying in-focus nerves and 
not overlapping more than 20% (Vagenas, et al., 2012), were selected by 
inspection and analysed using a fully-automated analytical system (Dabbah, 
et al., 2011) to quantify CNFD (the total number of major nerves per mm2), 
CNBD (the number of branches emanating from major nerves per mm2) and 
CNFL (total length of all nerves and branches in units of mm/mm2). 
6.4.3 Blood biochemistry and health parameters 
At each visit, blood biochemistry measures (HbA1c and lipid profile) were 
assayed by a local certified pathology laboratory, and clinical measures 
(height, weight and blood pressure) were assessed by a research nurse. 
6.4.4 Statistical analysis 
Statistical analysis of the data was performed using SPSS (version 21). 
Normal distribution of the data was determined with the Kolmogorov-Smirnov 
test. Quantitative variables are expressed by the mean ± standard deviation 
(SD) unless otherwise indicated. For the analysis of the categorical variables, 
the χ2 test was applied. The independent samples t-test was used to 
compare age, CNFD, CNBD and CNFL between sexes. Bivariate correlation 
was used, as appropriate, for assessment of association of the SNP 
parameters with alcohol consumption and absolute changes in those 
parameters with HbA1c. One-way and Welch ANOVA were used to compare 
the SNP parameters among age groups at baseline visit. Differences in 
characteristics from baseline to year-3 visit were assessed using paired 
sample t-test (for normally distributed data) and nonparametric Wilcoxon test 
(for not-normally distributed data).  
To analyse longitudinal data using the linear mixed model (LMM) procedure 
in the SPSS statistical software, the horizontal data format were converted to 
vertical structure; thus, there were four rows per participant corresponding to 
the four measurements collected over time on each participant. The 
relationship between age and the SNP parameters and the changes of these 
parameters over 3-year period were examined by fitting two linear mixed 
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models with restricted maximum likelihood estimation. The first model 
(LMM1) contained the SNP parameters, age at each annual visit and sex. 
The SNP parameters were individually inserted as dependent variable. Age 
(time-varying predictor variable) and sex (time-invariant variable) were 
specified as covariate and factor, respectively. Age, sex and the sex*age 
interaction were specified as fixed effects and Type III method of sums of 
squares was used.  
The assessment of linear change of the SNP parameters over time (36 
months) was carried out by fitting the second model (LMM2) in which these 
parameters were specified as dependent variable and time which was a 
variable capturing the order of observation, was defined as repeated variable. 
CNFL and sex were considered as dependent variable and factor, 
respectively. Time and age at enrolment were assigned as covariates.   
6.5 Results 
The demographic and clinical data of participants at baseline and 36-month 
visits are given in Table  6-1. A total of 60 participants completed the baseline 
visit and 52 completed the 36-month visit. Five participants discontinued 
during the study period due to poor health (n = 2), to loss to follow up (n = 2) 
and personal decision (n = 1). Two participants also missed the year-3 visit. 
The baseline cohort included 26 males and 34 females (χ2 = 1.07, P = 0.30). 
Mean age was 51.0 ± 14.7 years. Age (males: 53.4 ± 13.8 years, females: 
49.2 ± 15.3 years, P = 0.27), CNFD (males: 23.1 ± 7.9 no/mm2, females: 21.6 
± 8.2 no/mm2, P = 0.48), CNBD (males: 35.4 ± 26.6 no/mm2, females: 35.0 ± 
21.8 no/mm2, P = 0.95) and CNFL (males: 18.1 ± 3.5 mm/mm2, females: 18.1 
± 3.9 mm/mm2, P = 0.98) did not differ between sexes.  
Four participants (7%) reported to be current smokers with an average 19 
cigarettes per day. CNFD, CNBD and CNFL were not significantly different 
between current smokers and non-smokers (P = 0.61, P = 0.27 and P = 0.20, 
respectively). Forty-nine participants (82%) reported current alcohol use with 
an average 5 units/week. No significant correlation was found between 
alcohol consumption (units/week) and the SNP parameters at baseline visit 
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(CNFD, rs = 0.08, P = 0.57; CNBD, rs = 0.04, P = 0.75 and CNFL, rs = -0.03, P 
= 0.85). Nine participants were taking antidepressant medications during 
study period. No association was observed between using antidepressant 
drugs and mean SNP parameters at annual visits (independent samples t-
test, P > 0.50). 
Participants were divided into three age groups:  group 1 aged < 45 years (n 
= 19), group 2 aged 45 - 59 years (n = 24) and group 3 aged ≥ 60 years (n = 
17, Table  6-2). There was not a significant effect of age groups on CNFD 
(one-way ANOVA, P = 0.86), CNBD (one-way ANOVA, P = 0.65) and CNFL 
(Welch ANOVA, P = 0.60). 
Table  6-1 Clinical demographic, metabolic and ocular screening measures of 
study participants at baseline and 36-month visits. 
Parameter Baseline 36 months P-value  
(paired t-test) 
Age (years) 51.0 ± 14.7 - - 
Sex (male/female) 26/34 24/28 - 
HbA1c (%) 5.4 ± 0.3 5.3 ± 0.4 <0.01 
Total cholesterol (mmol/L) 5.5 ± 1.2 5.5 ± 1.2 0.84 
HDL (mmol/L) 1.5 ± 0.4 1.5 ± 0.4 0.16 
LDL (mmol/L) 3.5 ± 1.1 3.4 ± 1.0 0.12 
Triglycerides (mmol/L) 1.1 ± 0.6 1.1 ± 0.5 0.26 
Systolic blood pressure (mmHg)  116.1 ± 13.6 116.1 ± 14.0 0.95 
Diastolic blood pressure (mmHg) 72.8 ± 7.0 72.3 ± 8.4 0.50 
Height (cm) 170.3 ± 8.6 170.2 ± 8.8 0.70 
Weight (kg) 76.3 ± 15.3 75.8 ± 13.8 0.49 
BMI (kg/m2) 26.1 ± 5.2 26.2 ± 4.8 0.68 
Visual acuity (LogMAR) 0.04 ± 0.08 0.03 ± 0.08 0.17* 
Intra-ocular pressure (mmHg) 13.2 ± 2.8 13.2 ± 3.1 0.98 
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Table  6-2 Age and SNP parameters at baseline in three age groups. 










(mean ± SD)‡ 
Age, years,  
(mean ± SD)§ 
Group 1: <45 
years 
19 23.1 ± 6.5 33.3 ± 16.3 18.7 ± 2.4 33.4 ± 8.7 
Group 2: 45-
59 years 
24 21.8 ± 7.9 33.3 ± 22.0 18.0 ± 3.4 53.3 ± 4.5 
Group 3: ≥ 60 
years 
27 22.0 ± 10.0 39.7 ± 32.6 17.6 ± 5.1 67.5 ± 3.6 
Total group 60 22.3 ± 8.0 35.1 ± 23.8 18.1 ± 3.7 51.9 ± 14.7 
*, † No significant difference among groups (one-way ANOVA, P = 0.86 and P = 
0.65, respectively) 
‡ No significant difference among groups (Welch ANOVA, P = 0.64)  
§ Significant difference among groups (Welch ANOVA, P < 0.001) 
CNFD, corneal nerve fibre density;  CNBD, corneal nerve branch density; CNFL, 
corneal nerve fibre length  
 
Apart from a clinically insignificant decline in HbA1c (0.1 %, P < 0.01), over 36 
months, there were no significant changes to health, metabolic or ocular 
screening measures (Table  6-1). There also was no significant correlation 
between absolute changes in SNP parameters and HbA1c from baseline to 
the 36-month visit (Pearson, CNFD, r = -0.10, P = 0.50; CNBD, r = -0.09, P = 
0.54 and CNFL, r = 0.05, P = 0.75).  
The LMM1 was deployed to determine the association of age and SNP 
parameters. Using backward elimination procedure, fixed effects of sex*age 
interaction and sex were sequentially removed because their effects were not 
statistically significant. While no significant effect of age was found for CNFD 
(F [1, 87] = 0.72, P = 0.40) and CNBD (F [1, 42] = 0.53, P = 0.47), the Type III 
tests of fixed effects revealed that there was a significant influence of age on 
CNFL (F [1, 33] = 4.77, P = 0.04). Estimates of fixed effects and covariance 
parameters for CNFL are presented in Table  6-3.  
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Table  6-3 Estimates of fixed effects and covariance parameters from linear 
mixed model 1 in which the relationship of age and corneal nerve fibre length 
was statistically significant. 
Parameter Estimate Std. Error P-value 95% CI 
Estimates of fixed effects* 
Intercept 20.89 0.89 < 0.00 19.00 - 22.81 
Age -0.05 0.02 0.04 -0.09 - -0.01 
Estimates of covariance parameters* 
Residual 3.91 0.44 <0.001 3.15 – 4.87 














3.15 – 30.37 
-0.65 - 0.00 
0.01 - 0.03 
CI: confidence interval; UN: unstructured variance-covariance matrix for random 
effects 
* Dependent variable: corneal nerve fibre length 
 
The natural history of the three SNP parameters over the 36-month 
observation period is depicted graphically in Figure  6-1. The LMM2 revealed 
that the linear effect of time, sex, age at enrolment and time*sex interaction 
were not statistically significant for any of the three SNP parameters 
(Table  6-4). To eliminate further the potential confounding neurogenesis 
effect of antidepressant drugs (Castrén & Hen, 2013) on the analysis of data 
relating to the longitudinal course of CNFL in healthy participants, LMM2 was 
repeated excluding participants who were receiving antidepressant therapy 
during study period. The results were similar to the total cohort with no 
significant effect of time for the three SNP parameters (CNFD, P = 0.23; 
CNBD, P = 0.15 and CNFL, P = 0.57). 
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Figure  6-1 Quantification of corneal nerve fibre density and branch density 
(A) and corneal nerve fibre length (B) in healthy participants over 36 months. 
The three SNP parameters quantified in this study did not change over three 
years follow up (linear mixed model analysis, CNFD, P = 0.13; CNBD, P = 









































(B) CNFLn = 60 n = 56 n = 53 n = 52 
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Table  6-4 Estimates of fixed effects for the linear relationship of time and 
subbasal nerve parameters in linear mixed model 2.  
Dependent variable: corneal nerve fibre density 
Parameter Estimate Std. Error P-value 95% CI 
Intercept 23.37 2.7 < 0.00 17.98 - 28.75 
Time 0.19 0.47 0.69 -0.73 - 1.11 
Age at enrolment -0.02 0.05 0.49 -4.18 – 2.03 
Sex     
Male*time 0.71 0.72 0.32 -0.70 – 2.12 
Female*time 0† 0 - - 
Dependent variable: corneal nerve branch density 
Intercept 25.20 9.00 < 0.01 7.34 – 43.05 
Time 2.12 1.53 0.18 -1.00 – 5.24 
Age at enrolment 0.24 0.17 0.16 -0.10 – 0.57 
Sex     
Male*time -0.91 2.32 0.70 -5.7 – 3.84 
Female*time 0† 0 - - 
Dependent variable: corneal nerve fibre length 
Intercept 19.26 1.35 < 0.00 16.56 – 21.96 
Time 0.01 0.22 0.98 -0.68 - 0.67 
Age at enrolment -0.01 0.03 0.63 -0.06 – 0.04 
Sex     
Male*time 0.22 0.34 0.56 -0.81 – 1.25 
Female*time 0† 0 - - 
†This parameter is set at zero because it is the reference level of sex. 
6.6 Discussion 
The feasibility of assessing corneal nerve morphology via CCM and the 
promising role of these structural parameters as an indicator of corneal nerve 
recovery following surgical and pharmacological intervention, and the 
potential for screening for peripheral neuropathies, has led to an increase in 
the scope of this approach. An increasing number of studies showing a 
relationship between quantitative analysis of the SNP parameters and 
various ocular and systemic pathologic conditions or surgical-induced 
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changes, highlights the importance of understanding the natural 
morphometric characteristics of the SNP over time.  
In this longitudinal prospective study, participants were followed over 36 
months with repeated monitoring of ocular, health and the SNP measures. At 
baseline, our cohort was sex balanced (45% male) and age was not 
significantly different between sexes. The sex of participants was also shown 
to have no influence on the SNP parameters. While the variability from the 
mean of SNP parameters increased with age (Table  6-2), mean CNFD, 
CNBD and CNFL between the groups was not significantly different. This 
finding is consistent with those of Patel et al. (2009b) who found no 
significant differences in mean CNFL between three age groups in a cohort 
of 60 healthy participants. On the other hand, Grupcheva et al. (2002) 
reported a significant difference in mean CNFL between two age groups (25 
± 5 years vs. 70 ± 5 years) of 50 participants.  
Using laser-scanning CCM (LSCM), a great diversity has been reported in 
quantification of the SNP parameters in healthy individuals (Table  2-1). The 
mean central corneal nerve fibre length in the current study was 18.0 ± 3.6 
mm/mm2 which is similar to that reported by Wu et al. (2012) (18.0 ± 4.0 
mm/mm2), but slightly lower than the findings of Niederer et al. (2007) (20.3 ± 
6.5 mm/mm2) and Parissi et al. (2013) (18.6 ± 4.8 mm/mm2). Differences in 
methodologies including number of participants, selected images, age range 
and method of image analysis may account for differing results.  
A strength of the present study was consistency in respect to the location of 
corneal assessment (central), which was facilitated by an optimized sampling 
paradigm for the central region of the cornea that involved selection of a 
prescribed number of centrally-located images with minimum overlap 
(Vagenas, et al., 2012). As well, employment of an objective, fully-automated 
analysis system for image analysis facilitated reliable and objective 
quantification of the SNP parameters, which was important for ascertaining 
the natural course of these CCM measures. It has been demonstrated that 
fully-automated analysis of SNP parameters obtained from laser-scanning 
CCM images agrees very well with semi-automated and manual analysis 
 99 
Age Effect and Longitudinal Assessment of Subbasal Nerve Structure in Healthy State 99 
(Dabbah, et al., 2011; Dehghani et al., 2014; Petropoulos, et al., 2014) and 
yields results with a high level of reproducibility. 
In the current literature, there is some discrepancy among studies as to 
whether corneal nerve structure changes with age. While subbasal nerve 
fibre density has been reported to reduce with age in an ex vivo study in 22 
donor corneas aged from 19 to 80 years (He, et al., 2010), Marfurt et al. 
(2010) using an immunohistochemical staining technique, found no 
significant correlation between CNFL and age in corneas of six donors aged 
19 - 78 years. Such a disagreement exists among studies using in vivo CCM 
as well (Erie, et al., 2005a; Niederer, et al., 2007; Parissi, et al., 2013; Patel, 
et al., 2009b).  
The majority of studies reporting the relationship between age and corneal 
nerve parameters have concentrated on the total length of nerve fibres in unit 
of area of corneal images which is similar to the definition of CNFL adopted 
in this study. Hence, it is difficult to make a direct comparison of our findings 
in terms of CNFD and CNBD with previous reports in which these measures 
have not been included. Furthermore, the usual design employed in previous 
studies reporting the effect of age on corneal nerve morphology has been 
cross-sectional, in which measurements are made on participants of various 
ages and the detected differences are attributed to the effect of age. 
However, such results do not necessarily reflect real age changes. A 
longitudinal design with serial measurements in the same individuals over 
time allows true age changes for individuals to be determined. The findings of 
the current study (LMM1, Table  6-3) showed that while CNFD and CNBD 
were not affected by age, there was a significant linear decrease in the CNFL 
with age. The mean estimated initial status (at birth) and the linear change 
rate (per year) of CNFL for the total group were 20.90 mm/mm2 and -0.05 
mm/mm2, respectively. This suggested that 1 mm/mm2 reduction in central 
corneal nerve morphology would require 20 years to take place in normal 
participants. The cross-sectional studies of Niederer et al. (2007) and Parissi 
et al. (2013) reported  a gradual decline in CNFL with age at a rate of 0.9% 
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and 0.30% per year, respectively, which exceeds the finding our longitudinal 
study reported here (0.05 mm/mm2 per year).  
Although marginally non-significant at α < 0.05, the estimated covariance of 
the two random effects in the LMM1; that is, intercept and age (β = -0.30, P = 
0.05) was negative (Table  6-3), which suggested individuals with high CNFL 
had a slower linear decrease, whereas individuals with low CNFL had a 
faster decrease, with age. There is also evidence of significant variance in 
these random effects (β = 0.01, P = 0.02), indicating variation among 
individuals in the rate of change of CNFL.  
However, it is not clear why age did not have any significant effect on CNFD 
and CNBD which are the metrics of the major nerves and the branches 
emanating from them. Figure  5-4 illustrates how the three SNP parameters 
are quantified from CCM images. Considering the definitions of the SNP 
parameters and these outcomes, it can be speculated that the age-
dependent alterations of the SNP mainly occur at short interconnecting links 
which appear to be not connected to any major nerves or branches in CCM 
images. The orientation of these fine, low contrast nerve fibres such as their 
non-parallel arrangement in relation to the ocular surface as well as the 
limited resolution of the current CCMs may restrict their visibility. 
Apart from HbA1c with a minor (0.1 %) but statistically significant difference, 
the average of all clinical metabolic and ocular screening measures remained 
stable from baseline to 36-month visit. The LMM2 (Table  6-4) showed that in 
this 3-year longitudinal study, the SNP parameters appeared to be stable as 
a function of time. The relationship of time with the change of three SNP 
parameters did not vary depending on sex, yielding a similar longitudinal 
pattern over three years for males and females. It is also worth noting that, 
while neuronal plasticity and regeneration can be influenced by 
antidepressant treatment (Baudry et al., 2011; Castrén & Hen, 2013), when 
our analysis was restricted to participants who were not receiving these 
medications, our results closely resembled those from the total cohort. 
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To our knowledge, no previous study has reported a longitudinal analysis of 
corneal nerve morphology in healthy individuals. The results presented here 
demonstrate, for the first time to our knowledge, stability of human corneal 
nerve morphology as assessed by LSCM over a 3-year period. These 
findings are important in demonstrating a significant, albeit weak, association 
between CNFL and age and the 3-year morphometric stability of the SNP 
structure in healthy individuals. These data provided in vivo evidence for 
stability of these structural parameters in healthy individuals and added a 
longitudinal perspective to consider alongside the results of cross-sectional 
studies demonstrating the dependence of CNFL parameter with age. The 
outcomes of this study may improve the ability of clinicians and researchers 
to understand the time-course of central corneal reinnervation following 
interventions such as keratorefractive surgeries and pharmacological 
treatment, and will assist in the interpretation of longitudinal studies using 
corneal nerve morphology as a screening/monitoring marker for peripheral 
neuropathies. 
Although we found stability of the corneal nerve structure over a 36-month 
follow up period, this finding might not apply to the SNP changes over longer 
time periods. Furthermore, these findings are limited to nerve changes in the 
central cornea, and may not be applicable to other more peripheral regions of 
the human SNP. More recently, in vivo wide-field maps of the human SNP 
have been generated successfully (Edwards, et al., 2012a; Patel & McGhee, 
2005) which might be useful to provide insights into changes in the entire 
SNP, if this procedure were to be deployed in longitudinal studies.  
In conclusion, the current longitudinal in vivo CCM study confirms a slight 
reduction in CNFL as a function of age while there was no significant 
dynamic morphologic change in SNP morphology over 36 months.  The data 
of this longitudinal study constitute a better understanding of SNP in living 
human cornea in a healthy state, which has implications in investigating the 
effect of corneal surgery, known transient or chronic alterations as a cause of 
or secondary to, local disease, or peripheral neuropathies, using corneal 
nerve structure as a non-invasive biomarker. 
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CHAPTER 7. NATURAL COURSE OF SUBBASAL NERVE STRUCTURE 
IN TYPE 1 DIABETES WITHOUT AND WITH MILD NEUROPATHY 
7.1 Foreword 
This chapter examined the natural course of subbasal nerve structural 
parameters in diabetic participants without and with mild neuropathy over 
four years and compared the trajectories to non-diabetic/non-neuropathic 
controls. Additionally, the longitudinal association between established 
measures of neuropathy with corneal nerve parameters was also assessed. 
In fact, this chapter addressed two main research questions defined in 
section 1.5 Research questions of Chapter 1. This chapter presents a study 
published by the Investigative Ophthalmology and Vision Science journal. 
Dehghani C, Pritchard N, Edwards K, Vagenas D, Russel AW, Malik AR and 
Efron N. Natural History of Corneal Nerve Morphology in Mild Neuropathy 
Associated with Type 1 Diabetes: Development of a Potential Measure of 
Diabetic Peripheral Neuropathy. Investigative Ophthalmology and Vision 
Science, 2014;55:7982–7990.  
7.2 Abstract 
Purpose: To investigate longitudinal changes of subbasal nerve plexus 
(SNP) morphology and its relationship with conventional measures of 
neuropathy in individuals with diabetes.  
Methods: A cohort of 147 individuals with type 1 diabetes and 60 age-
balanced controls underwent detailed assessment of clinical and metabolic 
factors, neurologic deficits, quantitative sensory testing, nerve conduction 
studies and corneal confocal microscopy at baseline and four subsequent 
annual visits. The SNP parameters included corneal nerve fibre density 
(CNFD), branch density (CNBD) and fibre length (CNFL) and were quantified 
using a fully-automated algorithm. Linear mixed models were fitted to 
examine the changes in corneal nerve parameters over time. 
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Results: At baseline, 27% of the participants had mild diabetic neuropathy. 
All SNP parameters were significantly lower in the neuropathy group 
compared to controls (P<0.05). Overall, 89% of participants examined at 
baseline also completed the final visit. There was no clinically significant 
change to health and metabolic parameters and neuropathy measures from 
baseline to the final visit. Linear mixed model revealed a significant linear 
decline of CNFD (annual change rate, -0.9 nerve/mm2, P = 0.01) in the 
neuropathy group compared to controls, which was associated with age (β = 
-0.06, P = 0.04) and duration of diabetes (β = -0.08, P = 0.03). In the 
neuropathy group, absolute changes of CNBD and CNFL showed moderate 
correlations with peroneal conduction velocity and cold sensation threshold, 
respectively (r, 0.38 and 0.40, respectively, P < 0.05). Among the important 
risk factors for corneal neuropathy, CNFD was found to have the highest 
association with HbA1c (β = -0.58, P = 0.03).  
Conclusion: This study demonstrates dynamic small fibre damage at the 
SNP, thus providing justification for our ongoing efforts to establish corneal 
nerve morphology as an appropriate adjunct to conventional measures of 
DPN. 
7.3 Introduction 
Diabetic neuropathy is a substantial and burdensome complication of 
diabetes, affecting up to 50% of these individuals (Dyck, et al., 1993). 
Diabetic peripheral neuropathy (DPN), which is the most common form of 
neuropathy, manifests as a distal, symmetric polyneuropathy that begins in 
the lower extremities and may progress proximally (Chin & Rubin, 2010). 
DPN leads to morbidity in diabetic patients in the form of painful neuropathy 
and foot ulceration with consequent lower limb amputation (Frykberg, et al., 
2006). It accounts for reduced quality of life and imposes a significant 
economic burden that affects both individuals and society (Happich, et al., 
2008; Van Acker, et al., 2009). 
Several established tests are commonly used for screening, detection and 
assessment of DPN and to monitor its progression. The majority of these 
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tests examine neuronal function; however, direct observation of nerve 
structure is also possible. Neurologic symptoms and signs, quantitative 
sensory tests (QST) and nerve conduction studies (NCS) are the most 
commonly used tests for DPN (Dyck, et al., 2010). Indeed symptoms, 
neurological deficits and NCS constitute the basis on which diabetic 
neuropathy is diagnosed. QST provide quantitative measures of sensation; 
however, these tests require cooperation and concentration of the examinee 
and they may also be affected by anthropometric variables (Boulton, et al., 
2004b). Whilst recent studies have shown that the proficiency of QST 
assessment is adequate (Dyck, et al., 2014), the reproducibility of symptoms 
and signs (Dyck, et al., 2010) and NCS (Litchy, et al., 2014), has been shown 
to be limited. Furthermore, studies in patients with impaired glucose 
tolerance (IGT) (Asghar et al., 2014) and recently diagnosed type 2 diabetes 
(Ziegler, et al., 2014b) show a marked small fibre neuropathy accompanying 
large fibre dysfunction.  
Quantification of nerve pathology is possible through direct morphometric 
examinations of nerves including sural nerve biopsy (Malik et al., 2005) and 
skin biopsy (Lauria, et al., 2009). However, these techniques are invasive, 
require expertise for quantification and cannot be repeated from the same 
site for longitudinal studies. Accurate detection and estimation of progression 
are needed, especially to test putative treatments, which may alleviate the 
condition, and/or prevent or delay the development of sequelae. As reviewed 
in more detail elsewhere (Li, et al., 2013; Varkonyi et al., 2013), based on the 
pathogenesis of DPN, several potential therapeutic approaches have been 
developed targeting these mechanisms; however, apart from glucose control 
and pain management, currently there is no approved treatment for DPN 
(Callaghan, et al., 2012a; Li, et al., 2013).  
Lack of a sensitive, accurate and reliable clinical endpoint has been one of 
the obstacles in mounting treatment trials for DPN (Malik, 2014a). Growing 
evidence supports a prominent association between corneal subbasal nerve 
plexus (SNP) morphology measured with corneal confocal microscopy 
(CCM) and DPN. CCM as a quick, non-invasive and reiterative technique has 
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a demonstrated capacity to detect early small nerve fibre damage in diabetic 
patients (Quattrini, et al., 2007), and diagnose (Ahmed, et al., 2012; 
Edwards, et al., 2012b; Malik, et al., 2003) and classify severity of DPN 
(Petropoulos et al., 2013a; Tavakoli, et al., 2010b). Conventional measures 
of neuropathy and corneal nerve parameters are also related (Edwards, et 
al., 2012b; Sivaskandarajah, et al., 2013; Tavakoli, et al., 2010b). 
Furthermore, the demonstration of early corneal nerve regeneration following 
simultaneous pancreas and kidney transplantation (Tavakoli, et al., 2013) 
and optimised glycaemic and lipid control in an observational study (Tavakoli, 
et al., 2011b) suggests that CCM may well fulfil some of the criteria for a 
surrogate end point for diabetic neuropathy. 
To our knowledge, no study has been conducted to date concerning the 
natural course of the SNP structure over time in diabetic patients. Therefore 
in this study, we sought to investigate the natural history of the SNP 
morphology in type 1 diabetic individuals without and with mild neuropathy. 
Furthermore, the longitudinal relationship between changes in corneal nerve 
structure and established measures of neuropathy in individuals with 
diabetes was also addressed. 
7.4 Methods 
7.4.1 Study design and participants 
This prospective, observational, longitudinal study was conducted following 
approval from Queensland University of Technology, Princess Alexandra 
Hospital, and Mater Hospital research ethics committees as a part of the 
LANDMark study (Pritchard, et al., 2014) in Brisbane, Australia. Prior to their 
enrolment, written informed consent was obtained from all participants and 
the research adhered to the tenets of the Declaration of Helsinki. Based upon 
the inclusion/exclusion criteria, 147 type 1 diabetic participants were recruited 
from Diabetes and Endocrinology Research Centre at Princess Alexandra 
and Mater hospitals and the general population in Brisbane. Sixty healthy 
participants, without peripheral neuropathy and/or diabetes were also 
recruited as controls. All participants were assessed at baseline and 
assessments continued for four annual subsequent visits (five time-points in 
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total and approximately 960 case visits). Participants were excluded in this 
study for any of the following: history of ocular trauma or surgery, ocular 
disease or systemic disease with potential corneal effect, and systemic 
disease (other than diabetes). Diabetic participants had no other known 
cause of neuropathy except from diabetes. Other causes of neuropathy were 
excluded. Diabetic participants with moderate and severe neuropathy were 
also excluded. All participants underwent neurologic and medical evaluation 
as well as ocular screening (visual acuity, slit lamp examination and 
intraocular pressure) and CCM, which were repeated annually.  
For the definition of DPN, we followed accepted criteria (Tesfaye, et al., 
2010) that rely on the presence of abnormal electrophysiological finding, 
based on age-matched controls at the site, in addition to clinical signs and/or 
symptoms, which was defined as one or more of the followings: (i) 
neuropathy disability score (NDS) ≥ 3 of 10 (Young, et al., 1993), or (ii) 
diabetic neuropathy symptom score (DNSS) ≥ 1 of 4 (Meijer, et al., 2002). 
The methods used during this study to assess neuropathy and health and 
metabolic factors have been presented in detail in Chapter 5 and will be 
described only briefly here. 
7.4.2 Assessment of neuropathy 
Neuropathy signs and symptoms: The neuropathy disability score (NDS), 
which is a scale of 0 to 10, was employed to assess neurological deficits. 
This measure included assessment of vibration, pin prick and temperature 
perception as well as presence or absence of ankle reflexes to both lower 
limbs. Diabetic neuropathy symptom score (DNSS), a scale of 0 to 4, was 
used to assess symptoms of neuropathy. 
Quantitative sensory tests (QST): QST comprised of vibration perception, 
measured on the plantar surface of the big toe, and thermal (warm and cold) 
sensation which was assessed at the dorsal surface of the foot on the hand-
dominant side. 
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Nerve conduction studies (NCS): Peroneal motor nerve conduction velocity 
(ankle to fibula head), amplitude (ankle to extensor digitorum brevis) and F 
wave latency were determined on the hand-dominant side of the participants. 
7.4.3 General health and metabolic assessment 
At each visit, all participants underwent assessment of height, weight, body 
mass index (BMI), blood pressure (BP), HbA1c and lipid profile.  
7.4.4 Corneal confocal microscopy and image analysis 
CCM was carried out using Rostock Cornea Module in combination with a 
HRT 3 confocal microscope (Heidelberg Engineering, Heidelberg, Germany). 
Eight images of the SNP, showing in focus nerves and not overlapping more 
than 20% (Vagenas, et al., 2012), were acquired from the centre of cornea 
on the hand-dominant side using manual focusing and section mode. 
Automatic segmentation and quantification of the SNP parameters including 
nerve fibre density (CNFD), branch density (CNBD) and length (CNFL) was 
performed using ACCMetrics (Dabbah, et al., 2011), which is a fully 
automated analytical system. The SNP parameters for each participant were 
the average value obtained from the eight captured images and expressed in 
the unit of number/mm2 for CNFD and CNBD, and mm/mm2 for CNFL. 
7.4.5 Intra- and inter observer repeatability of the SNP parameters 
The findings of intra- and interobserver study of the SNP parameters have 
been explained in detail in Chapter 4. Overall, CNFL and CNFD achieved the 
highest values for repeatability and reproducibility, whereas CNBD showed 
an acceptable consistency within- and between observers.  
7.4.6 Statistical analysis 
Normality of the data was examined using Kolmogorov-Smirnov test and the 
appropriate test was applied for analysis. Data are presented as mean ± 
standard deviation (SD) or median and interquartile range (IQR). Four sets of 
analyses were conducted. First, the demographic and clinical characteristics 
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variables were compared between control and diabetic groups as well as 
between baseline and final visit.  Second, using Toronto criteria, participants 
with diabetes were stratified as without DPN (DPN-ve) and with DPN 
(DPN+ve). Corneal nerve parameters and established neuropathy measures 
were compared between control, DPN-ve and DPN+ve. For the purpose of 
the two aforementioned analyses, parametric data were analysed using the 
independent samples t-test, paired t-test, one-way ANOVA and Scheffe post 
hoc test (pairwise comparison). Nonparametric data were analysed using the 
χ2 test, Kruskal-Wallis test and Mann-Whitney U test. 
Third, a linear mixed model was employed to examine changes over time in 
the SNP parameters and whether the changes were different in DPN-ve and 
DPN+ve compared with controls. In building a model for the data in SPSS, 
the following procedure was implemented. The wide format of the data was 
restructured to long format. The baseline values of time were set at 0, and 
the number of years from baseline was calculated for each time point of data 
collection.  
Since change in the SNP parameters (i.e. CNFD, CNBD and CNFL) over 
time was one of the main parameters of interest in the current study, they 
were individually considered as response variables and time was added to 
the model to test the linear effect of time on the response variables. The first 
model contained CNFD as the response variable, group (i.e. controls, DPN-
ve and DPN+ve), time and time*group interaction as primary fixed effects of 
interest and Type III sum of squares was selected. Group was included as a 
time-invariant predictor variable to explore any group differences over time.  
The association between the initial CNFD parameter and the change of this 
parameter was estimated by calculating the covariance matrix. Here, the 
‘variance components’ option was chosen and also the restricted maximum 
likelihood estimates for parameters was used. The process of the 
aforementioned model was repeated for CNBD and CNFL. Depending on 
whether the time*group interaction was statistically significant or not, a 
second set of fixed effects – namely sex, age at enrolment, duration of 
diabetes, HbA1c, lipid profile, blood pressure, BMI, alcohol and tobacco 
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consumption – were included and their effects were examined. A stepwise 
elimination of the variables with non-statistically significant P-values was also 
applied. 
The relation between risk factors and the changes of SNP parameters in 
diabetic individuals, regardless of their neuropathy status, was analysed with 
the latter model where all relevant risk factors were included. Control 
participants were excluded and group, as factor, was also removed from the 
model. 
Finally, to explore the relationship between changes in corneal nerve 
parameters and functional measures of neuropathy, absolute change in all 
parameters was calculated (∆parameter = parameter value at final visit – 
parameter value at baseline). Bivariate correlations between absolute change 
of corneal nerve parameters and neuropathy measures were estimated using 
Pearson r and Spearman's rho correlation coefficients, where appropriate.  
IBM SPSS 21 was used for all statistical tests and a two-tailed α=0.05 level 
of significance was considered for all analyses. 
7.5 Results 
Table  7-1 shows the clinical characteristics and demographic data of 
participants with diabetes and controls at baseline and final visit. 
Approximately 95% of the entering participants were Caucasians of 
European decent. There was no significant difference between the mean age 
of participants with diabetes and controls (P = 0.11). There were no 
statistically significant differences between diabetes and control groups with 
respect to high density lipoprotein (HDL), triglycerides, diastolic BP, BMI and 
number of cigarettes smoked per day (P > 0.25). Compared to controls, 
individuals with diabetes had a higher HbA1c (P < 0.001) and systolic BP (P = 
0.03) and lower total cholesterol (P < 0.001), LDL (P < 0.001) and alcohol 
consumption (P = 0.001). 
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Figure  7-1 Flow chart diagram of study participants at baseline and follow-up visits  
Baseline 
Enrolled, n = 207 
Type 1 with DPN, 
n = 39 
Discontinued n = 1 
Enrolled, n = 38 
Attended, n = 36 
Discontinued n =1 
Enrolled, n = 37 
Attended, n = 35 
Discontinued n= 0 Enrolled, n = 37 
Attended, n = 35 
Discontinued n = 0 
Enrolled, n = 37 
Attended, n = 37 
Completed 
37 
Type 1 without 
DPN, 
n = 108 
Discontinued n = 2 
Enrolled, n = 106 
Attended, n = 102 
Discontinued n = 4 
Enrolled, n = 102 
Attended, n = 98 
Discontinued n = 3 
Enrolled, n = 99 
Attended, n = 91 
Discontinued n= 3 
Enrolled, n = 96 




Enrolled, n = 60 
Discontinued n = 2 
Enrolled, n = 58 
Attended, n = 58 
Discontinued n = 0 
Enrolled, n = 58 
Attended, n = 57 
Discontinued n = 3 
Enrolled, n = 55 
Attended, n = 53 
Discontinued n = 4 
Enrolled, n = 51 
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Figure  7-1 is a flow chart of study progress and shows the number of 
participants that enrolled, attended and discontinued at baseline and 
subsequent visits. Overall, 23 participants discontinued during study period. 
The number of participants attending annual visits is also depicted 
graphically in Figure  7-2. Altogether, 184 participants (89% of the baseline 
participants) completed the final visit. Personal decision was the main reason 
for withdrawal (13 participants) followed by poor health (6 participants). Four 
participants were also lost to follow up during the study period. The median 
follow up duration was 3.7 years (range, 3.4 – 4.3) for the cohort. 
As can be seen from Table  7-1, at final visit HbA1c showed a clinically 
insignificant decrease in controls (mean difference 0.2%, P < 0.001), while it 
remained the same in participants with diabetes (P = 0.65). Lipid profile, 
blood pressure, height and alcohol consumption did not differ at final visit 
compared to baseline visit for both diabetes and control groups (P > 0.05).  
Whilst BMI showed a statistically significant increase at the final visit in 
participants with diabetes (P = 0.02), there was no change in controls (P = 
0.42). Both control and diabetic participants reported less smoking (number 
of cigarette/day) at the final visit compared to baseline (P = 0.001).  
 
Figure  7-2 Distribution and number of participants examined at various time 
points. DPN-ve, diabetic participant without neuropathy; DPN+ve, diabetic 
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Table  7-1 Demographic and clinical characteristics of the participants at baseline and final visit. Results are expressed as 
mean ± SD or counts for categorical variable. 
 Baseline Year 4 follow up P-value 
Parameter Control (A) Diabetes (B) Control (C) Diabetes (D) A vs. B A vs. C B vs D 
n (male/female) 60 (26/34) 147 (71/76) 51 (22/29) 133 (67/66) 0.52* 0.98* 0.73* 
Age (years) 51.0 ± 14.7 47.3 ± 15.4 57.0 ± 13.7 52.0 ± 15.3 0.11† - - 
Duration of diabetes (years) 0 19.8 ± 14.5 0 24.0 ± 14.8 - - - 
HbA1c (%) 5.4 ± 0.3 8.1 ± 1.4 5.2 ± 0.5 8.0 ± 1.5 < 0.001‡ < 0.001§ 0.65# 
Total Cholesterol (mmol/L) 5.4 ± 1.2 4.7 ± 0.9 5.5 ± 1.1 4.6 ± 0.9 < 0.001† 0.83§ 0.23§ 
HDL (mmol/L) 1.5 ± 0.4 1.6 ± 0.4 1.4 ± 0.3 1.5 ± 0.4 0.26‡ 0.06§ 0.78# 
LDL (mmol/L) 3.5 ± 1.1 2.7 ± 0.8 3.5 ± 1.1 2.5 ± 0.7 < 0.001† 0.96§ 0.07§ 
Triglycerides (mmol/L) 1.1 ± 0.6 1.1 ± 0.6 1.2 ± 0.5 1.1 ± 0.8 0.43‡ 0.27§ 0.40# 
Systolic BP (mmHg) 116.1 ± 13.6 121.0 ± 16.5 117.1 ± 13.7 118.8 ± 12.1 0.03§ 0.88§ 0.12§ 
Diastolic BP (mmHg)  72.8 ± 7.0 72.7 ± 8.6 71.7 ± 8.2 71.2 ± 7.0 0.89† 0.27§ 0.13§ 
BMI (kg/m2) 26.1 ± 5.2 26.5 ± 4.4 26.8 ± 4.9 26.9 ± 4.7 0.46† 0.42§ 0.02§ 
Alcohol (units/week) 5.0 ± 5.7 1.9 ± 1.8 5.2 ± 6.1 1.8 ± 1.8 0.001‡ 0.78# 0.20# 
Cigarettes (number/day) 6.7 ± 11.5 5.1 ± 8.0 1.3 ± 5.2 1.3 ± 5.6 0.74‡ < 0.001# < 0.001# 
*Chi square test, †Independent samples test, ‡ Mann-Whitney test, § paired samples t test, #Wilcoxon test 
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Comparison of the mean or median change from baseline to final visit in 
neuropathy measures of individuals with diabetes showed that there were no 
significant changes in DNSS [median 0 (0 – 0) vs. 0 (0 – 0), P = 0.56], cold 
sensation threshold [median 28.5 (24.8 – 28.5) vs. 28.5 (26.0 - 28.5) °C, P = 
0.85], vibration threshold [median 6.8 (2.5 – 6.8) vs. 6.6 (2.9 – 6.6) Hz, P = 
0.42] and peroneal F wave latency [mean 52.0 ± 5.1 vs. 52.2 ± 7.7 ms, P = 
0.85]. NDS [median 1.0 (0.0 – 1.0) vs. 0.0 (0.0 – 0.0), P < 0.01], warm 
sensation threshold [median 37.6 (34.9 – 37.6) vs. 36.6 (34.8 - 36.6) °C, P < 
0.01] and peroneal amplitude [mean 4.6 ± 2.6 vs. 5.0 ± 2.5 mV, P = 0.03] 
showed slight but significant improvements, whilst peroneal nerve conduction 
velocity [mean 45.3 ± 6.0 vs. 44.4 ± 5.8 m/s, P = 0.03] was the only measure 
that declined significantly from baseline to final visit.   
Using Toronto criteria, in 147 individuals with type 1 diabetes, 39 (27%) were 
diagnosed with DPN at baseline. Table  7-2 delineates the outcomes of the 
SNP parameters and neuropathy assessment by DPN status. SNP 
parameters were significantly reduced in DPN-ve and DPN+ve groups 
compared to controls (P < 0.01).  
All established neuropathy measures were significantly different between 
groups. QST, peroneal F wave latency and peroneal amplitude displayed 
greater deficits in DPN+ve group compared to DPN-ve and control groups (P 
< 0.05). Peroneal nerve conduction velocity was significantly lower in both 
DPN-ve and DPN+ve groups compared to controls and there also was a 
significant difference between DPN-ve and DPN+ve groups (P < 0.05). NDS 
and DNSS were significantly higher in DPN+ve group compared to control 
and DPN-ve groups (P < 0.001). 
Figure  7-3 illustrates the 4-year time course for the SNP parameters in the 
cohort by neuropathy status. The results of the three created basic linear 
mixed model (LMM) analyses for CNFD, CNBD and CNFL can be found in 
Table  7-3. The Type III tests of fixed effects shows overall test of significance 
for the predictors included in the three basic models (LMM 1-3).  
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There was a significant effect of group for all three models; however the 
effect of time was not significant in any of them. The Type III F test for the 
interaction between group and time was only significant in LMM1; therefore 
no more models were fitted for CNBD and CNFL as response variables.  
A second subset of fixed effects was included in LMM1. Upon sequential 
removal of non-statistically significant fixed effects and considering the lower 
resultant Akaike’s information criteria (AIC) for comparing alternative models 
(Shek & Ma, 2011), a final model (LMM4) contained the fixed effects of 
group, time, age, duration of diabetes, HbA1c and the group*time interaction 
was fitted. Parameter estimates and corresponding standard errors, P-values 
and 95% confidence intervals are given in Table  7-4.  
Group and time did not show a significant effect, while the effects of age at 
enrolment (β = -0.06, P = 0.04) and duration of diabetes (β = -0.08, P = 0.03) 
were significant. LMM4 also showed a differential effect of time on the 
trajectory of CNFD with the slope decreasing by 0.91 nerve/mm2 for DPN+ve 
individuals compared to controls (the reference level of the group). 
The examination of significant risk factors for corneal neuropathy in diabetic 
individuals, irrespective of the baseline neuropathy status, showed that 
CNFD was associated with HbA1c (β = -0.58, P = 0.03) and duration of 
diabetes (β = -0.08, P = 0.03). CNBD was found to be affected by the 
duration of diabetes (β = -0.21, P = 0.01) and smoking (β = -0.25, P = 0.04). 
No statistically significant association was found between CNFL and the 
included risk factors.     
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Table  7-2 Baseline comparison of corneal nerve parameters and neuropathy 
measures of the study participants according to presence and absence of 
neuropathy defined by Toronto criteria. Outcomes are mean ± SD. 
 DPN status at baseline  
Characteristics Controls 







Corneal nerve parameters 
CNFD 
(number/mm2) 
22.3 ± 8.0 18.3 ± 7.1 16.3 ± 8.3 < 0.001* 




35.1 ± 23.8 24.2 ± 17.4 23.7 ± 20.9 0.003‡ 




18.1 ± 3.7 16.0 ± 3.8 15.0 ± 4.3 < 0.001* 
Controls vs. DPN-ve, 
DPN+ve†  
Quantitative Sensory Tests 
Cold sensation 
threshold (°C) 
28.4 ± 2.8 27.4 ± 5.1 23.4 ± 7.2 < 0.001‡ 
Controls vs. DPN+ve§ 




38.0 ± 4.1 37.4 ± 3.8 41.6 ± 3.7 < 0.001‡ 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Vibration 
threshold (Hz) 
7.0 ± 8.1  8.7 ± 10.3 25.7 ± 22.2 < 0.001‡ 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
Nerve Conduction Studies 
Peroneal F 
latency (ms)  
49.6 ± 5.2 51.5 ± 4.9 55.7 ± 5.0 < 0.001* 
Controls vs. DPN+ve†  
DPN-ve. vs DPN+ve† 
Peroneal nerve 
amplitude (mV) 
4.7 ± 2.3 5.2 ± 2.7 2.7 ± 1.8 < 0.001‡ 
Controls vs. DPN+ve§ 




49.0 ± 5.5 46.7 ± 5.0 39.6 ± 5.9 < 0.001* 
Controls vs. DPN-ve, 
DPN+ve†  




0.4 ± 0.9 0.6 ± 0.9 2.2 ± 1.5 < 0.001‡ 
Controls vs. DPN+ve§ 





0.1 ± 0.3 0.2 ± 0.5 1.1 ± 1.0 < 0.001‡ 
Controls vs. DPN+ve§ 
DPN-ve vs. DPN+ve§ 
DPN-ve, diabetic participant without neuropathy; DPN+ve, diabetic participant with 
neuropathy 








Figure  7-3 Longitudinal course of corneal nerve fibre density (A), branch 
density (B) and fibre length (C) over time. On each graph, the solid (green) 
line represents control participants, the dashed line (blue) represents diabetic 
participant without neuropathy and the dotted line (red) represents diabetic 
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Table  7-3 Results of Type III tests of fixed effects from the three initial linear 
mixed models analysis. Dependent variables were CNFD in linear mixed 
model 1 (LMM1), CNBD in LMM2, and CNFL in LMM3. 
 LMM1 LMM2 LMM3 
 F P F P F P 
Intercept 1420.0 < 0.001 423.2 < 0.001 4254.4 < 0.001 
Group 8.2 < 0.001 7.4 0.001 10.9 < 0.001 
Time (years) 0.03 0.87 1.8 0.18 0.5 0.49 
Group*Time 4.0 0.02 1.4 0.24 1.6 0.20 
 
Table  7-4 Maximum likelihood of the fixed effect parameters for linear mixed 
model 4 with CNFD as the continuous response variable. 
Parameter Estimate (95% CI) Std. Error P-value 
Intercept 27.57 (23.01-32.12) 2.32 0.00 
Time 0.35 (-0.10-0.80) 0.23 0.13 
Group 
DPN+ve -1.36 (-5.17-2.45) 1.94 0.48 
DPN-ve -1.33 (-4.18-1.52) 1.45 0.36 
Controls 0* 0  
Age at enrolment -0.06 (-0.12-0.00) 0.03 0.04 
Duration of 
Diabetes 
-0.08 (-0.16 to -0.01) 0.04 0.03 
HbA1C -0.41 (-0.89-0.08) 0.25 0.10 
Group*Time 
DPN+ve * Time -0.91 (-1.63 to -0.20) 0.37 0.01 
DPN-ve * Time -0.26 (-0.82-0.31) 0.30 0.37 
Controls * Time 0* 0  
* This parameter is set to zero because it is the reference level of the 
group. 
 
Since peroneal nerve conduction velocity was the only measure that showed 
a significant worsening in the diabetes group, we sought to compare the 
trajectories of this parameter between groups utilizing an additional mixed 
model (LMM5). The above-mentioned basic model was repeated with 
peroneal nerve conduction velocity as the response variable. There was a 
significant effect of time (P < 0.01) and group (P < 0.01), but the group*time 
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interaction was not significant (P = 0.92), indicating that the observed time 
effect was not different between groups (Figure  7-4). 
 
Figure  7-4 Natural course of peroneal nerve conduction velocity of the 
participants in this study. The solid line (green) represents control 
participants, the dashed line (blue) represents diabetic participant without 
neuropathy and the dotted line (red) represents diabetic participant with 
neuropathy. Error bars indicate mean ± SEM.  
In the diabetic group, bivariate correlation revealed a modest association 
between absolute changes of CNBD and peroneal nerve conduction velocity 
(Pearson r = 0.23, P = 0.02) (Table  7-5, A). In the DPN+ve group, there was 
a significant correlation between CNBD and peroneal nerve conduction 
velocity (Pearson r = 0.38, P = 0.05). Absolute change in CNFL was also 
positively correlated with the cold sensation threshold (Pearson r = 0.40, P = 
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Table  7-5 Correlation coefficients and estimated P-values among absolute changes (∆) of corneal nerve parameters and 
established measures of neuropathy in (A) diabetic participants and (B) diabetic participants with DPN. Shaded areas indicate 
significant correlations (P < 0.05). 
A: Diabetic participants (with and without DPN) 
  ∆ NDS ∆ DNSS ∆ CST ∆ WST ∆ VT ∆ PNL ∆ PNAm ∆ PCV 
∆ CNFD Correlation coefficient -0.02 0.01 0.00 0.12 0.09 -0.14 -0.10 0.13 
 P-value 0.81 0.93 1.00 0.18 0.34 0.21 0.27 0.16 
∆ CNBD Correlation coefficient -0.01 -0.03 0.17 0.10 0.03 -0.07 -0.01 0.23* 
 P-value 0.96 0.73 0.06 0.28 0.74 0.55 0.94 0.02 
∆ CNFL Correlation coefficient 0.01 -0.06 0.06 0.08 -0.02 0.01 -0.07 0.15 
 P-value 0.97 0.53 0.50 0.37 0.85 0.93 0.46 0.12 
B: Diabetic participants with DPN 
∆ CNFD Correlation coefficient -0.08 -0.04 0.08 -0.08 0.21 -0.14 -0.10 0.24 
 P-value 0.67 0.84 0.67 0.67 0.26 0.58 0.63 0.24 
∆ CNBD Correlation coefficient -0.24 -0.13 0.33 -0.14 -0.03 -0.44 0.37 0.38* 
 P-value 0.17 0.46 0.054 0.42 0.86 0.08 0.06 0.048 
∆ CNFL Correlation coefficient -0.28 -0.23 0.40* -0.18 -0.27 -0.29 0.36 0.24 
 P-value 0.11 0.18 0.03 0.30 0.15 0.26 0.06 0.23 
CNFD, corneal nerve fibre density; CNBD, corneal nerve branch density; CNFL, corneal nerve fibre length; NDS, neuropathy 
disability score; DNSS, diabetic neuropathy symptom score; CST, cold sensation threshold; WST, warm sensation threshold; 
VT, vibration threshold; PNL, peroneal nerve latency; PNAm, Peroneal nerve amplitude; PCV, peroneal nerve conduction 
velocity. 
 
 Natural Course of Subbasal Nerve Structure in Type 1 Diabetes Without and With Mild Neuropathy 121 
7.6 Discussion 
In vivo assessment of the SNP morphology using CCM has emerged as a 
valuable clinical modality to improve our understanding of the relationship 
between this rich nerve plexus and various ocular and systemic conditions 
and diseases. As reviewed in more detail elsewhere (Villani et al., 2013a; 
Villani, et al., 2013b), morphometric evaluation of the SNP has been used to 
diagnose, assess and follow up ocular surface conditions including ocular 
allergy, dry eye, infectious keratitis, and glaucoma and after keratorefractive 
surgery and contact lens wear. Currently, considerable evidence exists that 
advocates the utility of CCM for assessment of small nerve fibre pathology 
induced by systemic and neurological conditions, in particular DPN. This 
study examined the longitudinal aspect of the utility of CCM to serve as an 
acceptable measure of DPN in clinical research and practice.  
We report data from a cohort of individuals with type 1 diabetes (n = 147) and 
healthy controls (n = 60) collected from baseline to a median duration of 3.7 
years. Although we demonstrated the stability of corneal nerve morphology in 
a 3-year longitudinal study in healthy individuals (Chapter 6), to our 
knowledge no previous study has examined the dynamic natural course of 
SNP microstructures in relation to DPN. With reference to the lack of 
previous investigation concerning the natural history of corneal nerves in 
diabetes, the present study is a positive response and attempts to fill this 
research gap. 
At the baseline visit, age was matched between participants with diabetes 
and controls. Diabetic participants showed moderate glycaemic control and 
excellent control of cardiovascular risk factors including the BP and lipid 
profile in accordance with the current treatment guidelines (American 
Diabetes Association, 2014). The lower level of total cholesterol and LDL 
cholesterol in our diabetic patients as compared to controls is attributed to 
the fact that 35% were receiving lipid-lowering medications. 
Comparison of the clinical parameters at baseline and final visit showed that 
there were no substantive and clinically significant changes to health, 
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metabolic and anthropometric measurements, indicating stable glucose 
control and desirable maintenance of cardiovascular risk factors. Although 
the Hawthorne effect (McCambridge et al., 2014) may have been involved, 
the finding of lower alcohol consumption in the diabetic patients at baseline 
which is maintained at follow up reflects good diabetes education. In addition, 
the significant reduction in tobacco consumption over time in both diabetic 
patients and control subjects presumably reflects overall population level 
education to stop smoking.  
Except for peroneal nerve conduction velocity, with a statistically significant 
but clinically trivial decline (-0.9 m/s, P = 0.03), the remaining established 
neuropathy measures remained unchanged or improved slightly from 
baseline to the final visit. However, LMM5 showed that changes in peroneal 
nerve conduction velocity in DPN+ve and DPN-ve patients did not differ 
significantly from controls, indicating a similar effect of time for groups 
(Figure  7-4). The low rate of change over time in these measures can 
possibly be attributed to (a) the maintenance of a healthy lifestyle and 
compliance with medical advice among our diabetic cohort; (b) the inclusion 
of participants with only mild neuropathy; and (c) the relatively short duration 
of study. Negligible worsening or no progression of the traditional measures 
of DPN has also been observed in the placebo arm of a recent interventional 
study (Ziegler, et al., 2011) of 227 patients with predominantly type 2 
diabetes, but with substantially worse glycaemic control at baseline (8.8 + 
1.9%) and a reduction of 0.67 + 1.41% over 4 years. Our findings are further 
supported by a 3 year longitudinal study of 62 subjects with predominantly 
type 2 diabetes and good glycaemic control (HbA1c 7.23 + 1.03%), which 
interestingly demonstrated stability in a range of neurological examinations, 
symptom scores, autonomic testing, QST and nerve conduction studies with 
worsening only in the sural nerve amplitude and the axon-reflex vasodilation 
test, a measure of small fibre neuropathy (Gibbons, et al., 2013). 
All three SNP parameters were significantly reduced in diabetic participants 
without and with neuropathy at the baseline visit. This finding is consistent 
with other studies, which also show a depletion of SNP tissue in diabetic 
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patients without and with DPN, reflecting early subclinical small fibre damage 
(Ahmed, et al., 2012; Petropoulos, et al., 2013a; Petropoulos, et al., 2014; 
Tavakoli, et al., 2010b). Based on the reported association of SNP 
parameters and DPN severity (Petropoulos, et al., 2013a; Tavakoli, et al., 
2010b), we hypothesised that participants with diabetes and DPN would 
demonstrate quicker deterioration of SNP tissue than those without DPN. In 
order to examine this hypothesis, we built several linear mixed models. Such 
models afford robust methods of analysing longitudinal data with repeated 
measurements, in particular when the data is incomplete or unbalanced due 
to missing data, dropouts or differences in observation time points (Shek & 
Ma, 2011). 
According to the three basic mixed models developed here (Table  7-3) and 
regardless of group, there was no significant effect of time for any of the 
three SNP parameters. A group*time interaction term was not significant for 
CNBD or CNFL (P = 0.24 and P = 0.20), indicating that the presence or 
absence of DPN at baseline did not appear to impact CNBD and CNFL 
changes over time. Mean CNBD (23.7 ± 20.9 vs. 22.7 ± 16.9, no/mm2) and 
CNFL (15.0 ± 4.3 vs. 14.4 ± 4.1 mm/mm2) declined slightly over 4 years in 
the neuropathy group, but to an extent that is neither clinically nor statistically 
significant.  
However, the Type III F test for the interaction between time and group was 
statistically significant for CNFD (P = 0.02), suggesting that the relationship 
of time with CNFD change varies depending on the group. LMM4 (Table  7-4) 
demonstrated that whilst CNFD trajectories were not statistically different 
between DPN-ve and controls, the mean CNFD decreased significantly in the 
DPN+ve group during follow up, with a loss of approximately 1 nerve/mm2 
per year. This observed CNFD change was best predicted by participant age 
and duration of diabetes (both P < 0.05). One may anticipate that such a 
change would be influenced by glycaemic control, however, HbA1c did not 
reach statistical significance (P = 0.10) in LMM4, where CNFD was 
considered as a dependent variable, possibly because of the relative stability 
of this factor during the study period. Although the outcome of CNFD decline 
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indicates dynamic structural small nerve fibre damage at the SNP, the 
relevance of CNFD change in the neuropathy group and the relative stability 
of CNBD and CNFL are not clear. Disparate changes to these three corneal 
nerve parameters have also been reported in diabetic individuals after 
improvement in risk factors for DPN (Tavakoli, et al., 2011b) and after 
simultaneous pancreas and kidney transplantation (Mehra, et al., 2007), 
suggesting a complex, dynamic and perhaps non-linear relationship between 
these parameters. 
The baseline cross-sectional findings in the present study (Table  7-2) 
confirmed that all the three parameters were reduced in the neuropathy 
group compared to controls. The parameter that underwent the most marked 
reduction over time was CNFD. This suggests that branch damage (thinner 
branches emanating from major nerves) might represent the primary 
pathological change in DPN, whereas CNFD (a parameter related to the 
major nerve trunks) deterioration occurs later. The reduction in CNFD along 
with a non-significant decline of the other two parameters may also suggest 
degeneration of major nerve trunks with concomitant regeneration reflected 
by an increase in the CNBD and CNFL. Therefore, it is conceivable that loss 
and indeed repair of different SNP parameters may occur at different stages 
of the disease.  
Limited studies are available documenting the link between corneal small 
nerve fiber change and risk factors of DPN (Edwards, et al., 2012b; Ishibashi, 
et al., 2012; Tavakoli, et al., 2011b). In the present study, when the data were 
restricted to include only diabetic individuals and upon removal of the effect 
of group in the linear mixed models, we found that every one-unit increase of 
HbA1c was associated with a decrease of approximately 0.6 nerve/mm2 in 
CNFD. There also was a negative effect of diabetes duration on CNFD and 
CNBD. Each 10-year increase of diabetes duration at baseline resulted in 0.8 
and 2.0 nerve/mm2 decline of central corneal CNFD and CNBD, respectively. 
CNBD was also significantly affected by smoking. Increasing one cigarette 
per day had a negative effect of 0.25 nerve/mm2.  
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These results demonstrate the link between risk factors of DPN and 
morphologic parameters of corneal nerves. We have no clear explanation 
why HbA1c has an effect on CNFD, but not CNBD and CNFL.  Nevertheless, 
this finding is consistent with the study of Tavakoli et al. (2011b) who 
reported a significant correlation between changes in HbA1c and CNFD (r = -
0.52, P < 0.01) but not for CNBD and CNFL. In a study of 38 type 1 diabetic 
patients with and without neuropathy, Ishibashi et al. (2012) reported time-
dependent effects of HbA1c on SNP parameters. While nerve beading 
frequency was positively correlated to the mean HbA1c levels at time of, or up 
to three months prior to CCM examination, no significant association was 
found between CNFD and CNFL with HbA1c up to 6 years before CCM 
examination. 
These findings emphasise the importance of including different SNP 
parameters in future studies where these parameters are to be used as 
measures of small nerve fibre damage and in particular repair. Additionally, in 
this study, only the central cornea has been investigated. Recent studies 
have revealed that loss of corneal neve structure in the SNP mainly occurred 
at the inferior whorl, which is slightly more distal than the central cornea and 
may therefore be expected to show more marked pathology (Davidson, et al., 
2014; Edwards, et al., 2012a). Further longitudinal work assessing the 
inferior whorl as opposed to the central cornea may provide additional 
insights and ability to discriminate change in relation to DPN. 
In previous cross-sectional studies, SNP parameters have been shown to 
correlate with functional and structural measures of neuropathy (Quattrini, et 
al., 2007; Sivaskandarajah, et al., 2013; Tavakoli, et al., 2010b). Quattrini et 
al. (2007) reported a significant correlation between CNFD versus NDS (r = -
0.30, P = 0.03) and cold sensation threshold (r = -0.40, P < 0.01). In a 
subsequent study, moderate correlations were found between NDS and 
corneal nerve parameters (r; -0.48 to -0.58; P < 0.001) (Tavakoli, et al., 
2010b). In a recent study by Sivaskandarajah et al. (2013), CNFD, CNBD 
and CNFL were related to cold sensation threshold (r;  0.32 to 0.37; P ≤ 
0.01). In this longitudinal study, we examined the relationship of change in 
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corneal nerve parameter with conventional measures of neuropathy by 
calculating the absolute change from baseline to final visit for participants 
with diabetes. We found a modest correlation between CNBD and peroneal 
conduction velocity (Pearson r = 0.23, P = 0.02). When the data were 
restricted to the DPN+ve group, this correlation increased to 0.38. 
Furthermore, CNFL also correlated to cold sensation threshold (r = 0.40, P = 
0.03), which indicates that SNP parameters do change in a fashion 
comparable with some traditional measures of neuropathy. 
The key strengths of this study are its longitudinal nature, inclusion of a range 
of traditional neuropathy measures (small and large nerve fibre dysfunction) 
in a relatively large number of type 1 diabetic participants, the consistency 
and strict adherence to technical and methodological procedures such as 
capturing and selection criteria of the SNP images, and employing a fully-
automated image analysis algorithm, which is essential to eliminate 
shortcoming associated with manual and semi-automated analysis. Thus, we 
used a fully automated image analysis algorithm which has been validated 
and compared against the manual and semi-automated analysis (Dabbah, et 
al., 2011; Dehghani, et al., 2014; Petropoulos, et al., 2014) in individuals with 
diabetes. 
In this study, a multimodal approach (the Toronto criteria) has been used for 
the case definition of DPN and comprises nerve electrophysiology and 
clinical signs and/or symptoms of neuropathy. Given the availability of 
different definitions for DPN, one may argue whether using the Toronto 
criteria is the appropriate approach for the utility of corneal neve morphology 
in diabetes. It is known from previous studies that due to high variability and 
poor reproducibility of signs and symptoms of neuropathy, their application in 
clinical research is limited if they are to be used alone (Malik, 2014b). Hence, 
the published consensus definitions for clinical research of DPN such as the 
San Antonio criteria (American Diabetes Association & American Academy of 
Neurology, 1988), the American Academy of Neurology, American 
Association of Electrodiagnostic Medicine and American Academy of 
Physical Medicine and Rehabilitation guidelines (England et al., 2005) and 
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the Toronto Diabetic Neuropathy Expert Group (Tesfaye, et al., 2010) 
recommended inclusion of signs and/or symptoms of neuropathy and nerve 
conduction studies. 
The notion of including nerve electrophysiology for case definition of DPN in 
relation to the utility of CCM has been confirmed by Halperm et al. (2013). 
They studied the effect of different definitions of DPN on the validity of 
corneal nerve structure (CNFL) in type 1 diabetic participants and found that 
definitions that included electrophysiology had a better performance while 
including clinical criteria alone resulted in a substantially lower performance 
of detection capability of corneal nerve morphology. 
A limitation of this study is that a majority of type 1 participants were enrolled 
from specialized clinics, where the glycaemic and cardiovascular factors 
were optimally controlled, which may not represent the typical population with 
type 1 diabetes. Additionally, four years of study might be insufficient to 
discern changes over time, particularly in the case of patients with mild 
neuropathy or the limited number of apparently motivated participants with 
well-controlled diabetes available in the neuropathy group.  
In conclusion, the findings presented herein provide evidence that CCM has 
the potential to track the structural alterations of the small nerve fibres in 
DPN. Furthermore, these findings support the notion that quantification of the 
SNP morphology has a substantial potential to be employed as an 
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CHAPTER 8. SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
In this chapter the main findings and novel contributions of the research 
study presented throughout this thesis are summarized. Recommendations 
for further research in this field are also highlighted for possible future 
studies. 
8.1 Summary of the research project  
In cross-sectional studies, morphology of corneal subbasal nerve plexus 
(SNP) has been suggested as a potential marker for diabetic peripheral 
neuropathy (DPN), which is a debilitating and prevalent complication of 
diabetes and currently has no effective therapy. This research project sought 
to examine the longitudinal aspects of the suitability of the SNP structure in 
the context of DPN.  
Application of CCM in this longitudinal study required employment of a fully-
automated quantification system of SNP parameters to reduce or eliminate 
the limitations that are associated with manual and semi-automated 
techniques. The objective of the first experiment presented in Chapter 3 was 
to compare a fully-automated technique (ACCMetrics) (Dabbah, et al., 2011) 
with manual (CCMetrics) (Dabbah, et al., 2009) and semi-automated 
(NeuronJ) (Meijering, 2010) methods regarding agreement, association and 
detection capability in a cohort of healthy participants and diabetic individuals 
without and with DPN using Bland-Altman method (Bland & Altman, 1986) 
and intraclass correlation coefficients (ICC). An important finding of this study 
was that the fully-automated technique could compute CNFL values which 
were in close agreement with manual and semi-automated methods. 
Furthermore, the three techniques examined in this study were able to 
diagnose diabetic participants with DPN from controls.  Therefore, due to its 
speed, objectivity, and consistency, the fully-automated algorithm was 
chosen for analysis of CCM images in this longitudinal project.  
While addressing the issues of repeatability - within and between observers - 
is an essential element of any scientific research, this is of more importance 
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when longitudinal studies with repeated measurements are conducted in 
order to track changes over time. The purpose of the second experiment 
presented in Chapter 4 was to examine the intra- and interobserver 
repeatability of three main SNP parameters namely – CNFD, CNBD and 
CNFL using statistical procedures including Bland-Altman method, ICC and 
coefficient of repeatability. The findings of this study showed that CNFL was 
the most repeatable and reliable parameters followed by CNFD, whereas 
CNBD achieved only an acceptable level of repeatability. 
Given the cross-sectional reports of the utility of the SNP structure as a 
potential novel marker of DPN, there was uncertainty as to whether age 
influences this rich nerve plexus. To appreciate the real age effect and also 
to examine the time course of SNP morphology in healthy individuals, the 
experiment presented in Chapter 6 was conducted. An established image 
sampling protocol (Vagenas, et al., 2012) was implemented and all images 
were analysed by fully-automated algorithm to quantify CNFL. To assess the 
relationship between age and CNFL and the time-course of CNFL over three 
years, two linear mixed models were fitted using SPSS statistical software. 
Although the SNP morphometric parameters showed a stable course over a 
3-year period in healthy individuals, there was a slight linear reduction in 
CNFL with age (linear decrease of 0.05 mm/mm2 per one year increase in 
age). This finding clearly confirmed the age effect on SNP morphology, but 
not to an extent reported by some cross-sectional studies. Indeed CNFL, 
which is perhaps the most important structural parameter, only declined by 
0.23% per year and it would take 20 years for a clinically insignificant decline 
of 1 mm/mm2 to be observed in CNFL. This is an important attribute for 
corneal nerve structure if it is to be considered as measure of DPN. 
In the last experiment, presented in Chapter 7, the longitudinal application of 
CCM in combination with automated image analysis was moved towards in 
the context of DPN assessment. The purpose of this study was to assess the 
natural history of SNP structural parameters in diabetic participants without 
and with mild neuropathy over four years and to compare their trajectories to 
non-diabetic/non-neuropathic controls. Additionally, the longitudinal 
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relationship between established measures of neuropathy with SNP 
parameters was also studied. While there was no clinically significant change 
to health and metabolic parameters and neuropathy measures in diabetic 
participants during study period, there was an evidence of dynamic small 
fibre damage at the SNP in the neuropathy group which was revealed by a 
significant linear decline of CNFD (decrease rate of approximately 1 
nerve/mm2 per year). The observed decline was associated with age and 
duration of diabetes of the participants. The findings also demonstrated that 
the SNP parameters did change in a fashion comparable with some 
traditional measures.   
The findings of the studies presented in chapters 6-7 demonstrated that there 
was a difference between age-related and DPN-related changes in corneal 
nerve morphology. CNFL was the only SNP structural parameter influenced 
by age while CNFD and CNBD were not affected in healthy individuals. On 
the other hand, CNFD was the parameter that underwent the most marked 
decline over time in DPN+ve group. The former implies that age-dependent 
alterations of the SNP mainly occur at short interconnecting links while the 
latter indicates that major nerves are the primary target in the process of 
DPN. Hence, it is plausible to assume that there is a distinct difference 
between physiological and pathophysiological features of nerve damage 
associated with normal aging process versus diabetic neuropathy in the SNP. 
Once again, those findings highlight the importance of including the three key 
SNP parameters in CCM investigations.  
8.2 Contribution to new knowledge 
The works embodied in this thesis, which comprised of three publications and 
two linking chapters add to the current knowledge regarding application of in 
vivo corneal confocal microscopy and the appropriateness of the SNP 
morphology as potential measure of DPN. The major contributions of this 
project include:  
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• confirming the suitability of CCM combined with a fully-automated 
algorithm in terms of quantification of structural parameters, detection 
capacity and the repeatability of procedure at operator level; 
• establishing the true age effect on corneal nerve morphology and the 
stability of this nerve plexus in healthy state, which not only confirmed the 
suitability of corneal nerve morphology as a potential measure for DPN, it 
has implication in respect to appreciation of the effect of pathology and 
surgical or treatment modalities on the morphology of the SNP, and 
• providing evidence that CCM has the potential to track the structural 
alterations of the small nerve fibres in DPN, which has a major contribution 
to support the notion that quantification of the SNP morphology has a 
substantial potential to be employed as an appropriate adjunct measure to 
conventional measures of DPN.    
8.2 Recommendations for future research 
The work presented in this thesis is the first study that has employed CCM in 
a natural history study of SNP microstructures in relation to DPN. Although 
this project, in general, provides additional evidence with respect to the 
suitability and capacity of CCM as a small fibre structural measure of DPN, 
more research is required to establish this technique as a marker of DPN and 
to emerge as a clinical tool. This section provides some recommendations on 
how the outcomes of this study may enhance future research. 
Accurate and reliable automated segmentation of the images obtained from 
CCM is still in the early stages and needs more attention. For example, while 
the fully-automated image analysis software reported here has been 
validated for the quantification of SNP parameters, the underestimation of 
morphometric measures compared to manual method may limit the efficacy 
of this technique to detect early changes in respect to DPN. Therefore, future 
efforts should concentrate on eliminating or alleviating such shortcomings.   
These longitudinal outcomes that have been reported here are limited to 
nerve changes in the central cornea and may not be applicable to other more 
peripheral regions of the human SNP. Recent studies have shown that loss 
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of corneal neve structure in the SNP mainly occurred at the inferior whorl 
(Davidson, et al., 2014; Edwards, et al., 2012a) which may enhance the utility 
of CCM in relation to DPN. This area is located 1 to 2 mm inferior to the 
corneal apex and is slightly more distal than the central cornea. Therefore 
this region may be an appropriate region for future longitudinal studies to 
investigate more marked pathology and early nerve damage or repair.  
The low rate of change in established measures of neuropathy over time, as 
experienced in this study, may be avoided by selecting diabetic patients with 
varying degrees of neuropathy severity and recruiting them in a fashion 
which best presents the typical population with diabetes. Additionally, 
considering the availability of the proper diabetic care, longer study duration 
is required to discern changes over time.  
Nevertheless, it is hoped that the present work will serve as a basis for 
developing further efforts to employ CCM as a surrogate endpoint for DPN, 
perhaps to extend the utility of this technique to clinical trials and to find an 
effective treatment for DPN which is the main factor predisposing diabetic 
patients to ulceration and subsequently to amputation. Therefore, due to the 
practicalities of CCM, it is time to move forward and employ this valuable 
alternative to conventional measures of small nerve fibres in clinical trials of 
DPN to assess the therapeutic efficacy of new drugs or treatments. 
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